>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 1; Drug: Control
bsbRjRsmbLibLcbLcbLcbLobLcbRobRsLsbRgbLsbLjLsmbLobRcbsbLsbRsbRjbLcbLiR
sbLcLsLsmmbLcRsbLgbLsbRcRsLsmbRiLsbLjbLcRsbLobsbRibsbRcbLobRebLhbRsbRc
RsRsmmbLsbLcbLoRsbRobsbLobLgbsbLsbLsbLsbRhLsbRibLsbRoLsbRgbLsbRiLsbLsR
ibLcbLobLcRsbLgbLgLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 2; Drug: Control
bLhbsbLibsbRibRgbRibLcbRcbRgbLobLiLsbLebLobRoLsbLibLcbLobRebLcbRsbRsbL
gbLgbRgbLiRsbRibRsRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 3; Drug: Control
bsbLibLgbLsbLsbRsbLhRsbLibLsbLgbLgbLcbLgbLgLsbsbLgbLcbLjLgbLcLsmbLgbLc
bsbLcbLcbLcLsmbLcLsmbLcRsbLcbsbRsbLcbsbLobLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 4; Drug: Control
bsbsbLobRobsbRobsbLsbsbRgbsbsbsbLoLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 5; Drug: Control
bLibLgLsbLsbLhbLsbLsbLsbLsbsbLsLsmbRsbLsbLsbLsLsmbLgbLgbLsbLgbLgbLsRsb
RsLsLsmbLsbLsbLsLsmbLgbLsbsbLsbLgbLibLibLsRsbLgbLsbRsbLsbLsbLsbRsbLibL
gbLibLsbLsbLsLsmbLibLgbLibLibRsbLsbRcbRcbsbLcbLhbLgbLibRsbRgbLgbLsbLgb
LgbLgbLgbsbLjbLibLgbLjRsLsbLsbRsbRgbRgbsbRebRjbLobLibRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 6; Drug: Control
bRsbsbRcbRgbRgbRibRgbRsbRsbRgRsmbRgbLibLibLgbLcbLibLiRsRsmbLiLsbLgbLib
RsbLibLibLibRsbLhbLibLgbLgbLgbRibLjbLgLsbLgbLjbRcbRsRsRsmmbRibRsbRibLs
bLibLibLibRibLsbLgLsbRsbRoRsmbLibRgRsRsmmbRgbRgbsbsbsbLcbLgRsbLibRhbRc
bLsbLgbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bRibLobLhbLobRcbRcLsbsbLcbsbRcbRcbLhbRgbLibRibLgbLjbRcbLsbLcbRhbRhbLcb
sbRhbLhbLsbLobRcbRcbLjbLcbLcLsmbRjbLhbRsbLiLsRsbLibRibRsbLibLibRsbLibL
iLsbsbLgbLgLsbsbsbRhbRhbRobRoLsRsbLibRibLibLibRhbLcRsbLhbRibLsLsmbLibL
ibRibsbRcbLhLsbLhbsbLibLsbLgbLcbLcbRiRsmbLjbsbLcbLsbsbLhbLjLsmbLsbLjLs
LsmmbLhLsbRcbLcbLibsbRoRsRsmmbRhbLibRib

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bLsbLibLsbLsbRsLsbLgLsbLgbRsbLgbLsLsmbLsLsmbLgbRsbLsbLjbRjbRhLsbRiLsbL
cLsmbRsbLsbLgbLgbLgRsbLgbRsbLgLsbLsbLsbLsLsmbLsbLsbLsbLgbLobRibLibLsbL
cLsmbLcbRgbLcbRgbRjbRhbLjbRiLsbRsbRgbLcbLobLsbLgbLgbLcLsmbLibLsbLoLsmb
RgbRsRsmbLibLibLgbRsbLibRgRsmbLcbLiLsbRgbRsRsmbsbLcbLgbLsRsLsbLgLsbLsb
LiLsbLsbLsbLsbLgbLcbLcbRibRiRsmbLcRsbRsbRgLsbRsbRebLhbLibRebLobLsLsmbL
cbRobRibLjbRobRjbRebLsbLgbLsbLgbLibRsbLcbRsbLgbLsbLsbLsLsmbLgbLgbLsbLg
bRgbLsbLsbLgbLsbLsbLgLsbRsbLsbLcbRjbRebLibRobsbLibLebLcbRgbLjbRibLsbLs
bLiLsbLsbLsbLgLsbRsbLcbLibRsbLgbLsbRsLsbLobRsbRgbLibLsLsmbLsbLsbLsbLsb
LibLjbRsbLibRibLcbRjbLsbLobRsbsbLcbRsbLcbRsbLjbLcbRjbLsbRsbRsbLsbLibLc
RsbLgbLgLsbRgbRsbRobLjbRhbRibLjbRcbLgbRhbRebLsbLsbLgbRjbLhbLibRsRsmbLi
LsbLgbLsbLsbLibsbLiLsbRhbLhbLgbRibRibLsbLsbRibLjbRhbRibRjbLiRsbLgbLibL
sbRgbRsbLsbLgbLibRsbLiLsbRjbLibRsbLsbLgbRsbLsbLibLcbLsbLcbRibLcbLcbRhb
LcbRjbLcRsbLibRgbLsbLsbLiLsbRsbLgbLsLsmbLgbLgLsbLsbLgLsbLgLsbLgbLgbLsb
sbLcbRibRsbLcbLcLsmbRjbLibLiLsbLsbRgbLiLsbLobLibLibRjbLhbRibLobLibRsLs
LsRsmbRsbLibLsbLibLgbRgbRcbLibLgLsbLsbLgbLsbLsLsmbLsLsLsmmbLsLsmbLsbLs
bLsbLibLgbLibRibRcbLgbRgLsbRcbLcbLgbLhbRgbLibLjLsLsmmbLcbRsbLgbRgbLgbR
ibLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bRiRsmbRibLiRsbLjbRjbRiRsmbLobRjRibRsbRgRsmbRgbRhbRjbRibRgbRgbRibLibRi
bRgbLibRibRsbRgbLibRgbRibLobRhRsmbLibRcbLebLibRibLibLibRjbRjRibRibRsbR
gbRsRsmbRgbRgbLibRibRibLsbRibLgbRgbRibRibLjLsmbRibLjbLcbRjbLibLsbLgbLs
bLgbRobLcbLcLsmbRibLgbLibRsbRgLsbRebRibsbRibLibRcbLibRibRgbLibLcbRebRo
bRobLcbRcbLhbRgbRsbRcbLobRcbLcbRjbLoLsmbRibLibLgbRobLcbLcLsmbLibRsbLib
LsLsmbLibRsbRsRsmbLibLgbLoLsmbLibRobLcbRcRsmbLcLsmbLsbLibsbRcbLobRgbLi
bRsbRebsbLjbRcbRhbLcbRcbLcbRobRgbLoLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bLsbLsbRsRsmbsbLgbRgbRsbsbLiLsbLgbLgbLsLsLsmmbRsbsbsbLgbLibRsLsbLibLib
LjLsLsmmbLsbsbRcbLibLibLhbsbsbLjLgbsbLibLgbsbLibLibLjLsLsmmbLhbLibRcbR
ibsbRjRsRsmmbRibRgbRibRjRgbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bRgbLibLgLsbRibLgbRibRibLcLsmbRcbLhbRibLhbLhbLjbLibRibLhRsbLiLsbLibLiL
sbRiRsmbRjbLiLsbRjbRibLsbLsbRibLgbRibLgbRibLsbRgLsbLsbRgbLsbRgbRibRibR
sbLsbLsbRsbRibLiLsbRhLsbRibLgbRiLsbLsbRgbLsbsbRsRsmbRgbRibLsbRgbLsbRgb
LsLsmbRibRibLibLiLsbRgbRibsbRgbsbRjbRiLsRsbLgbRgRsmbLgbsbRibLjbLobRcbR
cbRibLhbLsbRsbRibRibLgbRiLsbLgLsbRibLgbRibLsLsmbRsbRgRsLsmbRibRgbRgbLg
bRgbLsbRibRgbLgLsLsmbLsbRibRibRgbLiLsbRibLsbRsbLsbRgbRibRsRsmbLsbRgRsm
bLsbRiLsbLgbRsRsmbRgbLsbLibLibRebLjbLcbRibsbLsRsbLibLibLgbLgLsbLgbLgbR
eLsbLjLsmbLhbRgbLibLgbRsbRgbLibLsbLsbRsbLgbLsLsLsmmbLsbLgLsbRsLsbLsbLg
bLgbRsbRsbRgbLibLsbLsbLgbLgRsbLsbLgbLgbLsbLsbLsbLsbLgbLgbLgbRsbRsbLibR
sbLgRsbLsbLgbRsbLsbLsbLsLsmbLsLsmbLgbRgLsbLibLgbLgbRsbRgbLiLsbRgbLibLg
bLgbLgbLgbLgbLgbLsbLgLsbLhbLsbLsbLiLsbLgLsbLgbRibRsbRsbLsbLibLiRsbRibL
ibLibRibLgbLibLibRibLibLsLsmbLgbLgbRcbLjbLibRgLsbLibRsLsbLsLsmbLgbLgbR
sbLebLebLcbLgbLsbLgbLgbLsLsLsmmbLsLsmbLsbLgLsbLsRsbLgLsbLsRsbLgLsbLgbL
sbLsLsmbRgbLgLsbLibLibRsbLsLsmbLgbLcbRcbLsbLgbRsbLibRgbLgbLgLsbLsbLgbL
gbLibsbLibRcbLibRjbRhbLiLsbLibRjbLibRgbLibRjbLibLgbLiRsbRhbRsbLjLsLsLs
mmmbLgLsbLgbLibLsbRibLgbLibRcRsmbLoLsmbLibRcbRobLjbLcbLcbRebLhbRcbLcbR
cbLibRibLgbLibRjbLiLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bRibLgbRibRibLjbRiLsbLsbRiRsmbRiRsRimbRcbRsbRgbLiRsbRsbLibRjbRibRsbRgb
LsbLibRibLjbRibRibRibRibLibRhbRgbLcbRcbLjbRibRibRsbRibLcbLibRibRibLjbR
iRsmbLjbsbLobLhbRibRgbLibLgbLgLsbRgbLibRsbLgbRgbRjbRibLjbRhbRibLibRibL
jLsmbRgbLsbLibRibRibLibRibLgbRsbRgbLsbRgbsbRgbLgbRiRsmbLgbRibLsbRibLcb
LoRsbLsbRjbRcbsbRcbLibRiRsmbLjbRibRhbLgbRibLgbRibRibLibRobRcbLcbLobRcb
RcbRoRsmbRcbRobLibRobLibRobRcbRcbLcLsmbRibLobRibLsbLsRsbRcbRcbRcbsbLcb
RcbLibRcbLibRcbLcbRcRsmbLcbRobLiLsbRjbLibLcLsmbRjbRcbLcbRobLobRobRcbRi
bRhbRobRhbLoLsmbLcLsmbLsbRcbLcbLibRsbRgbRibRhbLcbRobRhbRcRsRsmmbLobLcb
RcbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbRgbLcbLibRgbLibLibLgbRsbLcbRsbLcLsmbRsbRgRsmbLgbRsbRgbLgbRgbRsbRgb
RsRsRsmmbRgbLsRsbRsRgRsmbLsbRiRsmbLgRsbLibLsRsbLibsbRjbLcbRibRgbLsbLsb
LibLgbRgbLibLgbRgbLgbLgbRsbLgRgLsbsbsbRsbLgbRsbLiRsbLgbLsbLgbLgbRjbLib
RgbLiLsbLgbRsbRgLsbLgbLgbLgbRsbLsbLgbLsRsbLgbRsbLibRgbLcRsbLsbLibRibRg
bLibRsbLibRgbLibLgLsbRsbLgLsRsbRgbLgbRsbLibLgbRgbLgbRsLsbLsbLibRgbsbLg
LsbRsLsRsbLhRiRsLsmbRibRsbRgRsmbLsbRgbsbRgbLsbRgbLsbsbRgbRsbRgbLsbRsbR
ibLjbLibLgbLcbRibRgbRgRsmbRibLgbRiRsmbLsbRgbRsbRgbLgLsRsbLhbLibRibRcLs
LsmbLhLsbRcbsbRcLsbRibLsbRcbLsbLgbRibRgbRsbRgbRibRgbRsLsbLjbRgbRgbRgbL
ibLibsbRgbLcLsmbRibLhbLgbRgLsbLibRjbRsbLhLsbRjbLsbRjbLcbRjbLibLgLsbLsb
LhbRsbRgbRibLhbLiLsLsmbRsbLibRsbLcbsbRibLibLgbRgRsmbLibRgbLibRgbLgbRsL
sbRobRcbsbRiRsmbLibRgbRibRibLsbRsbRgbLsbLjbLiLsbRcbRibLcbRebRhbLjbLibL
gbRsbLcbLgbRibRgbLibLibLgbLgbRjbLibRgbLibLsbLibRgbLibLiRsRsmbRsbLibRgb
RgbRibRsbRibLsbsbRhbRcbRhbRsRsmbRsbRibRgbLcbLhbRgbRgRsmbRsbRibRibLjbLc
bRibRsbRiRsmbLsbRgbLsbLcLsmbRobLebLiRsbLgbRgbLsbLgbLsRsbLgbRgbLgbRsbLs
bLgbRgbLgbLsbLgbRsbLgbLibLibRgbRsbRgbRoLsbRcbRsRsmbRsbRgbRgbRgbLjLsmbL
ibRjRsmbRsRibLsbRibLjbRgbRgbRsRsmbLsbRgbRsbRgLsbRsbRgbRgbRgbLibRsbRibL
sbRiRsmbLsbLobLobRcbRibLjbRcbRsbRibRsbLsbRgbRgRsmbLsbRgbRgRsmbRsLsRsbR
gbLsbRgRsmbLsbRgRsmbRgLsbRgbLgbRhbLgbRibRgbLgbRgbRgbRsbRibLsbRgbRgRsmb
LsRsbRgbLsbRgbRgbRgbRgbLibRgbRgbRgbLsbLsRsRiRsmbRsbRgRsmbLsbRgbRsbRgbR
hbRcbRhbLibLibRibRsRsmbRobLcbLhLsLsmbRgbRjbLibLgbRcLsbLebLibRibLibLgbR
gRsmbLsbLibLibRgbLgLsbRsbsbLgLsRsRsmbLgbRcbRcbsbRcbLcbRjbRcRsmbLcLsmbL
ibRcbLcbLcbRebRjbRiRsmbRcbLeLsbLibRcbLcbRcbRibLsbRibLsLsmbLcbLoLsmbLsL
sRsmbRsbRcbLcbLibsbLcbLibRiRsLsmbRgbRibLsbRibLcbReLsbLebLsbRjbRibRsbRg
bRgbRsRsmbRgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbRibLjbRibLsbRibRobRibRgbLcLsmbRsLgbLibRgbLiLsbRsbRjbLcbRsbLibRgbLg
RsbLibRjbRoLsbLjbRibLhbRobRgbLibLcbRsbLibRsbRcbLjbLcbLibRobRgbLobLcbLo
bRhbLobLibLibRgbRobLjbRibRobsbLiLsbRsbRibLobRibRiRsmbLjbLobRibRgbLibLg
bRgbRcbRibRgbLsLsRsmbRibRoRsmbRsbLsbLhRsbRgbRobLibRibRgbLsbRiRsRsmmbRg
bLsbRgbLsbRgRsmbLsbRgRsRsmmbRibLgbRgbRobRhbLsbRsbRoRsRsmmbLgbRhbRibRsb
LsbRgRsmbLcbRcbRobRcLsbRhbLhLsbLsbLgbRgbRgbRsbRibLsbLsbRobLibLibLsbLib
RsbLibRsbLibLibLobRibLgLsbLibRibRibsbLjbRhbLsbLcbLoRsbRiRsmbRjbLoLsmbR
ibLhbRjbLhbRgbLoLsmbLsbLhbRibLsbLsbLibLibLsRgbLiLsbRsbLibRsbRsbLibLhbR
ibLeLsbLobRibRgbLiRsbRgbLsbLsbLhbLiLsbLsbLibRgbLiLsbLhLsbRibLcbRgbLibR
gbLgbLibLsbLgbRjbLiLsbRgbLibLiLsbRsbLgbRgbLibLsbRjbLibRgbLibRjbLibRjbL
ibRjbRjbRibLsLsmbRgbLcbRiRsmbRgbRhbLcbLcbLcbRgbRgbRibRgbRsbRgRsmbLgbRi
RsmbLsbRhbLebRobRiRsmbRgbRsbRibRsbRcbLoRsbLobRibRgbRjbsbLobRjbRobRibLg
LsbRibRgbLcbRsbRgbLibLobsbRibLsbLgbLibRibRsbRjbRibRgRsmbsbRiRsmbRobRcb
LgbLsbRoLsbRibRibRgRsmbsbLibRgbRibLibLcbRcbLobRibRjbRibRcbRcbLhbRcbRcb
RgbLibLibRgbRobLhbRhbLgbRibRsbLgbRibRsbLsLsmbRiLsbRibLcbRcbRsbLibsbLob
RjbRcbLibRcbLjbRcRsmbRibRhbRibLibRibLebLcRsbRibLgbLcbRhbRsbLobLsbRgbLc
bRcbsbLcbReb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbRcbLiLsbRibLsbLibLcbsbLibRgbRsbLjLsmbLgbLgLsbLsbLsRsbLgLsbRgbLibRs
bLgbLgbRgbLgLsbRsbRgbLibLgbLgbLgRsbLgbRgbRsRsmbLibLgLsbLgbLgRsbLsLsmbL
gbLibRsbLibRsLsbLiRsbRgbLgbLgLsbLgLsRsbLgbRsbLsbLibLgbLsbLgbRsbLgbLibL
gbRsbRsbLsbLibRsbLsbLgbLgbRjbRcbLjbRobRsbLsbLibLibLhbRsRsmbsbLgbRgbLib
LibLibLiRsbRsRsmbLgbLgLsbLibLhbLibLibLgbLibLibLgbLibRgbLibRsbLgLsbLgbR
gbLibLgbRsbLgbLgbLgbRgbLgbLibRgbLibRsbLgbLsbLgLsbRgbLgbLgbRgbLibLsLsmb
LgbRcRsmbLiLsbRcbLsRsbRhbRsbRobsbRibLsRsbLobRsLsbRsbLibLgbLgRsbRibLibL
cbLgbRsbRgRsRsmmbRsbLsbLebLcbLhbRibRiRsmbRibLcbLibRgbLhbRsbLsbRibLhbRi
bLobLgbLgbRsbLhbRibLobLgbRibRcbRsbRibRgbRsbLsbLsbLgbRcbLibRcRsLsmbLsbL
ibRcbRobRibLsbLgbRhbLjbLibLsbLhbLgLsbRiRsmbLsbRsRsmbRsbLibLibRibsbLhbR
cbRoLsbLgbRgbRhbRgRsmbLibLjbRcbLgbRoLgbRsbLgbRoRsmbLibRoRsLsmbRcbLcbRc
bRgbLgbLibLhbRibRoLsbLhbRcbRcbLgbRibRcbLgLsbLibRcbLibRibRhbRibsbLibRiR
smbRsbLgbRobLiRsbRcLsbLibRhbLsLsmbRiLsbRibLibLibRcbRibRibRibLibLibRgRg
bRcbRjRsmbLibRcbLibRibRiLsbLjbLsbRibRibRcLsbLgLsbRcbLjbRcLsbLibRhbLjbR
ibLsbRcbRibLsbLgbLcbRobLcbRcbLhbRobLebLhbLhLsbRcbRibLcbLsbRjbRcbLjbLcb
RgbRibLcbRsbLibLsbRjbLcbLsbRgbLhbRgbLiLsbRsbLibsbLibRsLsbLibRsbLibLiLs
bLibRjbLsbRcbRobsbRibLibRcbLcRsLsbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbLsLsmbLgbRsLsLsmbLgbLsbLgbRsbsbLiRsbLgbsbRgbLgbLgbLsbLsbLgbRgbLcRs
bRsRibLcbRjbLhbLsbsbsbsbLsRsbLsbLgbRjbRjbRjRsmbRsbRibRgbRgbRibRcbLsbLs
bRebRibRjRgbRgbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bLsLsmbLgLgbRsbRebRgbLiLsbLsLsmbLibRibLibRsbLobLcbLhbRjbLjbLjLsmbLcbLs
bLoRsbLgbRgbRgbRgbLjbRibLjbLobRjbLiLsbLibLsLsmbLibLibLsbLgbLgbRsbLiRsb
RsLsbLibRsbRhbRgbLjbLcLsmbRibLgbLibRsbLibLsbLsbLsbLhbRgbLgbRjRsLsmbRcb
RibRcbRiRsmbLibRsbLgbRsbLibLibRgbLgbLsLsmbLgbLgbLgbRgbLibLgbLsbLgLsbLi
bRgbLibRsbRsbLhbRgbLgbRjbRibRobRibLibLgbRgbRgRsmbRibRhbLebRibLsbRibRib
LsbsbLsRcbLjLsmbLcbLibRibRjbRhLsbRobRhLsbLsbLiLsbRgbLobLobLibLsbLibLcb
RebLhbLibLibRibRgbLhbRgbLhbLibRsbRibLobsbRibLiLsbLibLiRsbRibLibRibLiLs
bRcbRcbLibLhbLiRsRsmbRcbLhbRibRhbLibRibRhbLjbLobRjRsmbLcbLjLsmbLgbLibR
ibRjRsmbLcbLgLsbLjLsmbLibRibLjLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbRhbRgbLsbRcbRhbRibLgbRcbLjbLobRjbLiLsbRsbRobLjbLobLcLsmbRebLsbLsbL
obRgbLhbRgbLiLsbLsbLoRsbRgbLoRsbLibRgbLibLgLsbRsbLgbRjbsbLibRgbLibRsbR
gbRebLsbLgbRgbLibRibLcRsbLgLsbLibRsLsbsbLeLsbsbRsbRgbLcbRibRibRsRsmbLg
RsbRgbRibLgbRsbLebLibRjbLibLiRsbLobRjbLgbRhbLcbRibsbRgbLsbRobLibLsbRsR
smbRjbLsbRgbLgbRibLgbRgbRsbRsbRgbLgbRibLgbLhbLsbsbRjbLjbsbRibLsbRgRsmb
RebLsbRjbRsLsbRebRibRgbLgbRjbLibRsRsmbLiLsbLsRsbLcLsRsmbRibRsbRjbLobRg
bRjbRobLsbRobLibRibLibRibRsbLgbRhbsbLgbRibLobLcbRibRibRiRsmbRibLgbLcbR
ibLhbRibLcbRjbLcbRibLibLebRobLibLibRgbLibRebLsbLcbLhbRibRjbLhbRjbRobRo
bLgbRcbRebLgbRebLiLsbLobRiRsmbLoLsmbRcbLjbRcbLjbLibLibRibLibLiLsbLsbRc
bLhbRgbRhRsmbLibLibLibLgbRibRsbLhbLibLibLibLiRsbLgbLgbLibLibRsRsmbLgbL
cRsbLibLib

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bLsLsmbRsbLgbLsbLgLsbRsbRsLgbLgbsbLgbLgbLhbLhbLibLjbLiLsbRsbRjLsbLcLsm
bLibLhbLgbLgLsbRgRsmbRcbRiRsLsmbLjbLjbLgbLibsbRjbRcbRibLibLjbLsRhbRhbL
ibLjbLhbRgbLgLsbLibRsLsbLgbLgLsbRsbLgbLgLsbRsLsbLgbLgbRgbLibRsLsbLgbLg
bRsbLsbLgbRsbRsbLibLsbLibRibRebRcbLibsbLibLgLsbLsRsbRsbsbLibRgRsmbLgbL
gbRgRsmbLibLgbRsbLibsbRgLsbLsbLgLsbLgLsbRgbLsbLibLgLsbRjRsmbsbLhbLgbLi
bLgbLgbRsbLibLgbLgbRsRsmbRsbLsbLiLsbLiLsbLibLgbLsLsmbRsbsbLcbLsbRjbsbR
cbLibLibLsbRgbLgbLgbLibsbLgbRgbLsLsmbLibLibLsbLgbLgbsbsbLcLsmbLgLsbLib
RsbLibRsbRsbsbLgbLgbsbRsbRsbLhbRsbRsRsmbLibLsbsbLgbRsbRgbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bRgbLsbRibLsbRsbRgbRsbLsbRiRsmbRsbRgbRsRsmbRsbRgbRgbRgRsmbRsbRsbRgbRgb
RsbRiRsmbRgbRgbRsbRsbRgbLibRiRsmbRsbRgbLsbRgRsmbLsbRgbLsbRgbRgbRsbRgbR
gRsmbRgbRgRsmbRgbRsbRgRsmbRsRsmbRsbRgbLsbRsRibLibLibRibRsbLcbRibRibLgb
LcbLibLcbRibRgbRgbRgbRgbRsbRgbRsbRgbRgbRsbRgbRibRgbLsbRibRsbsbRiLsbRsb
LgbRgRsmbRsbRgbLsbRsbRgbLjbsbRibRsRsmbLsbRibRgbRsbRgbRsbRgbRsbLsLsmbRi
bsbLgbRibRgbLgbsbRibLgbRhbLibRsLsbRiRsmbRgbsbRgbRgbsbLsbsbsbLsbRgRsmbL
sbRsLsbRgRsRsmmbsbLsbLcbLiLsbLgbRgbLsbLoRsbLibsbRgbRibRsbsbsbsbLcRsLsb
LjbLcbRjbRhbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbLgbLgbLgLsbLiLsLsmbLgbLsLsmbLsLgbLhbLsRsbLsbLgbLibRsbLgLsbLsbLsLsm
bLibLgbLsbRsbLibLgLgbLibLsbRsLsbLsbLibLsbLsbLgbLcbLjbLgbRsbRjbRebRcbLs
bRsbRgbLgbLcbRgbLjbLcbRsbLsbLhLgbRsbRsbLsbLsbLgbLsbRsbsbRsRsmbRsbRgbsb
LsbRgRsmbRgRsmbRebLibLgbRsbRsLsbRsRsmbLsbsbsbsbRibRsbRgbRgbRgbLjbRjbLc
bRsbsbLsLsmbLsRsbLibLgRsbRsLsbRsLsbLsRsbLsbLhbLsLsmbRsbLgLsbLgbRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bRobLcbLobRgbRgbRgRsmbRsbRgbLsbRgbRgbRgbLgbLgbLsbLiLsbLgbRsLhLoRsbLgbR
ibLsbRgbRgbRgbRibRiLsbRibLsbLgbRsbRcbRcbRgLsbLgbRgbRibRsbRgRsmbLgbsbRi
RsmbLsbRgRsmbRgRsmbRgbRibLsLgbRcLsbRcbRhbRibRibRgbRgRsmbLgbRibLsbRgbLs
RsbRgbLsbRgbLsbLsbLgbLsbRsRsmbRgRsmbLsRsbRibRgbLsbRgbRibRibLgbRgbRibRi
bLsbRgbLsbRsLsbRhLsLsmbLgLsbLgbRibRsbRibRgbLgbLsbRibRgRsmbRsbRgbLsbRiL
sbRgbRibRsLsbRsLsbRsbRibRgbRgLsbRibRgbLibRsbLibLgLsbRibRibRibRgRsmbLiL
sbLgbRibLsbLcbRsbLibsbLsbLibLgbLiLsbLgbLgbLibRhbRgRsmbLjbRcbRsbLibLsbL
sbLsbRibRhbLgbLibLsbLiLsbsbRibLiLsbRcRsmbLibRsbRsbLgLsbLsbLibLgbRcbRgb
RsbRsbLiLsbLiLsbRhbsbLibRcbLjbLiLsbRcbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bLgLsLsmbLgLgbsbLsbRgbLsbLjbLsRsbRjbLjLsmbRibLjbRcbRiRsmbLebLsLiLsbReb
LebLeLsbLsbLibLsLgbLgbLsbLgbLgbLiLsbLgRsLsbLgbLgbRgbRjbLhLsbLgbLsLsmbL
gRsbLgbLgbLsbRibRhbRibRgbRgbLjbLhRsbRjbRhbRgbRiLsbRgRsRsmmbLsbRjbRjbLj
bLgbLibLsbsbLibRgbRsbRsbLsbLibLebLjbLcbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bRgbLsLsmbLibLgbLgbRgbLibLsLsmbLsbLgbRsbLgLsbLgLsRsbRsbsbRgLsbRcbLcbLi
bRibRcbRcbRjbLsbLsRsbRsbLibRgbsbRgRsmbLsRsRsmbRsRsRsmmbRsbLsbsbLsbLsLs
mbRgRsmbRsbRsbRibRgbRgbRgbRgbRibRsRsmbRsbRgbLgbRsbLibRsLsbRibRjbRoLsLs
mbsbLibLgbLgbRsbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 25; Drug: Control
bLsbRgbRibLgbLgbLgbRgbRgbRgbRibLibLcbRibLiRsbRsbRibRcbLibLibLgbRcbLjbR
cb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 26; Drug: Control
bRsbLgbRsbLibLiLsbRgbsbsbLiLsbRiRsmbRjRsRsmmbLcbLhbsbRsbRsbsbLsbLsbLib
sbsbsbsbRgbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 27; Drug: Control
bRsRgbLsLsmbRsRsmbLgbRiRsmbLibRsbLjLsmbLhbLjLsmbRiRsmbRibLibLsLgbRsbLi
bLibLibRsbRgRsmbLgbRsbRhbLsbLjLsmbRjRsmbLjbRobLebRcbRcbRibLcRsbLibLjRs
RsmbRiRsmbLibRsbRgbLibLsbRibLiLsbRibLiRsbRebLhbRjLsbRebRsbLsbRobLgbLgR
sbRgbLcbLoLsmbRebLibRsLsbLsLsmbLsbLgbLsbsbRcbLsbLjbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 28; Drug: Control
bsbLgLsLsmbRibLibLgbLsbRjbRibRcbLsbLibRcbRhbRsbLsbLsbRgRsmbRibRgbRibLs
bLgbRibRibRcLsbRsbRsbRsbRsbRsbLjRsbLobRibLsbLoRsbRibLibLsbLsRsbLgbLsbL
ibLgbRsbRjbRibLsbRibLsbLjbRibRgbLsbRibLsbRgRsmbRhbRsbLgbLgbRsbRibRsbRg
bLsbLsbRsbRgRsmbRsbRsbRgRsmbLsRgbRsbRsbRsbRgbLsbLgbRgbRgbRsbLsbRgbLsRs
bRibLibRibRibLsbRgbLsbRibLsbRibLsbRgRsmbLibLsbRgRsmbRgbsbsbLhbRibLgbLo
bLibLcbLcbLibLebRsbLibRsbLgbLsbRcbRcbLsbRibRsbRsbRgbRgbRgbRsbRsbLibLib
LibRgbLgbRgRsmbRsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 29; Drug: Control
bsbsbsbsbRhbRebLob

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 30; Drug: Control
bRsbLiRsbLsbLibLgbLgbLgbLgbLsbLsRsbLgLsbLsLsmbLgbRgbLgbLgbLsbLgbLgbLib
LibLibLgbLsbLgbLsbLgbLibLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bRgLsbLsbLgbRsbLsbLgbLgLsbLsLsmbRsbLgbLsbLgbLgbLgbLsbLsbLgbLgbLgbLsbLi
bLgbRsbRibLjbLibRgbLsbRcbRgbLcbLjbRiRsmbLsbLoLsmbRsbRibRibRgbRsbRgLsbL
sbRgbRgRsmbLgbRgLsbLoLsmbRsbLobLgbRsbRgbRsbRgbRsbRsRsLsRsmbRgbRsRsmbRg
bLgbRgbRgLsbLobLhRsbLibRgbRgbRsbLsbLgbLsbLibRsbLgbLsLsmbLsbLgLsbLjbLib
RsbLcbLgbRsbLibRjbLibLsbLhbRjbRhbRgbLibRibRsbRgbLgbRibRgbRgbLsbRsbRgbR
obRibLibRgbLgbLibLgbRsRsmbRsbLibLgbLsLsmbLhbRjbsbLsbLsbLsbLsbLsRsbLhbL
ibRibRibRgbRgbRgbRgbLcbLibLiLsbRjbLibLibRgRsmbLiLsbLhbLcbRebLibLibRibL
jbRjbLcbRibLgbLgbRgbRsbRcbRcbRibRsbRcbRibRgbRibRgbLsbRobRcbRibRgbRgbRi
bLsbRibLgLsbLjbLcbRsbRcbRcbRcbRibRgRsmbLsRsbRgbLibRibRcbLcbLobRgbLibRs
bLibLgbLsbLibLgbLhbLgbLgbRsbRgbRibLsbRibLsbRibLsbRsLsbRgbRsbRgbLcbLibL
ibRgbLgbLsbRsbLibLgRsbRibRjbLsbLcbLibRcbRibRibLjbRibLjbLcbRjbRobRobRib
RgbLibRebRibLsRsLsbLgbRibLsbRibLgbRgbRsbRcbRcLsbRibLgbRsLsbLibRsbRsRsm
bLsbLibRsbLhRsbsbRgbRcbRcbLcbRoRsmbRobRibRsbRibRcLsbRobRhbLibLgbLsbLib
LibRsbLibLiRsbLibRsbRibRsbRgbLibLibRgbLjbLcbLibRsbRsbLcbRibLhbRjbRhLsb
RibLjbLcbRcRsmbLjbLhbRgbLibRsbLsbLcRsbLjbsbRjbRhbLgbRgbRsbLiLsbLgbLjbL
jLsmbRgbRebLibRjbsbRjbLcbLgbLgbLgbRgbLsbLcbRgLsbRcbRibLgbRobRcbRsbLibR
ibRgbRiLsbRiLsbLcbLcbRgbLgbLiRebLgLsLgbLsRsbLgbRsbLsRsbRcbRibRhbRcLsbR
ibRibRiRsmbLjbRiRsmbRsbLjbLcLsmbRcbRibLcbLibRibLibLsbRjbRiRsmbLjLsLcmb
LsbLgLsbLibRgLsbRgbLjbLiLsbRsbLiLsbsbLgbLgLsbRsbLsLobLcbLibLsbRibRsbLg
bRsbRiLsbLsbRibLgbRsbRibLsbLsbRsbLcbLgbRibRgbLibLcbLibLcbRsbRibRobLhbL
hbLibLcbRcbLsbLcbRibLsbRsbLcbLiLsbRcbRcbRcbRibLsbLsbRsbLcbLcbRibLcbLib
LibLibLsbLibLgbLsbRgRsmbRsbRiRsmbLjbLibLsbLibRgbRcbLjbLcbLgbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bRhbLgbRibLibRcbRhbLgbRhbLgbRcbLgbRibRiRsmbLibRobRibsbRibLgbRibRiRsmbL
ibRhbRcbRibLibRibRibLibRiRsLsmbLcbRcbRibLsbRibRibRibLibRhbRibLibRibLjb
RcRsmbRiRsmbLibRibLiLsbRcRsmbLibRcbLibRhbRibLibRhbLibRjRsmbLibRcbLsLsm
bLhbRhbRcRsmbsbLjbLcbLjLsmbRcRsmbLcRsbLcRsLsbLcbLibRcbRcbRhbLiRsbLjbRs
bRcbsbsbLjbLeLsbLiRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bLcbLiLsbLibRsbLibLibLgbRoLsbRoLsbLgLsbLibLjLsmbRgbLibLcbLibRjbLibLgbL
ibLsbLhbRgbRgbLibLibRsbLiLsbLsbRgbLibLgRsbRgbLibLibRhbLibLibRgbLibLgbR
gbLgbLgbRgbLibLgbLgLsbRgbRsLgbLgbLgbLsLsmbLgbRsbLgbRjbLiLsbLibRsbLibLi
bLibLibLibLibRjbLcbsbLgbRsRsmbLibLibLibRgRsmbRibLcbLgLsbLgbLibLhbRgbLg
bLgbLhbLiLsbRibLibLgbLsbLgLsLsmbRsbLgLsbRgRsmbLgLsbLibRgbLhbRoLsbLjbLo
bRsRsmbLobRsLcbLhbLibLibLibLibRsbLibRsRsmbLibLgbLgLsbRgbLibLgRsbRgbRjb
RcRsmbLibRcbsbRsbRibLgbRibLsRsbRiRsmbLgbRsbRsbRibLgRsbLoLsmbRgbLcbRibL
ibLobLibRibRsbRsbRobLhbRobsbRhbLobRobLcbRcbLibLhbRobRjbRcbLsbRsbLobLib
RsRsmbLcbRgbLcbLobLibRebLcbRjbLibLibRcbLcbRsbLibLsbLjbRibLjbLiLsbLgbLg
bRibLhLsbRgbLibRsbLibLcbLcbRjbLjbRcbLgbRibLsLsmbLobLibRsbLibRsRsmbLibR
ibsbLcbLhbLibLibRebLhLsLsmbLibLsbLjbLhbRgRsmbRebLibRsbLcbLcbLibRebLcbL
jLsmbLcbLcbRob

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bRgbLjbLcbRibLibLgbLiRsbLibLsLsmbRgbLebsbRibRibRibRgbRgRsmbLsbLjbLcbRg
bLjbLibRgLsbLibLsbLhbLcRsbRgbRobRsbLgbRgbRcRsmbRgRsRsmmbRgbRsbRgbLgbRo
LsbLsbRibLsbLgbRgbRsbRibRiLsbLsbRgbRgLsbRsbRsbRgbRgbRsbRgRsmbRsbRsbRgb
RsLsbRgbRgbLsbRgbRsbRgbRgbRsbRgbRobRgbRibRibRgbRgbRgbRsLcbLgbLsbLgbLgb
LgLsbLgbLsbRsbLibRsbLibLibLgbRsbLsbRsbLhbLgbLibRgbLgbLiLsbLgbRgLsbLgLs
bLgbLsbLibLiRsbRgbRsbRgbRibLgbLgbLgbLgLsbLsLsmbLgLsbRebRhbRibLibRgbRib
LsLsmbRgbRsbRsbLsbRcbLsRsbRsbRibLsbRgbLsbRgbRsbRcLsbLibRsbRibLsRsbRiRs
mbRsbRgLsRsbRsbRgbLgbRibLsbRhbRgbLsbRhbLgbLgbLgbLgbLgbLsbLgbLsLsmbLgLs
bLgRsbRsbLibRjbLgbLgbLgbRgbLsbRsbLgbLsRsbLgbLgbLiRsbLsbRhbRcbLibRobRgb
RsbLsbRibRsbRgbRgbLibLgbLsbLiRsbLsbRsbRcbRibRgLsbLsbRgbRsbRgRsmbRgbRsR
smbRsRsmbRsbRsbRgbRsbRsbRsbRsRsmbRgbLsbRgbRsbRibLsbRibLgbLobLhbRcRsmbL
ibLgRsbLsLsmbLsbLgbLsbLgbLgLsbLgbRsRsmbsbLibsbRgbsbLgbLibRgLsRsbLibLcb
LcbLibRiRsmbRibLsbRgRsmbRsbRgLsbRsbRgbRgbsbRsbRsRsmbRsbRibLoRsbLjbRsRs
mbLgbLgbRibRsbRsRsmbRgbRsbRsbRsbRsbRibLjRsbRgbRgbRsbRsbLcbLgbLcbRsbRjb
RcbRibRibLibRgbsbRgbRgRsmbLcbLcbRibRiRsmbRsbRsbRsbRgLsbRgbRsbRsbRgbRsb
LgbRgbRsbRgbLsbRibRsbRgbLsRsbsbRsbRgbRsbRsbRsbRgbRgbRsbRgbRsbRgRsmbRsb
RsbRgbLgbRgbRibRgbRgRsLsmbLgbRibRsbRgbLsbRgbLsbLsbRsbLgbRibRsbRsbRgbRs
bRgLsbRgbRgbRsbRgbRsLsbRsbRgbLsbRgbRhbLsbRcbLsbRgbRgbRgbLsbRgbRsbLsbRg
bRsbRsbRgbRgbRsbRsbRgRsmbRsbRsbRgbRgbLgbRibRgLsbLsbLsbRgbRgbRgbRgbLgbR
ibLgbRibLsbRgbLsbRgbRsbLjbRibRsbRsbRibRobRiRsmbRcbRcLsbRibRsbRsbRgbRgb
RgbLjbLhbLcbRobRoLsbLhLsbLsbRibRobLcbLgbRgbRjbRsbRgbRgbRibRsbRgbRsbRsb
RsRsmbRgbRsbRsbRsbRsbRgbRgbLjbRibRsbRgbRgbRgbLsRsbRsbRgbRsbRgbRgbLsbRg
bRgLsbRgbLibRsbRibRgbLsbRibRgbRhbLgbLsbRsbRibRgbRsbLsRsbRgbRgbRgbRsbLs
bRibLsbRsbRsbRgRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bLibLsbLibRhbLibRibLcbLsbLibRgbRoLsbRsRsmbLibRhbLibLcLsmbLibLsbLsbLiLs
bRsbRjbRsbLiRsbLjbRgbRsbLibRibRsbsbRsRsRsmmbsbLcLsmbRsLjbLcbRcRsmbLcbL
hbRjbLcbLibRsbsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bRsbLobLhbLgbRsbLsRsbRjbLcbRgbRebRgbLgLsbLibLibRhbRibLsbLgbLibLibLibRs
bLhbsbLsbRsbLgbLiLsbLcbLgbRebLsbLgRsbLiLsbRsbLiRsbLiLsbLibRsbRgRsmbLib
LibRjbLobLsbsbRgbsbLibLgbLibLgbLsbLgbLsbLgbLjbRobLobRjbRobLjbLibLibLsR
sbLibRjbLibLgbRsbLibRgbLiLsbRsbLhbRgRsmbRjbLibLibLibRibLibRgbRibLcbLob
LiLsbRgbRibRgbLsbLcbRsLsbLibRjRsmbLcbLcbLibRebLcbRcbLcRsbRgbLjbRjbLoRs
RsmbLibLsbRsbLjLsLsmmbRibLhbRsbRibLjbLobLsbRoLsbRcbLeLsbRcbLcbLsbRsRsm
bRjbsbRjLsbRjLsbLcRsbLsbsbRjRsmbLcbRiRsmbRsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bLcRsbRsbRibLcbLsbRsbLobLgbsbLibRibLhbLsbLibRjbLhbRgbRsbLibRgbLiLsbLgb
LsbLgbLgbLgbLibLibRgbLgbRsbRibRgbLibLobRibRibLgbLibLgbLgbLsbLgbLgbLsLg
bLobLebRibLiRsbLsbLjbLibLsbLsbLgbRsbLibRsbLsbRgbLobRgbRgbLsbLcbLiRsbRj
RsmbRibLibLibLgbLibRibLibRsbLgbRsbLgbRjbLobRibRgbLibRibLibRgbLgbRsbLhb
LgbRsbRgbRsbLhbRjbLobsbRibLhbLibRgbRsbLgbLgbLgbRjbLcLsmbRcbRcbLsRibRsb
LsbLsbRgbRhbLsbLhbLsbLibRjbRebRsbLibLsbLgbLsbLobRgRsmbLsLcbRhbLcbLobRc
bRcbRhbLibRgbLsLsmbLgbRsbRgbLsbLcbRibsbLcLsmbRsbLibRsbRgbLgbLgbLhbLibR
gbLibRgbLgbLsbRsbLgbLibLgbRsbLgbLsbRsbLibRsbLibRsbLibLsbLsbRjbLobRsbLi
bLgLsbRsbLgbLcRsbRcbLsbsbRoRsmbRibLhbLibLibRibLcbRgbRsbRsbLobRibLcbRib
LibLgbLsbLibRsbLgbLgbLobRgbLibLcbRcbRobRcbRibLgbLgbRibLeRsbLibRsbLobRg
bLsbLsLsmbLgbLgRsbLibLsbLibRgLsbLsbLibRgbLibRgbLibRgbRsbLibLibRgbLibRg
bLgbLobLsbRgbLiRsbRgRsmbLsbsbRhbLcbLcbRgbLhbLsbLgbLsbRibLibLgbRsbLgbLg
bLobLiRsbLobLibLibRsbLgbLgbLgbLgbLgbLsbLobRobRcbRhbLibRibLibLgbRjbLcbR
jbRobRcbRibLibRgbRsbLsbLibRsbLoRsbRgbRsbLhbLibRibLgbLibRhbRjRiRsmbRjRs
RsmmbLgbRcbLibLibRibRibRcbRgbLgbLhbLgbLgbRsbRjbLcbLgbLsbLibRgbLibLsbRg
bLoLsmbRgbLibLibRgbLibRgbLcbRhbLhbRjRsmbLhbRobRcbRcbLgbRgbRsbRhbLhbRjb
LcbRhRsmbRhbLibRhbLjbRebLjbRhbLibLgbLgbRobLibLjbLobLsbRjRsmbLcbRgbRsbL
cb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRgLsbLsbLibRibRibRjbRcRsmbLibRhbLgbRoLsbRsbLgbLsLsLsmmbRsbRgbRsbRgbRc
bLibRiRsmbRhbLgbsbRsRsmbRsbRsbRsLsbRgbRgbRsLsbLsbRgRsmbRoRsRsmmbLgbLib
RsbLgLsbRcbRgRsmbLcbRhRsmbLgbRsbLibLgbRgbLcbRiRsmbLcRsbLsbLhRsbLsRsbLi
bLcbRsLsbRgbLibRibLibLibRjbLsbLgbLgbLsbLsbLsbRsbLibRgRsmbLgLsbRsbLgbLg
bLsbLsbRgbLsbLgbRgbsbRibsbRgbRhbLibRibLsbLsLjbLibLgbRsbRjbRgbRibLjbRib
LgLsbRibRsbRgbLsbRgLsbRibLsbLibRsbRsRsmbRgRsmbRgbRgbRgbRgbLsLsmbRcLsbR
ibLibRsRsmbRsbRibLibLobRhbsbRjbRibLgbRobsbLgbRcbLibRgbRibRibRgbLgLsbRi
bsbRsbLgbRiRsmbLsbRgbRgbRgbRgbLsbRgbRibLgbRgbLobLcbRgbRsbLibLsLsmbLsbL
gbLsRsbRsRsmbLoRsbRibRsbLibLgbRgbLgbRgbLibRsbRjbLgbLsbLgLsbLsbLgbRgbLg
bLgbLsbLgbLsbLgbRgbLibRsbRsbLibRsbLibLgbRobRobLjbLibRjbLhbLsbLibRobLgb
LcbLcbsbLibRsbRibLobRcbRibLsbRcbRcbLibRgbLsbLsbLsbLcbsbLibLgbLsRsbRsbR
gbRibRgbRgbRibRsRsmbRgbLgbRibLgbLebLgLsbLibLgbRibRcbRobsbRcbRsbLibRobR
sbsbRsbRibLsbLgbRcbRibRsLsbRgbRgbRsbRgbRgLsbRsRsmbRgbRsbLsRsbRgbRgbRgb
RibRibLgbLsbLibRhbLsbRiRsmbRsLsbLsbRsbRibLsbRibRgbRibLgbRsbRgbRgbRiLsb
RgbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbRcbRcbLebRebLcbLoRsbRsRsmbRjbRibRjbRcbLsbRhbLibLebLcRsbRibRcbRgbLj
RsbRcbLgbLcbLobLsbRibLcbLoLsmbRgbsbLjbRcbRgbLjbRoRsmbRcRsmbLibLsbRsbRh
bRgbLibRjLsbLjbRjbRcbLcLsmbLcRsbRsRibRibRcLsRsbLibRsbRibRibRsRsmbRibLs
bRgLsbLibRgbRibRgbRsRsmbRgbLcLsmbRjbRibRgRsmbRibLsbsbRibLcbLcbRibRgbRs
RsmbRgbLsbRgbRibRcbLsbLibLsbRgbRibRcRsmbLibLcbRibRcbRiRsmbLgbRcbRgbLgb
LobRgbRjbsbLjbLsbRjbRibRgbRgbRgRsmbLgbRibRsbRibRibRgbLgbLibRibLgbLcbRj
bRjbRibRibsbLsbRibRibRibRgbLgbRibRiRsmbLsbRhbLsbRgbRgbRsbRibRgbLgbRibL
sbRibRcLsbLgbRgbLibLsbRjRibLjLsmbLcbRiRsmbLgLsbRsbsbRsbRhbLsRsbRoLsLsm
bRgRsmbLgRsbRgbRibRibsbRhbLcbLgbRsRsmbRsbRibRibRgLsbLgbRhRsmbLgbRibsbR
hbRiRsmbLiLsbRgbRsbLjbsbLsRsLsLsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bRibRibLibRcbRgbRibRgRsmbsbRgbRibLibRibRgbRgbLsbRibLgRsbRgbRibRibRgbLi
bLjbLcbLibLsLsmbLgbRgbLcRsbRibLhLsbLgbRgbLhbRgLsbLibRgbLgLsbRcbRibRibR
gbRsbRibRibRcbLibRcbRcbRgbRsbLsbRsbRgbRgRsmbLsRsRgbLgbRgbRgbLgbRgbLsbR
gbLsLsmbRcbRcbLibRiLsbRibLsbRibRibLobLcRsbRibRgbRgbRgLsbRibRibRsbLsLsm
bRgLsbRgbRgbRsbRsRsRsmmbRsRsmbRsbRgbLgbRgbRibLgLsLsmbRgbRibLsbLsRsLsbR
ibRsbRcbLibLjbsbLcbLibRibRjbRgbRibRhbRgbLsbLgbRcbRoLsLsmbRgbRibLibRsbR
sbLcLsRsmbLibRgbLiRsbRgbLcRsbLiLsRsbRgRsmbRsbRcbRoLsbRhbLgbRgbRgbRcbLc
LsmbRcbRhRsmbLhbLgbLobLibLgbRsbRibRhbRcbRibLiRsLsbLgbRhbLcbLcbLgbRgbLs
LsmbLsLsmbLcRsbRgbRibRgbRgbRibLcbLhLsbRjbLobRgRsmbLcbLibRgbRgbLibLgRsb
LiRsbRgbLibRjLsbRcbRcbRibRsbLgbRcbRhbLiRsbRgbRgbLibLcbRjRsmbLiRsbRgbLc
RsbRgLsbLibRjbsbLibRsLsbsbLobRgbRsbLibLcbRgbLhbRjRsmbRgbLcbLgbLibRgLsb
LibRgLsRsbLhbsbLiRsbRgLsbLibRgbLibLsbLsbLhbLcbRgbLsbLcLsmbRibRcbRibLgb
RibRiLsbLsbLibLgLsbRcbRhbLibLjbRjbLjbRibRcbLibRgbLcbLibLoRsbRgbRsRsLsm
bRgbRhbRobsbLiLsbLsbLibLhbRibLoRsbRibLobLibLcbRibLgbRgbLibLiRsbLibRgbL
ibLsbRgbLiLsbLiLsbRgRsLsmbRsLsLiRsbRgbLibLgbRgbRjbRibRobRibRsbLgLsbRgb
RcbRibLcbRcbRobRcbRiLsRsbRgbLcbLhbRibLgbLgbLgbRgbRjbRcbRibLiLsbRgbRiLs
bLgbRcbLgbLsbLcbLibLibRgbLibRgbRsbLgbRgbRgbRgLsbRibLsbRibLgbRibLsbRgLs
bLsbRgbLsLsmbRgRsmbRgbLgbRsbRgbLcbLcLsmbRibRcbLsLsmbRcbLibRgbLsRsbLgbR
gbLhbRcRsmbLhbRcbRibRgbRsbLsbLgbLcbLibRgbLiRsbLsbLgbRsRsmbLgbLgbLibRib
RjbRcbRcRsmbLibRgbRsbLibLibLibRjbLiLsbLibRgbLgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bLcbRibRobRhbLcbRobRsbRgbLgbRibLcbLiLsbRgbLcbRgLsbLhbLsLsLsmmbRsbLhbLs
LsmbRgbLjRsbRcbRcbLsLibRhbRgRsmbRibRsbLjbRibLsbRibRibLgbRgbLsRibLsRsbR
ibRcbRibRibLibRcbLcLsmbLcbRibRcbRobRsLsbLsbRgbRibRibLgbRibLsbRcRsmbRsR
smbLeLsLsmbRcRsmbRibLsbRcbRobLgbLcbRgRsmbLibLibRjbLcbLibLhbRgLsbRsbRob
RebRcbLhLsbRibLhbRsbLsbRjbLcbLibRgbLgbLsLsmbLgbLibsbLsbLhbRsbLibRibRcb
LjbRcbLiRsbLcbsbRjbLoLsmbLsbsbLibRsbRsbLibRsLsbLiLsbRsbLhbLibLgLsbRsbL
hbLsbRcbRcbLjbLcbRibLibLsLsmbLoLsmbRgbRgbRsbRibLsbLebLibRjbRoRsmbLjbRi
bLsLjbLcLsmbLhbLgbRsbLsRsLsbLgbLhbRcbRiLsRsbRhbRobLiLsbLhbRibLibLibReb
RcbLibLjbRcRsmbLjbLcLsmbLibLsbRsbRsbLcLsmbRhbRcRsmbRibLiLsbRcbLiLsbRib
RhbLiLsbLiLsbRcRsmbLgbRiRsmbLsbRhbLsbLcbLhLsbLiLsRsbsbLibRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbLgbLjbLhbRibLibLgbRcRsmbLjbRibRgbRsbRibLjLsmbRcbLibLcbLobLibRcbRgb
RhbLgbRibLgbLibLgbLsbLgbRsbLgLsbLibRjbLsbLibRgbRsbLgLsbLcRsbRgbRjbLhbL
ibLobRibRibLibRibLgbRgbLhbLiRsbLsRsbLgbLgLsbRgbsbRcLsbRibLgbRibLsbRgbL
cbRibRhbRgbRibsbLgbRibLgbRgbRgbRsbLsbLgLsbRjbRjbLgbRibRcbRjbLsbLsbLgbR
sbLibLgRsbLgbLcbRgbRibRsbRhLgbRibLeLsbLgbRibRiRsmbRsbRgbRgbRgbLsbRsbRg
RsmbLsbRibRsbRgLsbLsbRibRsbRsLsbRgbRgbRsbRgbLsbRibRsbRgRsRsmmbRgRsmbLg
bRibRhbLsbRsbRiLsLsLsmmbRibRibLsbRsbRiRgbRibLjbRiRsmbRgbRgbRgbLjbRibRs
RsmbRgbRibLgbLibLibRibLibLsLsmbLgbLgbRsLgbRsbLgbLsbLibRsbRjbLiLsbRjbRi
bRibLjbLjbLibLibRsbLjbLibLgRsbRsbLsbRjbLcbRjbsbRebRgbLibLhbRhbRcbLjbRs
bRcbRibRebLsbLibRjbLcbRgbLiLsLsmbLsRsLsbLjbRsLsbRsbRsLsbLgbLgLsRgbLsbL
gLsbLsbLiRsbRsbLgLsbRcbLgbRiRsmbRgRsmbLsLsmbRjbRsbRsRsmbRcbLibRobLiLsb
LcbLsbRhLsbLsbLgbRiLsbRibRjbRhbLjbRcLsbRhLsbLgLsbRgbRebLsbLibLsbLsLibR
sbLsLsRembRgbRgbRibLsbRibLgbRibRgRsmbRgRsmbLgbRibsbRsLsbLiLsbRibRgbRgb
RgbRgbLsbRgbRsRsmbRgbLsLsmbRgbRsbLsLsmbRibLgLsbRibRsbsbRgLsbLsbRibRibL
sLsmbRgbLsbRhbRgbLsbRsbLibLgbLhbRjbLhbRgLsbLcLsmbRgbLibLcbRgbLcbRibRgR
smbRibRsbRsbRibLjbRhbLgbRibRoLgbRibRgbRgbRsbRibLgbRibLgRsbRibRsbRhbLhb
RcLsbRcbRibLibRgbLibRjbLibRjbsbRcLsbRibRgbLgbRhbRibLibLsLsmbRcbRhLsbLi
bRcbLgbRibLibRiLsbLiRsbRjbLhbRjbLhbRsLsbLibRgbLsbRsbLcbRibLhbRsbLhLsbs
bRcbRcbLjbRcbLgbRibRsbRhbLgbLjbsbLibRibRibLsbRcLsbRsLibRgbLsbLgbRiRsmb
RsbRgbRsbRibLsbLsRibLgbRgbLsLsmbRsRsmbRibLsbRgbRgbRsbLsbRiRsmbRibRgbLg
bRhbRsbRsbRibLgbRibRiLsbLsbRhbRibRgbLiRsbLsbRibLsbRgbLsbRibRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bsbRsbRgbRsbReRgbRsbLgLsbRoRsmbLsRsbLgbRsbsbsbRsRsmbRsRsmbLsbsbsbRsbsb
sbsbsbsbsbsbsbsbsbsbRsbLsbLsbsbsbsbRsRsmbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bRebLcbLiLsbLgbLgbRsLsbLsbLgbRgbLhbRgbRsbRgbLibRgbLibsbLcRsbLcRsbRgbLs
bRsbRgRsmbRibRobRibRgbLgbLibRgbRcbRgRsmbLgbLcbLcbLiLsbRgbsbLgRsbLgbLgb
LsRsbLsbLgbLsbLhLsbLgbRibRsbLjbLgbLsbRgbLcbLsbLibRhRsmbRibLgbLgbLgbRsb
LobLibLibLsbLibLgLsbRsbLibRgbLibLsbRgbRibRgRsmbRgbLibLobLgbLgbsbRsRsmb
LibLsbsbLgbLsbLgbRsbLibLgbRgbLsRsbRgbLcbLibRibLgbRsbLibRjbRcbRibLibLcb
LgLsbLgbLgRsbLgbRgRsmbLibLgLsbRibRibsbRcbRibRgbRsbLgbRsbRhLsbLcbsbLibR
iLsbLoRsbLgbRsbRsbLibRjbRoLsbLsLsmbRibRgbRhLsbRoLsLsmbRgbRjRsRsmmbRobL
gbLsbLgbLobLgbLgbLibRhbRsRsmbLhbLibLgbLsbLsbRsRsmbLsbLibRsbLibRsbLgbLs
bRgbRgbLgbLgLsbLgbRjbLobLgbRgbLcbLsRsbRgbLsRsbRsbLibLgRsbLibRibLobLgbL
sbLgbLgbRgbLcbLibLsRsbRsbLsbLiLsbLgbLibRibLhbLgbLgbLgbRobRibRibRsLgbLg
bRibRibLgbRgbLgbLjbRibLhbLobLsbLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bLibRibRoLsLsmbLgbLhbLiRibRcbRcRsmbRobRsbRgRsLsRgmbLjbLiLsbRsLsbRcbRhb
RsbRgbRobLibRcbsbRibsbRibRsLsbRiRsmbLgbRibRgbRgbRgbRgbRgbRgbRsbRhbRgbR
cbLcLsmbsbLibRibRhbLjbsbLcbRsRibRibLjbRcRsmbRcRsmbRibRibRibRibRibLiLsb
RcbLcLiLsbLobRgbRgbRiRsmbRibLjLcbRsbLsbRsbRhbRibRibLcbRibRgbLjbLeLsbRh
RsmbRsRsmbRsbLeLsbRgRsmbRibLjbsbRibRgbLjbRhbRiRsRsmmbLcbRhbRibLcLsLsmm
bLhbLsbRsLsbRjbLjbRcbLjbRcbLcbLhbRjbRsbRjbRibLebRjbsbRibRibRibRibRjRsm
bLsRebRibRibRgbRibRcbRcLsbRibRibLibRibRgLsbRibsbRibRibRibRibRgbLjbLjbR
cLsbsbsbRibRgbLoLsmbRhRsmbRibLcLsmbRjbRjbRhbRcbRiRsRsmmbRibLsRsbRibLjb
RjRsmbLsbRsLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bLjbRibRebLjbsbLsRhRsmbRiRsmbLcbRebRibLcRsRsRsmmbsbRcRsmbRiRsmbRibLgbR
iRsmbLgbRcbLhbRgbRcbLiLsbRsLsbRibRgbLsbRgbLjLsmbsbsbsbRgRsmbRgbRgbLjbs
bRsbLsLsmbLobLebRsbLjbLgbLiLsbLgbLibRibRgbsbRibLsbRgRsRsmmbRsbRjbRgLsL
sLsmmbLhbLsbLiLsbLsbLgbLibLeLsbLgbLiLsLsmbRgLsbLsbLgbLgLibLsbLiLsbLibL
iLsbLibLibLobLsbLibLebLiLsbLibLgLsbLsLsmbLsbLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bRgbLgbRiRsLsmbLgbRgbLjbRibLcbRjbLjbRobLgbLgbLgbRsbRibRgRsmbRgbLsbRsbR
gbRgbLjbLjbLgbLsbRcbRoLsbRcbRibLsbRibRhbLgRsbLibLsbLgbRsbLgbRsbLgbRsbR
cbRsbRcLsbRibLgbLgbLsbLsbLsbLsbLgbLsLibLsbLgbLgbLsbLgRsbRgbRsbsbLcbRgb
LibRgbLiLsbsbLibRjbLibRobRsbRcbLjbLgbLgbRgbLsbLsbLgbLsbsbLsbLibLiLsbRg
bLsRjbLhLsbRcbLibLgbRgbLgbRsbRgbLhbLgLsbsbLibRgbLibRgbLibLgbLgLsbLgbsb
LsbLsbsbRibLsRsbLsRsbLgbLcbLsbLgbRgbLibLhbRibLcbRsbRgRsmbRcbRhbRcbLgbR
sbLgbLgbLgbRcbLibLcbLibRsRsmbLiLsbRgbLibRgbLibRsbRgbLgLsbLgbRgbLgbLibR
gbLibRgbLoRsbRsbRsbLibLsbRsRsmbLgbRsbLgbLsbRcbLobRibLibRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 161528; End: 162028;
Recording: 1-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbRsbLgbLgbLgLsbLsbLibLsbLsbRebRsbRibRgLsbLgLsbLsbRibLsbRsbLiLsbLiRs
bLsbRsbRsRsmbsbsbsbLsLsmbLsLsmbLsbLsbLibRsbRsRsmbLsRsLsRsLsbRhbRibRgbR
gbRgbLsLsmbsbLsRsbRgbRgbRgRsmbLsbRiLsbLsbRgRsmbRgbRsbRiRsLsmbLgbRibLsb
RsbsbLcbRjbRgbLjbReLsbLsRsbRibRibLgLsbRibLsRsbRhbLibRhbLsRsbRibLjbRgRs
mbRcbLgLsbsbRsRsmbLsbRgbRgbsbLgbRcbLgbLgbRobRhRsmbLgbLsbRibRgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 1; Drug: Control
bRcbRsbLibRcbLobRgbRgbLsRsbRsbLsbLobLgbLsLsmbLgbLsbLobLeRsbRcbLcbRebRc
bRibLsRsbRgRsmbLcbRcLsbRibRgbRgbRgRsmbsbsbLebLgRsbLcbRobRsbLjbRcbLoRsb
RgbLsbLhbRsLsbRsLsbRcbsbLoLsmbRcbsbLcbLiLsbLsbLibLcbLjLsmbLibLibsbRcbL
gb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 2; Drug: Control
bLgbRoRsmbRcbReRsmbLgbsbRsbReRsmbRobRcLsbLibRobRibRcbLjbRoRsmbRcLsbRib
RgbRgbRcbRhRsmbRgbRhbRcbRjbRoRsmbRjbRebRcbRjbRcbRoRsmbLgLsbLsbRgbLgbLs
bLgbRcbRhLsbRgbRebLgbRgbRsbRgRsmbRcbRebRibRjRsmbRgbRiRsmbRibRgbRgbRgbR
sbRhbRsLsbRsbRibRibRsbRiLsbRsbRgbRsbLsbLsbRcbRibRibRgbRgbRsbsbLibRiRsm
bLhbsbLjbLcbRob

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 3; Drug: Control
bRobRgbRcbLsbLcbLcbLhbLibLgbLebLebsbLgbLhbLibsbLjbLcbLibLcbsbsbsbLcbRg
RsmbLhbLebLibLeb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 4; Drug: Control
bRobRobRcbsbsbsbLsbRob

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 5; Drug: Control
bReLsbLobLobLjbRoLsbLobsbRjRhbLsLsmbRcbRoRsmbRcbRhbLibRiRsmbLsLhbRhbRs
RsmbLsRsbLcbLgLsbLibLjbsbLcbLcbsbRcbLcbLgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 6; Drug: Control
bRjRsmbRibLibsbLibRibLjbRgbRjbsbsbRgbRgbRjRibLob

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bLibRjbRjbsbsbsbLibRcbRgbLcbsbLcRsbLibLobLgbRhbRsbLibLgRsbRibLiLsbRobs
bLgbRibLiRsbRjbLgbRcbRibLsLgbRgbLgbsbsbsbsbRibLgbRgbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bLibRibLsbLiLsbRsbLibRjbRjRsmbLgbRhRsmbLjbLcbLhbRjbsbRcbsbLjbRibsbRiRs
mbRibLjbRcLsbLibRjbRcbLibLsbRsbRgbRgbLjbLobLibRjbLobLcbLiLsbRsbLsbLibL
ibLhbRjbRcLsbLibRjbRhLsbRgbRibRgbLibRhbRgbRcRsmbRiLsbRjbLcbLsbLcbRsbRg
bLibRsbLiLsbLcbLibRgbLhbLgbLsbLobRgbLjbLhbLcbRibLjbRibRiRsmbLjRsbRibRc
bRcbLibRibLsbLsbLjbLibRgbRhbRibRibLhLsbRibRsbRsbRgbRgRsmbLsRsLsbRsbRgb
RsbRsRsLsmbRsbRsbLjLibLibRgbLibRjbRibRsLsbRibRgbLibRsLiLsbLsbLsbLsLsmb
LsbLsbLibRcbRebLcbLobLjbLcbLcbLibLcbLsbLiLsbRgbLgLsbLgbRsbLibRgbLcbRsL
sbRsbLgbLsbLsbLgbRsbLgbLgbLsbLsbLgbRsLcbLsbRsbLgbRsbLgbRsbRsbLhbLibLib
RsLsbLgbLsbLhbRgbLsbLsbRsbLibRgbLsbLgbLsbLgbRsbLgbRsbLgbRsbLgbLsbLsbLs
bLgLsbLsbLgbLsbLsbLgbRsbLibRsbLibLgbRsbRsbLgbLgbLsbLgbLsbLsbLsbLgbLgbL
gLsbLsbLgLsbLgbLsbLgLsbRsbLgbLsbLgbLsbLsbLgLsbLgbLsbRjbsbRcbRibLhbLcbR
sbLhbLsbRsbLsbLgbLsbLgbRsbLgbLibLgLsbLsbLsbRgbLgbLibRebLebLebLcbRgbLgb
RjbRgbLhbRsLsbLsbLiLsbLsbLibRsbLsbLgbLgbLsbsbLsbLsbLgbRsbLgLsbLgbLsbRs
bLhbLibRibLsbLsbRsbLibLcbRibLgbRgbLiRsbRsbRsbRhbLhbLcbLhbRjbRcbRibLjbR
ibLsbRgLsbRsbRgbRsbRgbRsbLsRsLsbRgbLsbRsbLsbRibRibsbLobRsbLcbRibRgbLcb
RjRsmbRcbLibRobLgbRgbLgbRibRibLcbRgbRgbRibLgbRibRgbRiLsbRsbLgbRjbRhbRg
LsbLgbLsbRibLsbLgbRcbLebRhbRgbRgbLgbRiRsmbRsbLebLiLsbLsbLgbLsbLgbRsbLo
bLhbRibLibRibLsRsbLcbLcbLsbRjbRcbLhbRibLobLoRsbLcbLibRibRgbLibLsLsmbLg
bLsbRjbLjbLcbRgbLobLcbLgLsbRsLsbRsRsmbRgbLhbRgLsbRibRgbLjbRgbRibLjbRgb
RgbRgLsbLjbRjbRiLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bLcbLhbRcRsmbLhLsbLibLibLcbLsbLgbLgbRibRcbsbRhbLgbRgbRhbLcbRsbRiLsbLsR
hbRebRcbRibsbLhbLiRsbRcRsmbRjbRcbRgbRiLsbRsbRibRibRibRcbRibRcbLcbRjbLs
bLobRibLobLsbsbLgLsLsmbRibLsbRcbLgLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bRibsbLgbRcbRibRibRibRibRibLsbRsbRgbLsbRibRjRsRsmmbRiRsmbRgbsbLgbLsLsL
sLsmmmbLgLsLsLsmmbLebLcLsmbLibLcbLibsbLcbLsLsmbLibLibLgbLebLibLibRsbRe
bRibRsRcbLcbLcbReLsRsbRcRsmbRjRsRsmmbsbLgLsbLcbLebLjLsmbsbLiRsbLobLcbL
jRsbLibLiLsbsbLjLsLsmmbLhLsbLibLgbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bLcLsmbRsbRcbRibLibRibLibRjbLobLjbLibLjbRcbRsbLobLcRsbLibRibLibRcbLcbL
cbRobLcbLebsbLcbLiLsbLsbRjbRibRgbRgbRibLsbLsbRgbRsRsmbLhbLcbsbsbLsbLhb
RsbRsLsbLsLgLsbLiLsbLcbLibRsbRhbLsbRsbRsLsbRcbLibLcbLcbLgbLsLsmbLsLsmb
RibRcbLhb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bLibsbRcbRcbRibLebRcbRhbLhbRsbRcbLcbRcRsmbRcbLgbRhbRcbRjbLibRgbLcbLsbR
hbLcbRjbRibLcbRcRsmbRhbLcLsmbRcbLhbRjbsbLsbLjbLhLsbLsbRjbLjbLhbLsRsbRo
RsmbLcbLibRcbsbsbRcbRcbRcbRgbRcbRcbRgbsbRhRsmbRebRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bLcbLcbLcbRibRibRcLsbRibsbRcbRcbRcbsbLebLcbRcbLibLibLgbLsbRgbLibRgbLib
LsbLgbRoRsmbLjbLhbLiLsbLgbRgbLibRsRsmbLgRsbLgbRgbLibLsbLhbLcbLgbLibLcb
RcbRobLsLsmbLibLsbRcbLgbRibRibLibRiRsmbRobLibLiLsbLgLsbRcbRcbLibRiRsmb
LibLjbsbLcLsRsmbLcLsmbRibLgbLsbLsbRgbLgbLibLiLsbRebRobLiLsbLibRibLcbRi
bRhbLhbLiLsbLsbLibRsLsbLhRsbLcbRsbLibRsbLjbLibLiLsbRjbLibRjRsmbRibLebL
ebRhbLiLsbLgbRsbLgLsbRsbLibLhbRgbLgbRsbRgbLjbLibLcbLibLgbLsbLibLgbLgbL
ibRibLibRibLcbLeRsbLibLsbLsbRgbLgbLgbLgbLiRsbRoRsmbLcbLcbLcbLibRgbLiRs
bLgbRhRsmbRcbLibLgbRiLsbRibLibRjbRibLebLibLibRgbLiLsbLsbLibLgbRgbLibLg
bRgbLibLsbLgbLgbLgbRgbLgbRsbLgbLgbLibRobRcbLgbLjbLibRjRcbRcbRibLsbRgbL
ibLsbRgbRibLcLsmbRcbRobRibLibLsbRgbRsbLgbRgbLjbLibLibLgbRgbRcbRcbLibRi
bRsRsmbRiRsmbRhbLcRsbLibsbLjbLgbRgbRgbLgbLjbLiLsbRgbRibRiRsmbRebRcbRib
RjRsmbRibLhbLgbRcbRibLjbRcRsmbsbRibRgbRgRsmbsbRgbLibsbLibLibLib

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bLcbRibLgbLsbLgbsbsbLhLsbRcbLibsbsbsbLsLsmbsbRsbLhbLgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bRgRsmbRsbLcbRibRiRsmbRibLibRsbLgbRcbLgbRsLsbLsbLcbLcLsmbRcbRhbRibLgbR
gbRibRhbRcbLcLsmbLsbLsbsbsbsbRsbsbsbLsbRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbRjRsRsmmbRsbsbRibRsbRgbRhbRibRsbRsbRjbRgbRsRgbRsbRoLsbsbRibsbsbsbs
b

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbLhRsbRgbLjbLibsbLibRgbRsbLhbLgbRgbRgbLibLhbLhbRibLiLsbRibLsLgbRiRs
mbRcbLgLsbRsLsbRibLibRcbRsbRhbRibLgbLobLhbRsbLgbLgbLibRjbLiLsbLjLsmbRi
bLiLsbLibRsbLsbRgbRibLoLsLsmmbLibLsLsmbLgRsbLibRibLibLibsbLsLsLsmmbLib
LiLsbRsRsmbLgLsbLibLgbLobRsbLiLsbLsbLibLibRgbLibLhbRibLibsbLibRcbRobLg
bLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bRibLgbRcbLsbLgbRibRebRhbLhbRsbRgbLgbLoRsbLhbLibLsbLgbRgbLsbRibLebLiLs
bLgRsbsbLsbRgbLibLoLsmbRiRsmbLiLsbLiRsbRibLibRgbRsbsbLibLgbLsbRsLsLgbL
ibsbLiLsbRsRgbLibRgRsmbRgbLibLgbLibLhLsbLibLgbLgbReRsmbRsbLsbLgbRcbLib
LoRsbLhbRibLcbsbRibLibLgbLjbLibLibLobLsLibLgRsbLibRsbRibLsbLjbLcbLiLsb
LibLibLgbLibRibRobLibLibLebsbRibRgbLhbRsbLcbRcbRgbLcbLcbLibLibLibLcbLg
bLgbLjbLoLsmbsbLibLsbLsbLsbRgbLcLsmbLibLjbRgbLcbLibRgbsbLcbRiRsmbsbRgb
LcbLibLibRibLibsbRgbLibLsbLcbLjbLjLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bRsRsmbsbsbsbsbLgbLgbLsLsmbsbLhLsLsmbLibLgbLibsbLgbLgbLgbLsLsmbsbsbsbs
bLgLsbLgbRgLsRsbRjbLiLsbLgbLibLiLsbLibLibLsbLsbRsbLiLsbLgbsbsbLgbRsbLi
RsbRgbRjbLgLsbLgLsbLsbRsLsbRgLsbRebLibRibRsbsbRiRsmbLgbRsRsmbLgRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bLcbLcRsLsbLiRsbLsLsmbRsbRhbRhRsmbLjbLcbLibLhbRsbLsbLiLsbLibLsbLgbLgbL
sbLsbLibLgbRsRcbLjbLgLsbRibRsbRibLibLcbLibRsbLgbLsbLgbRgbLhbRibLsLsmbR
cbLsbRcbLgRsbRgbRgRsmbRgbLsRsbRcbRjbRibRsbRoLsbLibLgbRcRsmbLjbRcbLsbRi
RsmbLsbRibRibLhbRcbLsbRsbRibRsbLsbRsRibLsbRibLsbRhbLiLsbRibRibLsbRsbRg
bLgbLcbLgbRcbRcbRgbLgbRibRgLsbLcbLcbsbLcbsbLhbRsbRgbRsbLhRsbLiRsbRjbLh
bRjbLibLsbLibRgbLibLgbRsbLibsbRcbLjbLibRsbLgRsbLgRsbRgbLgbsbLgbRsLsbRs
bLcbLsbLiRsbLgLsRsbRgbLgLsbLgbLgRsbRgbLibLsbLgbRsbLhbLiLsbLgbLsbLibsbs
bLgRsbRiRsmbLibLgbRibLibRsbRsbLibLibLgbLsRsbRibLjbLibsbLgbLgbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bLjbLsLsmbLibRgbLgRsbRgbRsRiRsmbRsbLsbRsLsLsmbRsbRiRsRsRsmmmbLsLsmbLib
LibLsbsbsbsbsbLsbLgbLgLsbLsbRebRebRsbLiRsbLibRsLsbRcRsmbLgbLsLsmbLgbRs
bRsbLsLsmbRsRsRsmmbsbRsbLsbLibLsbsbRhbsbRiRsmbLeLsbLebRgbRsbRgbLibsbRs
bLibLsbLhbLsbRgbRhbRibLgLsbRsbLsbLsbRsbLjbsbRsbRcbRsbRsLsbRsbLgbRibLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bLiLsbRsLsbLjLsmbRibLiLsbRiRsmbLibRhbLibLibLjbRebLgbRhbLgbRgbRobsbRibL
sRsbRibLibLibRibLiLsbLgbRebRiRsmbRsbLebLibRiRsmbLibLiLsbsbLibRhbLjbLsb
LobLibLibRsLsbLsbRgRsmbLjLsmbLgLsbRsbRgbRibRibLcbsbReRsmbLgbRcbLsbRibL
gbRibRsRsmbRgbRgbRsRsRsRsmmmb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bsbLsRsbLsRsRsmbsbLsRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bRsbLgbLebLgbLgbLsLgLsbLgLsbRsLsbLgbLgbRobRhbLgbLjbRobLhbLibLsRsbLsRsb
LsbLibLgbLsbRsbLibLsbLgLsbLsbLgbLgbLsbRjbLibRgbsbLibRjbRgbRgbRjbRibRhb
LiLsbLsbLsbLgbLgbLgLsbRsbRgbLibRjbsbsbsbsbsbRsbsbRsbRsRsmbRsbLsbLobLgb
RibLgbLgbLsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 25; Drug: Control
bRebRgbLiLsbLibRibLibLcbsbRgbLhbLjbLhRsbRgbLibLgbRibLgbLsbLgbsbLibsbRg
bLsbRsbLhbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 26; Drug: Control
bLibRgbLjbLobLibRjbLgbLcbRjbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 27; Drug: Control
bLibRoRsmbsbsbRibRgbLsbLsbRsbRsRsmbRgRsmbRsbRgbLsbRgbRgbLgbLobLcbRsbRo
bLsbLobLhbLsbLibLcbLibLibLgbLibLcbLibLjbLjLsmbRjbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 28; Drug: Control
bRoRsmbLibLibLcbLsbLhbLobRibRhbRibLsbLsbRsbRibRsbRsbsbRgbLsbLjbRgbRgbR
sbRgbRsbRsbRgbRsbRsbRsbRsbRhbRibRsbRgbRgbRgRsmbRgbRgbRgbLsbRgRsmbRgbRs
bRgbRsbRibRsbLsbRgbRsbRsbRsbRcRsmbRgbRgbRgbRiLsbLsLsmbRsbRibRsbRsbRsbR
sbLsRsbRsbRsbRibRibRsbRsRsmbRsbRsRsmbLob

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 29; Drug: Control
bLobLjbsbsbRcLsbRsbLsbRgbLjRsbRoLsbRiLsbRoLsbRebRgRsmbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 30; Drug: Control
bRibLgLsLsmbLsRsLsbRsbRsRsmbsbRsbLsbsbLsLsmbsbRcbLjbsbsbRsbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bRsbLibRsbRjbLibLhbRgbLhbLgbLsbRgbRsbRjbRiLsbRibLjbLjbLcbRgbLsRhbLjbLc
bRsbLebRcbLjbRcbRcbLjLsmbLhbsbRgbLgRsbLgbRsbLgbLsbRoRsmbRobRhbRgbRcbLi
bLcbLjbRcbLcbLhbRgbLgbRsbRibRibRcLsLsmbRobRibRsbRgbRsbRgRsmbRsbRsbLsbR
iRsmbLsbRibRiRsmbRobLibRjbLiLsbRsbRibRiRsmbLsbLgbRgbRsbRcbLibLsbRgRsmb
LsbRibsbRsbRsLhLsbLibLcbLiLsbRibLibRcbRobRibLibLsbRgbLgbRibRiRsmbRcbRi
bRhbLibRgbLhLsbRgbLibRgbRjbLibLsbLibRsRsmbLoLsmbRsRcbRobRjRsmbLibLcbLj
bLebLibLsbLgbLsbLsbLgbRsbRibRgbLsbRibLsLsmbLcbLcbLibRibLgbLcbRhbRhbLsb
LhLsbLhbsbLcbRibLsbLibLjLsmbLhbRcbLcbLibLibRibLgbRsRgbLsbRjbRcbLcbLcbL
sbLgLsbLgbRibLgbLiLsbRsLsbRobRibRcbRibLibRhbRhbRhbLibLibLibLsbRgRsmbLi
bLgbLsbLhbLcbLibRcbRgLsbLibRsbLibRobLjbRibRsbLibLibRcbRcbLcbLgbRobRibR
iLsbLgRsbLsbRiLsbRcbLibLjbLibLsbLsbRgbRcLsbLjRsbRibLgbRsbRsbRgLsbRgbRs
bRgbLgbLcLsmbRsRjbRcbLjbLobLcbLibRgLsbLiLsbLiLsbRsbLcbRhLsbLibRcbRhbLj
bLcbRibLcbLsbLcbLibRibRsbLhbLgbRsbRsbLibLibLsbLhbRibLibLgbRgbRgbLiLsbR
sbLgbRjbLgbLsbLgLsbLgbRgbLibLsbLobLcbLibLgbRobRcRsmbLibLhbRobLjbRcbLjb
LibRgbRobRgbRsLsbRibLsbLibLsLsmbLhbLibRibRgbRsReRsmbLcbRgbLhbLibLgbRsb
RibLibRsbLibLobLebLibRcbLsbLcLsmbLjbLcbLcbLhbsbLsbLcbLcbLcbLjbLibLsbRs
bRgbLgbRibRibLebLjLsmbRjbLibLhLsbRobLibRsbRobRibLibLcbRcbRsLjbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRgRsmbLgbRsbsbsbsbsbRjRsmbLcbLsbLibRcbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bLiRsbLibRhbLibLhbLcbsbsbsbLibLgbLibLcbRhbRsbLiLsbLhLsbLibLjbRsbLebsbR
oRsmbLsbLiLsbLibLiLsbLgbLhLsbLibLiLsbLhbLibLcbLhbRcbsbLiRsbRibLhbLsbLi
Lsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bRgbLsbRibRgbRiRsmbRgbRgbRgbRsbRgbRsbRgbLsLsmbRgbRsbRgbRsbRibRgbLsbLgb
RibRsbLjbLsbRibRibRsbRgbRgRsmbLsRsbLsbRgbRgbRibRsbRgbLgbRibRgbRsbRgbLs
bLobLsbRibLsbRgbRsbRgRsmbRsbRsbRsbLsbRiLsbLsbRibRibLsbRgbRibLibRibRgbR
sbRsbRgbRsbRgbRgbRgbRgbRgLsbLgbRibRgbRgbLgbRibRibRsbRgbLsbRgbRsbRiRsmb
RgbRgbLsbRibLsbRibLjbLcbLibRjbLibLgbLgbRcbLjbRcbLsRibRebRibRibRsbRsbRi
bRsbRgbLibRjbLcbRebRcbRibRebLcbLhbLcbRgbRsbRgRsmbRjbLibLjbRcbRgbRibLgb
RjbLgbRjbRgbRgbRgbRsbRgbLgbRibLsbRgbRgbRgbRsbRgbRebRsbRsbRgbRgbRgbRsbR
gbRsbRsbRsbRsbLsbRgbRsbRgbLsbRgbRjbRsbRsbRsbRsbRgbRsbRsbLgbLobLobLibLg
bLsLsmbRjbRibLjbRsbRiLsbLsbRgbLgRsbRgbRgRsmbRgbRsbRsbLsLsmbRgbRsbRibLs
bRsbRsbRgLsbRsbRsbRsbRibRsbLsbRsbRebLgbLjLsmbRebLiRsbRgbRebRgbRjbRsbRs
bRsbRgbLsbRgbRgbRsbRgbRsbRsbLobLcRsbLcbRibRcbRoLsbRibLcbRhbLcbRibRcbRc
LsbLibLhbLgbsbLsbLsRsbLiLsbLgbLgbLgbLgbRjbRcbRobLcbLibRibRibRibRgbRsbR
sbRgbRgbRgbRgbRsbRsbRibRgbRsbRgbRsbRgbRsbRgbRgbRsbRsbRgbRgbRsbRsRsmbRs
bRsbLsbRgbRgbRgbRsbRsbRsbRsbRsbRsbRsbRgbLsbRgbRgbRsbRsbRgbRsbRgbRsbRgb
RsbLsbRgbRgbRgbRsbRsbRgRsmbLgbRibRgbRgbRgRsmbLsbRibRgbRgbLsbRibRsbRgbL
sbLgLsbRibRsbRgbRsbRgbRgbRgbRgbLsbLsbRgbRgbLsbRgbRsbRgbRsbRgbRgbRsbLsb
LgbRibRgbRsbRgbLsRsbRsbRgbRsbRgbRgbRgRsmbRsbRgbRgbRgbLgbLcbLcRsbRsbRcb
LhbLcbRcLsbRibRobLhbRcbRobRcbRibRhRsmbLibLcbLobLhbRgbLiLsbRhbRibLgbRgb
LgbRgbRgbRgbRgbRgbRsLsbRgbRgbLibRgbLjbLibRgbRobRjbLcbRcbRibRsbRoLsbRcb
RobRebLsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bLibRsbLsbLcRsbLgbLjLsmbRsRsmbLibRobRgbRgbLcbsbRsLibRibRsbLgbRibLcbLib
LgLsbLsbRsbRgbLcRsbLsbLibsbsbLsbLsLsmbLsbRcbsbLobLibLibLsbsbLcLsmbLsRs
bLib

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRgbRgbLibLibLibRibsbRsRibRibLhbRjbLobLjRsbRobLibRjbLcbLoRsbLibLibRs
bLsRsbRgbLgbLibLibRjbRobLjLjbLebLcLsmbLgbLcbLibRibLcbLcbsbRsbRsRsmbLsR
sbsbLobRibLcbRiRsmbRsbLhbLcbsbsbRgbLebsbsbLibLsbRiRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbLcbRibRgLsbRsbRjbRsbRiRsmbRgbLsbRoRsmbRibRibLcbLcbRibRgbLibRsbRjbR
ibLiLsbLgbRcbLsbRibRsRsmbRibLjbRcbReRsmbRibRcbLibRibRibLhLsbRjRsRsmmbR
jRgRsmbRhRsRsmmbLebRibRjLsbLibLsbRibRjRgbRsbLibRgbLebLcbLsRsbLibRibLiL
sbRgbRibLibsbRibRhbRgbLcbLgbRhbLoLsmbRcbLcbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbLsbRsbRgbLgbRgbRsbRoLsLgbLgbLsbLebLgbLiRsbRsLsbRsLsbLsbLcLsmbsbRsR
smbRsbRsbLcRsbLibRsRsmbRibRsLsbLcbRgbLsbLgbLcbLsbRibLibRgbLibLoLsmbRsb
LsbRsRsmbRibRsbRcbRsLsbRgbsbLsbsbRibRgRsmbRsbLobRsLsbRhbRsRsmbsbRibRsb
LgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbRsbRhLsbLsbRgbRgbRsbsbsbRibRgbsbsbsbsbLobLcbRgLsbLgbsbRcbRibLcbLcb
LsbsbLhbLsbLsbsbRjbsbsbRgbLgbsbsbLjbRcRsmbRgbRsbLiLsbLsbLcbLgbLgbRcRsm
bsbRgbsbsbRibRsbLsbLsbRibRsbRsbLsbLsLjbLsbRsbRhbRsbRibLsLsmbLibsbLhbLs
LsmbLobRsRsmbRsbRgRsmbsbRhbRgbLsbRiRsmbLsLsmbLebLgRsLsbLsLsLsmmbLgLsbR
sbRsbRsbLjbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbLsbLgbLgLsbLibLgbRibLjRsbRgbRsbLibRjbLgbRsRsmbRibLcbLcbRjbLebLsbLo
bLibLsbLgbRibRcbLgbRsbRcbRibRgbRgbLgbRsbLgbLgbLibRhRsmbRibLjbLcbLhRsbL
ibRjRsmbLibLsRsbLibRsbLibRgbLcRsbRibLiRsbLgbLibRgbLibRgbLibRgbLgbRsLsb
LibRsbLsbLgLsbLgbLgLsbRgbLgbRsRsmbLcbRibRcbLjbLjbLcbRgbLgbRgbLibRsLsbL
ibRibLiLsbLcbRgRsmbRiLsbLcbLibLiLsbLsbLibRibRjRsRsmmbLcbRgbLibLibRibLh
bRgbLibRgRsmbLiLsbLibLibRsbLhbLibRibRhRsmbLjbLjbLibLcbLcbLibRiRsmbRgbL
iRsbLgbLibRgbLgbLsbLhbLiLsbLgbRgbRgRsmbLsLsmbLsLsmbLhbLhbRibLibsbLibRc
bRcLsbsbRibLibRobRcbRobRibRibRgbLsbLsbLjbRibRibRcbRibLsbLsRsbLsRsbRgbL
ibRhbRcbReRsmbRibRibRgLsbRjbLjbRcbLgLsbRgbLibRjLsbRcbLcbLobRibLcbRsbRg
bLcbsbRhRsmbRcbRcbRibLhbLiRsbRcLsbLhbLcbRibRcbLibLsbLiLsbLcbLibLibLsLs
mbLsbLibLcbLibLsbLgLsbLsbRhbRiRsmbRhbRcbRiLsbLiRsbRjRsmbLhbLsLsmbLgbLc
bLibRibLgbRcbRcbLibLgbRgbRhbRibRsbRcbLsbLsbRibLgbRcRsmbRhbRibLibLibLib
RibLibLjRsbLcRsbLobRjRsmbRcbRiRsmbRibRgbRgRsmbRsbLgbLcbRjbLcRsbRjRsRsm
mbLcbRibLjLsmbRcbLjbLcRsbRsRsmbLgRsbLcbRgbLhbRgbRcbRcbRibLgbLgbRibRibR
sRsmbRjRsmbLcbLcbRjbLobLiLsbRgbRgbLibRcbLibLcbLgbLsbLsbLsLsmbLibRjbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbLsbLsbLcbRibLibLsbRjbLiRsbLjLsRsRsmmbReRsmbLebRibRibRjbRibLobLibLg
bLiLsbRebLcbLcbLiLsbLgbRsbRsRsmbRibsbLcbLgbLsbRibsbLhLsbLsbRsbRjRsRhRs
mmbLsbsbLjbLcLsmbLibRoLsbLcLsmbRibLcbLsLsmbLsbRsbLgbLsLsmbsbsbLgbLgbRs
bLsLsmbLsbRoRsmbsbRsbRibLgbLsbRibLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bLsRsbRcbRibRibRhLsbLgbLibRibRjbLcbLgbLgRsbsbRjbLsRsbLcLsRsmbRgLsLsmbL
ibRjLsRsbsbLhbRgbLibLibLcbRibLibLsbRhbLsbsbsbRibRcbLsbRibLgbRcbLibRcbL
gbRcbRibLibRgbLibLhRsbRgbLhbRgbLsRsbLibLgbRjRcLsLsmbLcbRjbRhbRhbRibLib
RgbLgbRsbRibRsbLjbRhbLcbRibRibLobLcbLgbLcbRgbLhbRibLjbRhbRgbRgRsmbRcLs
bRsbRcbRibLgLsbRsbLibRibRcbRibRsbRgbRibLgbRibLsbRiRsmbLjbRhbLsbLcbLgbR
ibRgbLgbRgRsmbLgRsbRibRibLgbLjbRhbRgbLcbLibLhLsbLibLsbLsbRgbRibRibRsLs
RsbRibLcbLcbRibRjbLhbLibLibRgbLcbLgbRibRsbRhbRhLsbLgRsbRcLsbLgbRcbLgbR
iRsmbRgbRsRsmbRibLgRsRsmbLsRsbRibRsLsbRgbLibLhbRcbRibRcbRcbRibRibRhbLj
bLcRsLsbRcLsbLcbLhbRibRiRsLsmbLcbLibRsbLsbLobRibsbRjLsbLsbLibLgLsbRjLs
bRcbLjbLsbLhLsbRjbLcLsLsmmbRibRcbLgbsbLcLsmbLcbLcbLibRibRgbRhLsbLgbRib
LibLibRcbRsLsbRibRcbLgbLcbRhbRibRibRibRibRiRsmbLgRsbRibLgbLcbLjLsLiRsm
bRjbRebRcbRcbRhbLjbLjbLibRcbLhbLgbRcLsbRibLgbLjbLcbRibLibLsbLsbLgbRgbR
jLsbRhbLjbRibRsRsmbRibLsbLsbRhbLgbRgbRgbLsLsmbRgRsLsmbRsRsLsmbRgRsLsmb
LgLsbRibRsbRsbLsbLsbRibLsLsmbLeRsbLibRsRsmbsbRjRsmbRcbRhbLgbLhbRjbLhbR
ibRcRsmbLjbRgbRiLsbLjbLjbRhbRgRsmbRibRsRsmbLsbRibRiLsbLgbRiRgbRsbRebRg
bLgbRibLjbRiRsmbRgbRhbLgbRhbRsRsmbRgbRibRibLsLsmbRsbRiRsLsmbRsRsmbRgbR
sbRgbLsLsRsmbRiRsmbRsbRgbRgbLjbRibRsbRiLsLsmbLibLibRiRsmbRgbRsbRgbLsbR
iRsLgmbsbRibRsbRiLsbRgbRibLsbLjbLibLhLsbRhbRcbRibLgbRcLsbLgRsbRgbLsbRi
RsmbRsRsmbRgbRsbRjbRsbLgbRibLgRsbRibRsbRibLsbRibLsbRibLsbRibLjbRibRiRs
mbRsRgbRcbRcbRjRsmbLcbLibLibRjRsmbLjbRhbRhb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
b

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bRgRsmbLgbLibLgbRjbRsbsbsbLcbLiRsbLgbRsbLsbRcbLjbLoLsRsmbLsbLibRgbLiLs
bRgbLibLsbLgLsbLhbRsbLgbRgbLibLsbLgbLibRsbLgbRgbLibRgbLibLsLsmbLgbRsLs
bLgbRsbLibRsbLgbLgLsbRsbLibLgRsbsbLgbRgbLibRibLibLibLgbRibLgbLibRsbLsb
LibRsbRsbLgRsbLgbLgbLgbLsbLgbLsbRcRsmbRibRibLgLsbLsbLhbLcbLibRsbLgbRgb
LgbLgbLibRgbRcRsmbsbLjbLcRsRsLsmbLiLsRsbRsbLiLsbLibLgbLsbLgbLjbRjbLhbR
jbLhbRcbRhbsbLjbRcRsmbRgbLcbsbsbsbsbLjbRgbLobLibLibLsbLsLsmbsbLobRcbRg
LsbLgRsbLibLcbLgbRsbRcbsbRgbLgbLsbLgbsbRsbRgbsbLsbRsLsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bRibsbRiRsmbRhbRibLcbsbsbRcbRebLebLebsbLjLsmbLcbRibsbRibRiRsmbLebRhbRj
RsmbRsRsmbsbsbRgbLjbsbsbsbRibsbLsbsbsbsbRiRsmbsbRjRsmbRsRsRsRsmmmbRgbL
jbRhbLsbsbRcbRobRgbRcbRibRsbRsbRgbRgbRsbRgbRgbRgbRibsbRhbRgLsbRsbLjbLo
RsbRgbRgbRcbRibRhLsLsmbLgbLgbLsbRjRsmbRhbLsbRibRcbsbRibRibRgbRibLibLsb
RcRsmbRiLsbRgRsmbRsLsRsbRsLsbRibRiRsmbLgLsbRibRgbLsbRiRsmbRgbLgbLibRcb
RibRsbLgbRobsbRibRgbLsLsmbLcbsbRiRsmbRibRgbLibRcRsmbRsRcbLiLsbsbRhRsmb
RibRgbRgbRsbRibLgLsbRibsbsbRibRsRsmbRiRsmbLjbRsLsRsRsmbRiRsRsRsmmmbLsb
LeLsbsbsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bsbLsLsLsRsmmbLebRebsbRgbsbLsLsmbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bLibLgRsbRgbsbLiLsbRgbLcbRgbLgbRsbLgbLsbLgbRjbLcbRgbRgbLhbRgbLibRsbLib
RgbLsLsmbLibRsbLibLiRsbRibLobRgbRgbLcLsmbLibRibLgbRsbLgbLgLsbLgbRgbRsb
RjbRhbRibRsbRibLsbRsbRgbLsbLgbLobLsbRjRibRgbRiLsbLsbLgbRibLsbRgbRgRsmb
RgbRsbLsbRiLsbRgbRsbRsRsmbRgbRcbRiRsmbRgbRgbLsLsmbLsbLsbRgbRsRhbRsbRib
RsbRsbRiLsbRgRsmbRsbRgbRgbLgLsbRsbRgRsmbRgbRsbRgRsmbRgbRgbRsLsLsmbLgbR
gbRgbRgbRibLgbLsbRhLsbRgbRibRibRgbLsbRibRibRgbRibRsbRiLsbRsbRibRgbRgbR
sRsRsmmbRsbRsbRsbLgRsbRgbRhbRiLsbRgbsbsbRgbRsbRsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162030; End: 162531;
Recording: 2-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bRibRgbRhRsmbRoRsmbsbsbRsbsbsbsbsbRgbLgbRgRsmbRsbLebLcbRoRsRsmmbRoRsRs
mmbLgbRibRgbRsbLsLsmbRgbLsbLsbRhbLgbRsbRibRgbRgbLsbRsbRgRsmbLsbRsbRibR
sbLsRsbLsbRgRsmbRgRsmbsbRgRsRsmmbRsbLsRsLsbLsRsbRsRsmbRibRsbRgRsmbRgbR
gbsbRibLsbRibRgbRsbRgbLsbRgbRgbRgbRgLsRsbRgRsmbRgRsmbLsRsbRgRsmbLsLsmb
RiRsmbRgbRiRsmbRibLibRibRgbLsbRiRsmbRgbRibRibRsbRcRsmbRibRgbLcbsbsbRsb
RjbRibRsRsmbLhbRibRibRgbRgLsbRibRgbRibRsbRebLgbLsbRoLsLsmbLibLsbRiRsmb
RibRsbRibRiRsmbLsbRibRsRsmbsbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 1; Drug: Control
bLcLsmbRiLsbRiLsbsbRsbLhLsbLgbLcLsmbLsbRhbLcLsmbLgbRiLsbLhLsbLibRoRsmb
LsRsbRgbLgbLgbLjLsmbsbRgLsbLjLsmbRoLsbLgLsbRsbRibRiRsmbRsLsbRibLcLsLsm
mbRibLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 2; Drug: Control
bLcbRibLoRsbRjbLgbRsbLsRsbRgbRsbsbRgbLsbLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 3; Drug: Control
bsbLibLibRoRsmbRgRsmbLhbRiRsmbRhbLsRobRcbRcbRcbsbsbRsbLebLcbRsLsbLcbLc
RsRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 4; Drug: Control
bLgLsbLhbsbRjRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 5; Drug: Control
bLsbRobLsbLgLsbLgbRsbLibRsbRgbRibLjLsmbLsLsmbLsbLjbLibRsbRsbRsbLgbLibR
sbLgbLsbLsbRsbLgbRsbLsbLgbLsbLsbLsbLsbLibLgLsbLgbRsbRgbLsbRsbRsbRgbRsb
LsbLsbLgbLjbLgbsbsbLgbLgbLsbLsbsbsbRcbRobLgbLsbLibLibRsbRsbRgbLsbLsbLs
bRibRsbRsbRsbLgbLsbRsRsmbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 6; Drug: Control
bLgbLcbsbRcbLsbRgLsbsbRgbRoLsbLcbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bLibRcbRiLsRsbLibsbReRsmbRsbRgbsbsbLiLsbRebLgbLibRjbLgbRsbLgbLibRjbReL
sbRgRsmbRgbRsbLcbLgbsbRsbRcLsbLgbLsbLgbLibRgbsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bRcLsbRhbRhbRjbRgbLcbRcbLcbLobRcbLsbRgbRcLsbRjbRibRibLhLsbLgbRobRhbLjb
RhbLgbRhbLjbRibLibLibRgbLibLgbLsLsmbLsbRjbLibRjbRibRjRsmbLiRsbRgbLsbLj
bRebLobRgbRgbRjbsbLjbRibRjbLcbLcLsmbLhbLobLibRibRgbRobLjLsmbRobRhLsbLe
bRcbLjbRibRgbLsbsbsbRjRsmbLjbLcbLibLsbLgbLgbLgbLgbLibLsbLsbLsbLcbLibLh
bLibRgbLgbsbLhRsbLgbRibLibLsbLcbLibLgbLgbRsbLgbLsbLobRibLjLsmbLjbLibLc
bLjRsbLhbLhbLjbLsLcbRgbRsbLcbRgRsmbLcbLsbLgbLgbLgbLjbLgbLhLsbLibRgbLib
RgbLibLcbLibLibLsLsmbRsbRhbRibRiRsmbRsbsbLhbLsbRsRsmbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bLcbRibLibRibRhbRcbLsLsmbRgbRibLgbLjLgbRiRsmbLibRgbLjLgbRiRsmbRobLgLsb
RobRsbLgbRcbLsLsmbLobLgbLobRcbRcRsmbRgbRcbLiLsbRcbRgLsbRcbRoLsbRgbLsbR
eRsmbRsbRhbRobRibRibRibRsRsLsmbLibRcbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRcbRebLgbLgbLibLibRjRsRsmmbRcbLcLsmbLgRsbLcbsbLgLgbRebRhbRhRsmbRsRi
bLhbLibsbLgbLhbLjbLibRgbRcbsbLjLsLsmmbRiRsmbsbRibRibLjLsmbLsLsmbRebLiL
sb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bsbsbRhbLibLjRsbRhbLsLsmbLsbRibLjLsLsmmbRibRibRibLgbRibLiLsbRsbLgLsLsm
bLgbLgbsbRgRsmbRibLhLsbLsbRsbLjbLgbRhbsbLjbLiLsbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRhbRsbRibRibRcbRcRsmbRhbRhRsRsmmbRcbRcbRibRcbsbLcbRoRsmbLcbRjbRcbLs
bLgbRcLsLsmbRcbsbsbLsbRibRibsbRsbRibRibRiRsmbRibRcbRiRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bReRsmbRibLibLebLhLsbLjbRcbRcbsbRhbLjbRsLobLcbRsRsmbRoRsmbLsRcLsbRcbLs
RsbRsbLibLobLibLcbLgbRcbRibRgRsRsmmbLibRgbRcRsmbLcbRjRsmbRsbLibLgbRjbR
ibRgbLibRsbLsLsmbRjRsmbRibLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbRsLsbRsbsbsbLsbRibRibRobRcbRjRgRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bsbRsbLcLsmbRibRibRhbRsbsbLjLsmbRcbRsbLibsbRcRsLsmbRhbLcbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbLsbRsLsRsbRsbRcbRobLsLsmbRobRibRsbRgRsmbRjLsbRsRhbLsbsbLcbLsbRcbRc
LsLsmbRsRsmbRsbLibLobRibLebLibRsbLsbLibLsbLsbLibsbLsbLobLibRsRibLiLsbR
jRsmbRsbRgRsmbRsRibRgbRgRsmbRgbRsbRsRibLsbRcbRsbLsbRcbRsRsmbRsRgbLsLsm
bRgbRsRibRgbRgbRgbRobRsbRsRsmbRsbRgRsmbRsRjbRsRsmbRibRsbRibRsbLhbRibLj
b

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bLibLcbLhbLibLgbLgbLibLibRibLiLsbsbLgLsbLibLiRsbRhbLibLgbLsbLgLsbLhbLg
LsLsmbLibLgbLibLiLsbLgbRhbLiLsbLibLibLgLsbLibRibLibLibLiRsbLgLsbLiLsbL
ibLibLibLiLsbRsbLibLgbLibLgLsbRgbLiLsLsmbLhRsbLhbsbRsbsbsbLsRsbLhbLgbs
bLgbLibLibLibLibLibLibLibLgbLjRsbLibLgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbLgbLhbLibRgbLibsbLiLsbLgbLcbRebLjbLibRcbLcRsLsbLibLibLibLhbsbLgbLs
bRhbRibLhbLibRsbRcbLsbLjbLhbLsbLcbLibLhbLebLcLsLsmmbLibLgbRgbRjbLcbLgb
LibRsbRsbRsRsmbRjRgRsRsmmbRgbsbsbRsbLsLsmbLsLsmbLsRsbLsRsbRiRsmbLsbRjb
LgbLsbRgbRsbRgbLsbRsRsmbRsbLjbLsbLsbsbsbRgbsbRsbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bRgRsmbLsRsbRibRgbRsbLsbLsLsmbLsbLsbRsbLibLhbLiLsbLgbLgbRjbLsLsLsmmbLs
LsmbRgbLibRibLgbsbRgbRsbLsbsbsbRsRsmbRgbRsbsbRsRsmbRsbLsRsbRsbLsLsmbRi
bRibLgbLgbLcbLgLsbRsbRgbLibLgLsLsmbLsbRsbLibLgbLsbLgbLgbLgbRgbLoRsbLib
LgbLibRgbLsbLiLsbLsLsmbLibLibLgbLsLsmbLibLsbRsbLjbRiLsbRgbLsLsRsmbRgRs
RsmmbRiRsmbLibLsbLhbLibsbLsbLibLsbLibRgbLsbLibLibRsbRsbLiLsbLgLsbLsbRj
bLcbRgbRsbLeRsbLiRsbLibLgbLsbRsbRsbRibRcbRibLgbLsbLsbRibLebLsbLcRsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bRgbLsbLibLgbRsbRgbLcRsLsbLgbLsbRjbLibLsbRsRsLsmbsbLiLsbLiRsbRibLsbLgR
sbLgbRhbLcRsbLibRgbLgbLgbLiRsbLcbLgbLibLibLgbLibsbLsLsmbLgLsLsmbLgbLgb
LgbLibLgbRsbLsbLibRsbRebRcbRgbRgbLsbLibLibRibLhbRsRcbLcbRsbLibRibLsbLc
bLgbLsbLgbLgLsbLgbLgbRsbLgbRsbLibLcbRhbRgRsRsmmbLsbRgbRobLibLcRsbLibRs
bRsbLgbLsbLibLsbRsbLgbLgbRsbLcRsbRibRsbLoRsRsmbRgbLgbLcRsRgRsmbLibLgbL
gbLsbLgLsbRsbRsLgbRsbLibRgbRcbRiRsmbLgbRibLgbRibLsbRibRsbRgbLsRsbRgRsm
bLsbRoLsbRsbLsbLiLsbRsbLcRsbLibsbRgbRsRsmbLobRibLibRsbLcbRgbRsbLhbRgbL
gbRsbLibRibLgbLibRgbsbLibRsbLibLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bsbRgbRgbsbRibLgbRsbRgbsbRsbLsbRibLsbRibRsbRsbRgbLsRsbRiRsmbLsbRgbLsbR
ibLsbRsbRgbLsbsbRgbRsbRcRsmbRsbRgbRsbRibRibLsRsbRibLsbRibRgbLsRsbRgbRs
bRgbLsRsbsbRiRsRsmmbRsbRsRsmbRgbLsLsmbRgbRsbRgbRibLsRsbRgbRgRsmbLsLsmb
RgbRgbLsbRebLiLsbsbLgbRsRsmbRgbLsbRibRcbLgRsbLgbRsbsbLjbLcbsbRsbRsbRsb
RsRsLsmbLsRsbLsbLsbsbsbLsbLgbLsLsmbRsbLsLgbRiRsmbRgbRsbLgbRsbRgbRobLhb
LcbLobLsbRgbRebRebLsbRsbRhbLgbRsbRibsbsbLsbRsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbLsbLgbsbLgbRsRsmbRhbRiRsmbLibLibsbRgRsmbLibRibLcbLibRobRsLsbLsbLgb
LjbRsbLeRsLsbLjLsmbRgRsmbLsLsmbRsRsRsmmbLsbLgbLibLiLsbLibRgbsbLibRjbLc
bLibRsbRoRsLsmbLsLibsbRiRsmbRsbRsbLibLibRcbsbLhbsbLcbLgbRsbRsbLibLgRsb
RsbRsbLibLgbRgbLsbLcRsRsmbLibLgbLibRsbLgbLgLsbsbLsbLsLsmbRjRsmbRgRsRsm
mb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bLhbLcbLgbRiRsmbLobRsbLsbsbsbLibLsLsmbRsLsLsmbRsbsbsbsbsbRsLsRsLsbsbLg
RsbRsbRsbLsbsbLsbsbsbRsbsbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bLcbRgbRhbRobLobLcbRcbLhbRobLebLebRibLebLibLgbRebLobLgbRobRebRsbRgbLcb
LgbLobLcbLebLcbRcbLibLcbRobLebLgbLcbLebRebRobRobLobRebLobLebRgbLcbRcbL
ibRcbRcbRebRebLebRobRobRebRobRobLcbLobRobLebLobRobLebRebLobLibLebRobLg
bRebLobLebRobRobLobRgbLobRcbRibLebRcbRebLcbRibRibLobLobRobRcbRobLobRcb
LhbLgbRobLibLobRobLobLcbLcbLebRebLobRcbLobRobRjbLebRobLobLebRobRibRobL
gbRebLobLobRcbRibRebLobRobLebLobLgbLgbRebRgbLebLebRebRcbRebLobRobRebRc
bRobLobLobLcbRcbRebRgbRcbLibRobLobLobLcbLebRobRhbRebRebRgbLobRgbLsbLob
RhbRjbLgbRobRebRebRgbRobRibRcbLobLobLobLobLcbRcbLobRibRibRcbLobLibLcbR
obLobLobLhbRobLobLcbLobLobLobRobRobRebRjbRobLobRibRobLobLebLgbLobRobLo
bLibRgbRobLobRebRobRobRsbLobLobLobRobRjbRebLebLobLcbLobLebLobLobLcbReb
RobRibRobRebLsbRibLibRhbLebLobRibRgbLcbLobRobLsbLgbLgbLsbRobRobLebRebL
cbRcbRcbRcbLebLibLobLibRebLebLobLebRobLibRcbRebRgbLobRobRcbRcbLebLcbRo
bRcbLobLgbLebRcbLobLcbLgbRobLebLobLebRobRgbRobRobRebLsbRobLobRebLobRcb
RobLcbRcbRebLhbLobRobRebLsbRobRcbLibLobLobRebLcbRobRcbRgbRobRsbLobLgbL
cbRcbLgbRobRobRobLobRebLibRobRsbLobLobRgbRgbRjbLebRebRibLobRobRibRhbRc
bLibRjbLcbRobLebLobLcbRobLebLobLcbRobLebLebRebRobLobRjbLhbLobRobLebRib
LcbRobRobRibRgbRobLgbLebRobLebRcbRobRgbLobLobRebRcbLobRgbLobRebLcbRobL
sbRebLebRobRgbRcbRobLebRsbRcbLibRsbLebLibRobLcbLebLebLobRobRsbRebRebLe
bLhbRobRebRebLgbRobLobRcbRobLobLobRebRebLibLsbLjbLobRobLsbRobRobRebLob
LebLsbLebLcbRcbLobLibRcbRcbLobRsbRcbLibRobRebRebLobRobLibLebRobRcbRgbL
obRobRobRobLobLobLcbLobLobLobLibLobRgbRebRobLebLobRibRobLgbRebRobRobRe
bLebLhbRhbRgbRobLebLobRobLcbLgbRebLobRsbRobRcbLobLobLcbRibLobRobRobLob
LebLobRhbLebLobRobLobLsbRibLebRobLebLobRcbLobLgbLobRebLebRebRobRibLobL
ibRsbLobLcbLobRobLobRibRobRcbRobRobRsbLobLebLsbLibRebRebLobLebLebLobLo
bRebLebLebRibLebLobLcbRebLobLobLcbRebLsbLebRobLebLcbRobLobRebRobRhbLeb
LobLobLcbRobLebLobRobRobLebLobLebLobLebLibRobRobRebLobRibRobRgbRcbLcbL
ibLsbRcRcbRobLobLebRobRsbRebLobRobRobLobRobLobRobLsbRobRsbLobRebLobLhb
RibRobLobRjbLebLebLobLobRgbLobLgbLebLobRobRibLobLobRcbRcbLebRgbRobRcbR
obLobRobLebRebLcbRsbLgbLgbRobLobRcbLobLcbLobRebRebLobLobLcbLcbLcbLobLc
bRobLibLcbLobRcbLobLcbLebRebRobRebRobRobRobRcbRobLhbLhbRcbRcbLsbRobRib
RebLebLhbLgbLcbLobLebRcbRobLobRcbRobRebRobLobLibRobLebRobLsbRobRcbLobL
ibLobLsbRobLsbLebLobRobLibRebRobRobLibRobRobLgbRsbRobLibLobRcbLebLobRo
bRebRobLebRibRsbRobLebRhbRsbLobRobLobRsbRebLobRobRobRobLobRcbLibRgbLgb
LcbRobRobLebLebLibRebRebRcbRebLobLcbRobLebLibRgbLobRobLhbRobRobLebRcbL
obLjbLobLebRebLobRobRsbRebLobLebRcbLobLebLibRobLhbLobRibRhbRobLebLcbRe
bRobRebLcbRebRcbLobLebLobRobLibLsbRobLcbLobRobRebLobRebLobLibLobLcbLeb
RobLobLebLobLobRcbLsbLebLsbRebRobRobLcbRobRobRsbLobLobLobRebLebRebRjbL
cbLsbLobLobLibLcbRobLobLobLebLebLebRibLobRebRgbLobRobRcbLebRobRebLgbRe
bRcbRobLgbRcbRebLobLjbRcbRobLsbLibRcbRjbRebRobRebLebRebRobLobLobLobRgb
LobRebLebLebLcbLsbLibRcbLhbRcbLobRsbRcbRobLcbRcbRobLebRobLebLgbLebLebR
jbRcbRobLobRebLibRobRobRobRobLobLobRsbLcbLobRcbRobRgbLebLobLgbLibLcbLo
bLcbRebLcbRebLebLobRebRobLcbLibLobLobLobLsbLobLcbLobRgbLcbRobLobLjbReb
LobLobLebRgbRgbLebLobRobLobLhbRgbRibRebRobLebLobRibLebRcbRobLsbRebLebR
obLibLobRsbLibLibRobLobRcbLobLobLebRcbRobLebLcbRsbLsbRobRebRebLobLibLc
bLcbLcbRobRobRobRcbRcbRcbLobLebRcbRobLebLob

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 25; Drug: Control
bLhbLgbLiRsbLibLgbLjbLeLsbLoRsbsbsbRgRsmbRcbLjbLibLgbLibRobLgbsbLsbLgb
Lib

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 26; Drug: Control
bLibRibLobRib

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 27; Drug: Control
bLcRsbLsbsbLsbLibLhbsbLoRsbLgbLjbLibLcbLcLsmbRgbRcbLsbRcbLsbLhbLibLsbR
sbLjLsmbLibLgbLsbRibRsbLibLiLsbRsbRsbRobRsRsmbRhLsbRibRsbLibLsbLsbLjbL
ibLgbLibRibRsRsmbLgbLsbLsbLibRsLsLsLsmmbLgbLsbLgLsbLsbLsLsmbLgbRsbRsbL
ibRjbRiRsmbRibLsbLsbRibLgbLibRcbRgbLsbLhb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 28; Drug: Control
bRcbRoLsbLsbRoLsbLsbRobRgbRsbRsRsRsmmbLsbRsbLgbLebLibLibRsRsmbLsbRcbRg
bRgbRsbReLsbLgbRobLsbRhbLsbLsbRibRcbsbRcbRsbLibsbRobRsbRsbRsRsmbLsbLgb
LibsbLiRsbLsbLsbLgbLibLhbLibLgbsbLsbRibRgbRgbRsbRjRibRsbRsbsbRgbRsbRsb
RhbRsbRgbLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 29; Drug: Control
bsbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 30; Drug: Control
bsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bRcbsbsbLhbRcbLjLsmbRobLhbLebRjbLobRobRcbLibLsbRsbRhbLjbRibLjbRhbRhbLo
bLsLgbLjbLcbRcbLsbRjbRhbLgbLsbLibRobLibLgbLsbLsLsmbLibRsbRgbLjbLsbsbLi
bLibLhbLcbRcbLibLibLsbLcbLhbLibLgbLibRcbLgLsbRcbLcbLgLgbRobLhbRjbLhLsb
LibRebRsbLgbRiRsmbLibLcbsbRibLhRsbLcbRhbLjbRobRcbLibRhbLjbLibRcbRsbLcb
LiLsbRcbRgbLhLsbLcbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbLsbRibLsbLibLsbLsbRiRsRsmmbLibRobLsLsLsmmbLhbRibLgbLgbRgbLibLjLsmb
RcbLsbLsbLgbRhbLsbLibsbsbsbRiRsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbLiLsbLgbsbsbLcbLebLibLiRsRsmbLibRcbLjbLcLsmbLibLjLsLsmmbLcbLibLcbL
hRsbRiLsbLsbLgbsbLibLgLsbLiLsbLibLgbLhbLibLibLibLcLsmbLsbLibLhbLhbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bLcbLcRsbLhbLgLsbRgbLhbLibLsbLgbRsbLgLsbLgLsbLsLsmbLgbLsbRsRsmbLibRsbL
sbLgbLsbLgbRsbLgbLibRsbLsbRcbLsbRcbRhbRcbLibRibRcbLgbRibLiLsRsbLcbRibR
gbLcbRgbLhbRgbLcbRibLgbLibRcbRcbRibRcbRcbLsbLibLcbLjLsmbLhbRjbLcbRibLc
bRcbRcbLhbLhbRhbRcbLcbLoRsbLibLibRhbRgbRsbRcbLcbLhbRcbsbRibLcbLoRsbLcb
LhbLsbLgbLobRcbRhbRsbRsbRsbRiLsbLsbLgbRibLjbRibRibLsbRibRsbRsRsmbRgbRg
RsmbRsbRgbLsbLjbLcbLcbLjbRcRsmbRcbRhbRcbRgbRgbLgbRsbRibRgbLsbRibLcbLcb
sbRibRcbRcbRoRsmbRcbRgbLebRobRibRgbRsbRgRsmbRsRsmbRibLgbLsbRibRgbRsLsR
sbRsRsmbRsbRgbRsbRsbRgbLsbRgbRsbRsbRgRsRsRsmmmbLsbRgbLsbRgbRsRsmbRsbRs
bRgbRsbRgbRgbRsRsRsmmbRibLsbLjbRgbLjbLcRsbLibLiRsbRobLcbLcbsbLsbLcbLib
RcbRibLsbLsbRibRsbRgbRsbRgbLsbRgRsmbRgbRsbLsbRiLsbRgbRgbRsbRsRsmbRgbLs
RsbRgbLsbRibRsbLgbRgRsRsmmbRsbRsbRsbRibRsRsLsmbRsbRsRsmbRgbRsRsmbRsbRs
bRgRsRsmmbLsRsLsbLsbLibLjbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bRibLcbLibLibLgbLhLsbRibRsbLsbLgbLibRibLiRsbRiRsmbRibLsbLiLsbRgRsmbRgR
smbRibLsbLgLsLsmbLgbRobLibRiRsmbLiRsbLgLsbsbLsbsbsbRgRsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bRhbLobLcRsLsbLobRjbRobRcbsbLcbRcbRcbLibRgbRoRsmbLhbRcbRcLsbRibRgbLgbL
sbRibLsbRibLibLgbLsbLsbsbRgbRsLsbLjLsmbRgbLsbRgbRibRgbLobsbRhbRsbLobRg
bRjbRjbLgbLob

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bsbRcbRhbsbsbRibRsRgbLgbRhbRgbLsRsbRsbLgbsbRjbRcbRiLsbReRsmbLcLsmbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbRgbRobRibLsbLsLsmbRsLsbLgLsbRsLsbLsbLsbLgLsbRsbLsLsLsmmbRcbRsbRsbR
ibLsbRgbRsbLsLsmbRoLsbLjLsmbRsbRibRhbLoRsRsmbRsbLobLcbsbLcbLhRsbLgbLcb
sbRgbRoRsmbLsbRgbLsbLcbRibRjbLsLsmbLcbRibRsbRgRsmbLsLsmbLsLsmbLsLsmbRg
bLcLsmbLobsbRgbLgbLgbLgbLsRsbLsLsmbRgbLgbRcbRsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bLiRsbLsbRhbsbsbsbLsLsmbLsbsbLsLsLsmmbsbLgbRsbRsbRsbRsbLsbLsbLsbLsbLsb
LjbLsbRsbLsbRsbRsLsbRsbRsbRsbRsbLsRsbRsRsmbLsRsbRobLjbLeLsbLgbRebRibRs
RgbRsbLsLsmbRcbLsbLsLsmbLgbLsRsLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bLjbRcRsmbsbsbLcbLibLhbsbLibLgbRibsbRsbsbLsbLjLsmbRcbRgbRcbsbRcbRcbLjb
LsLsmbRjRsmbRjbsbLcbRsbLobRoLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bRobRsbLibLgbRjbRcbLibLcbLibRiRsmbRsLsbsbRsbLsbLgbRsbLgbLgbLsLsLsmmbRs
bLcbRibLgbLsbsbLhbsbsbLsLsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bRibLjbsbLobLcRsbRhbRibLhbLgbRibRibRiLsbLgbRhRsmbLgbRibRibRsRsmbRgbLsb
RgbRibLsRsbRsbRgbLjbRiLsbRsRsmbRiRsmbRsbRibLgbLjbRcbRhLsbLcbLjbLcbLobR
cbRibLhLsbRsbRibLiLsbRjbLcbRgbLobLcbRgbRgbLibLhbRibLsbRsLsRsbRjbLibLgb
LcbRjbLcbLhbRcbRgbRsbLibLhbRibLibLsRsRsmbLsbRjbRhbLibLcbRhbRcRsmbLsbLj
bRcbLgbRibRibLsbRgbRibRibLibLgLsbLsRsbLsLsmbLcbRgbLcbRibRjbLcLsmbRjbLc
bRsbLibLhbRsbLibLibLgLsbRgRsmbLsRiLsbRgRsmbRibLsbRcbLibRhbLcbRhRsmbLgb
LibRibRsbLjbRcbLobRebLcbRhbLjbsbRobLjbLcbLibLcbsbLiLsbRcbLibLiLsbRjbRc
bLjbRcbLibLsLsmbRjbRcbLhRsbsbLcbLcbRibLibRibLibLibRcbLsbRjbRcbLjbRcbRs
bRgRsmbRiRsmbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bRgbRsLsbRsLsbRsLsbsbRsLsbLiLsbLsbRsLsbLibLibLgbRsbRsbLcLsmbLsbLibLsRs
bLibsbLebRsbLibLgbLgbRsLsbLgbLgbLsLsLsmmbRsbLsLsRsmbLgRsbRsbLjbRjbLcbL
ibLgbRjbLcbLibLgLsLsmbLgbLsbRsbRsbRcbRgRsRsmmbRsbRsbLsbReRibRgbRjbLobR
gbRsRsRsmmbLsRsbLsRsbRsLsbRsRsmbRjRsmbRsRiRsmbRsbRsbRsRgbRsbRsbRjbRibL
ibRsbLgbLgbLgLsbLsRsbLsLsLsmmbLgbLsbsbLgbLgbLsbLgLsbLgbLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bLsLsRsmbRcbLsLsmbLibLcbLsLsmbLibLiRsbLibRoLsbRibLsbRobRgbLcbLiLsbRsbL
ibLgbRsbLgbLgbRsbLibRsLsbsbLgbRjbRebLgRebRgbRgbLgbLjbLhbRgLsbLoRsbLgbR
gRsmbRibLobLibLgbRsbRgbRsbRcbRibLgbLsbRcbLgbRoLsbLgbRsbLhbLibRsbLsbLgb
RsbLgbsbLgbLgbRsLsbLgbLgbLgbRsRsmbLibLgRsbLsbsbLgbRsbRgbLjbRsRsmbsbsbR
jbRcbLsbRibRhbLibsbRhRsmbRibRgbRibRgbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bLsLsmbRsbRiRsmbRibRcRsmbRhbsbRjbRiLsRsbLcbLoLsmbRjbRgbRebRibsbLiLsbLi
bLjLsmbLsbsbReRsmbRcLsbLeLsbLibLcbRgbLcbLgLsbRibLjLsmbRjbRjbRcbReRsmbR
cRsmbRibRhbRgLsbRibRhbRibLhLsbLibLcLsRsmbRibRjRsmbLcbLjbLebRjRsRjmbRcb
sbRibLibLoLsLsmmbRsLsbRsbLcLsmbRsbLibRsbLibLiLsbLsLsmbRibRsbLoLsmbLsLs
mbRgbLibLcbRgbRsbLibRsbLsbRebsbReRsmbRsbLjbRcbsbRibRibLibLsLsLsmmbRibR
cLsbLjbLcbLebLibLsbRsbRcbLebRiRsmbRgLsbLcbRhRsmbLjbLcbRjbRcRsmbLsLsmbR
gbRgbRsLsbLgbLcbLobRibRibRcRsmbRgbLeRsbLsbLiLsbLsLsmbLsLsmbLsLsmbLcbLi
LsbRhbLcbLgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bRsLsRsbLcbLhLsbLsbRebRhbRsRibRibRibsbsbsbRhbRsbRsRsmbsbRgLsLsLsmmbsbL
sbRjRoRsmbLhbRcbRcbsbRsRsRsmmbRgbRsbRobLsLsmbRsbLgbLsbLibRcbRcbRsbRsbR
sRsmbRiRsmbRibRsbRsbLsbLibLcbRsbLhbRgbRsbLiLsbRsbLobRsbLgbLsbRgbLcbsbs
bRsRsmbLsbsbsbsbsbsbsbsbLiLsbRgRsmbLebLibLgLsbLsbLgbLsbRsbLibLsRsbLibR
sbLgbLgbLgbLsbsbRsbLsbLgbLgbLgLgLsbLsbLgbRsbLgbLgbLsbLgLsLsmbLsbLgLsbL
sbLsbLgbLgbLgbLsbLsbLgbLgbLgLsbLgbLgbLgRsbLgLsbRsbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bsbsbRsRsmbsbLcbRgRsmbRjRibRgbsbRsbRiRsmbLgbRsbRgbsbLsbRcbRgbRsRsmbRiL
sRgbRiLsbRibLsbRsbRibRiLsbLsbRibRibRsRsmbRibRibRibRiLsbRsbRibRibRibLgb
RhbRibRsbRsbRsbRgRsmbLjbLibLibRgbRcbRhbLiLsbRgRsmbRibLgRsbLcbLgbRibRgb
sbRsbRgbLsbLjbRcbRgbLsRsbLcbLibLibRsbLgbRgbsbLcbRgbLibLibRsbRgbRjbRibR
hbLsbRgbRsbLibLsLsmbLibLibLoRsbRgbsbRibLjbLcbRgLsbLgLsbLiLsbRgbRcLsbRg
RsmbRhLsLsmbRsbRgbLgbRgbLcbLgLsbLsbLsbLiRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 162532; End: 163032;
Recording: 3-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bRsbsbRgRsmbLobLibRjbRgbRsbLcbRgRsmbLcbRibRiRsmbRsRsmbLsLsmbLcLsmbLhbL
sLsmbsbLebRibLsbLhbRsLsRsLsbLgbRsbLibsbRsLsbRjbLcbRgbRiLsbRsLsbLsLsmbR
sLsLsmbRsbsbLsbRsLsbRsbLsLsRsRsmmbRsbRsbLcbRsbLiLgbLsRsbLsbLsbLiLsbRsb
LgLsbLiLsbLsbLgbLsLsmbLibRsbLsbsbLsbLsRsbRsbRsRsmbRsbRsLsbLsbsbRsbRsbL
sRsbRsbRsLsbLsbsbsbRsbRsbsbsbsbsbRsbRsbRsLsbRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 1; Drug: Control
bLcbRiRsRsmmbRsbRoLsRsbRebLeLsbRsbRgbsbsbRcLsbRoLsbRgbLibLsbLsbRcbLcbL
hbRgbLgbLiLsbLhbRibsbRsbLcLsmbLgbRgbRiLsbLsbRobLiLsbLjbRob

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 2; Drug: Control
bRjLsbRsLjbRjbLsbLsLobLsRsbsbRsbsbRsbRsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 3; Drug: Control
bLebLibLgbLgLsLsmbLgbRhRsmbRjRgRsmbLcRjbRhbRiRibsbRiRsmbRobRiRsmbRcRsR
smmbLgLsLsmbLcbLcbsbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 4; Drug: Control
bLgbRjbRsbRgbLob

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 5; Drug: Control
bLoLhbRebRgbRjbRibRiRsmbLebRcbRsRsmbLsbRgbLgbRibLsRsbRcbRsbLgbRobLgbLg
LsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 6; Drug: Control
bsbLibLibRcbLoRsbLobLsbLsbsbLoLsRsmbLob

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbRsRsmbRsbLobRiRsmbsbRsbLsbLcLsmbLibLgLsbLsbLsbLsbRsbRcLobRsbRgbRob
LsbLcbRcbLibLsbLcbLgbRcRsmbsbLibLibLcbLjbLgbLibLcbLhLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bLhbRhbRjbLjLsLsmmbLsbsbLibLgRsbLiLsbLcbLsLibLibLibLgbLibLgbLgbLgbsbLg
LsbLgLsbLgbLcbLibLgRsbLibLibLiLsbRibLgLsbsbLgLsbLcbLgLsbLsLsmbLobLibLg
bLcLsmbRsbLoLsmbRoLsbLsbLcbLibLjbLibLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbRcRsmbLgbRsbRhbLoLsmbRsbsbRcbRibRcbRobRgbLhbsbRibLobRoRsRsmmbRgbRs
bLiLsbLsbRcbRsbRgbLcbLgbRcbRgbRebRcbsbLibRgbLsbLcbLsbRcbLsbLcbRebLsbLc
bLcbRcRsmbLgbRobRibRcbLsbsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbLsLsmbLjLsmbLibLsbLsbLgbLsbsbLebRiRsmbLibLcbsbLcbsbLgLsbReRsmbRcbR
iRsmbLobLebLhbRhbLcbsbLibLcbsbLgLsbLibRoRsmbRiRsmbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bRsbRsbLjbRobLibRgLsbRsRsmbLcbLsRsbLiRsbRcbLgbReLsbLiLsbRebRsbRcbLobLo
LsmbRsRsmbLgbLgLsbReRsmbLjbRibsbLobLjbLcbLgbRibLibLsbLsLcLsmbLobLsbRcb
LgbRgbLsbLjbLcRsbRjRibRhbRsbLjLsmbRhbLibLhbLgbLibLsbRibRcbRcbLibRhbLsb
LibLjbsbLjbLcLsmbRcbRhbLibsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bRiRsmbRcbRibRibRcbRhbRsbLsbRibLsbRsbsbRsbRsbsbsbRhbRibRgbRhbRjbLsLsmb
RibsbsbRcbRobRcbLibRcbRsbLsbReb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bRhbRcbRoLsbRgbLhbLsbRhbRcRsRsmmbsbsbsbRsRcbRcbRhbLibLsbsbRcbsbLiLsbLs
bRhbLsRsbRgRsmbLgbLgbRibRgLsbLsRsbRgbRiLsbRcbRhbRgbLibLiLsbRcbsbRibLjb
LsLsLsmmbRibRgbLgbLjbRgbsbRjbLobLgbLibRjbRibLhLsbRgbRgbLibRgRsmbLsbRib
LhbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bLibRsRsmbRsbLsbsbsbsbsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bsbLsbRsLsbRsbRsLsbLsbRsLsbRsLsbRsLsbRsbLsLsRsmbRsbRsLsRsbLsbsbRsRsmbL
sRsbLsRsbsbLsLsmbRsLsLsmbRsRsLsmbRsbsbLsbLsbLsLsmbLsLsmbRsbRsbRsLsRsbR
sRsmbLsLsLsmmbRsbRsbLsbsbLsbLsbRsbLsLsmbLsRsbRsbLsLsRsmbRsbLsbLsbLsbLs
LsmbsbRsbRsbLsbLsLsmbRsbRsbRsbLsLsmbLsRsLsbRsLsbLsbRsLsRsbRsbsbRsLsbRs
LsbRsbRsbsbRsLsbsbsbLsbLsLsLsmmbLsbLgRsbLsRjbLcLsmbLcbLobLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bLibsbLsbLsbsbsbsbRsbRsbLsbLsbLsLsmbsbsbLgbRsbRsbLgbRjbsbLibsbLgbRsbsb
LgbsbsbRsbsbsbsbsbsbsbsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbLibLcbLibLcbLcbLgbLibLhbLgLsbLsbRgLsbLgbLibLiLsbLibLiLsbLibLhbLibL
hbLhbRcbLibLsbLsbLibLibRcbsbLhbLsbLjLsmbLhbRgbLcbLhbLibLsLsmbLiLsbRibL
hbLgbsbLibLibRiLsbReRsmbLsbRgbRgbRgbLcbLibsbLsbLsbLibLcbLibRibRhbRcRsm
bLgbLgRsbLsbLiRsbRhbLjLsmbLgbLsbRjRsmbLcbLiLsbLgbLibLibRebLcbLcbsbLgLs
bLibRcbLibRhbRcRsmbLcLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbRsbRgbLsLsmbLsbRgbRsRsmbLsbRsbRsRsmbsbRsbLgLsbsbRsbRiRsmbLibLsLsLs
mmbLibLsbRgbRibRibRsbRsbLsbRgbRsbLibRibRsbsbLeLsbRsRsmbsbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bRjbLhbLiLsbLsbRsbRibLjbRibLjbsbsbRsbLcbLeRsbLhbLibsbRibRibLgbLsbLgLsb
LibLjbLiRsRsmbsbsbRibLgbLsLsmbLiLsbLsbLgbLcbLgbRibLibLgbRsbRibRsbRibLg
bRsbRibLsbLcbLhbLgLsbRibRjRsmbLhbLgbLsbLibLsbsbLsbRsbLsbLibLibsbRgbLsR
sbLgbLiLsLsmbRsbLsbLgLsbLsbLjLsmbLibLsLsRsmbRsbLgbLsbLgbLsbLsRsbRsLsbL
iRsbLsbRsRsmbLibRsbLiLsbRsbLibLsLsmbRjbLibLsbLsLsmbLgbsbLgbLsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bsbRgbLibRsbLgLsbRgbLiLsbLgbLgbRibLibLsLsmbLgbLsbLibRgbRgbLibLsbLgbsbL
gbLibLgbRsbsbsbRsbLsbLgbsbLgbsbLgbRgbRsbLiLsbRibLibLgbLgbLsbLsbRgbLcbL
gRsbRgbLibLibLibsbRibLsLsmbLibLibLsbLsbRsbLebRibLjbRibLsbLibsbsbsbLibR
sbLgLsbLgLsbLgbLgLsbLsbRsbLgbLsbLsbLgLsbRcbRcbLjbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bRebRibRsbLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bLibRsbRsRsmbLsLsmbsbLgLsbLsbRsbLgRsbRjbLcbLibLgLsbRgbLibLsbLgbRsLsbRs
bLgbLibRsbLibRsbLcbLibLibRibLhbRjbLcbRgRsmbLiLsbRsbLibLgbRgbLibLsLgbLi
bRgbLobLjbLcbLgbLhbRgRsmbLibsbLibRsLsbLibLgLsbLgbRgRsmbLibsbLobLgbLibL
sbRsRgbsbRsRsmbsbRsbRsbRgRsmbsbRibLiLsbLgbsbRsRsmbLgLsbRibLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bLebLcbLgbRcbRgRsmbLgRsbRgbLsLsmbLoRcLsbRibLsbLjLsLsmmbRcLsbLjbsbLhbRh
RsmbRgbRebLcbRsbRjbLoRsRsmbLibLsbLsbRgbRhRsmbsbsbLsLsRsmbRcRsmbsbRjRsm
bRibRsbRibLcbRgLsbLgbRsbLsLgbLsbRsbsbLgbRsLsbRsRsmbLsbsbLsbLsRsbsbRsbL
sbLsbLsLsLsmmbsbsbLibLgLsLsRsLsmbLobLsLsmbLgbLgLsbLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bsbsbsbsbRsbsbsbsbsbsbsbsbsbLsbLiLsLsLsmmbLsbLgbLgLsbLsbLcbLgRsLsbLsLs
mbRsbLoLsmbLsbLhRsbLiLsbLsbRsRsmbRibRsbLeLsbLgbLgbLsbLgbLgRsbLibRsbRgb
RcbRibRibRgbLsbLcLsmbsbLsLsmbLibLibRgbLcbLiRsbLsbLsbRsRsmbLibLgbRgbLsb
LgbLsbLibRsLsRsbLcbRcbLibLibLgbLgbLibsbRgbLsLsmbLsbRsbLhbLibRgbLgLsbLg
LsbRsbLgLsbRgLsbLsLobLibLsbRgbLgbLibLgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 25; Drug: Control
bRsbLgbLgRsbLsbLiRsbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 26; Drug: Control
bLibRjbsbLiLsbLibRsbLibRibRgbRebRhbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 27; Drug: Control
bRcbRjbRgbLsbRibLgbRsbRibLibRibsbsbsbsbsbsbsbsbRhbLebLgbRcbLibLcbLcbsb
Lib

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 28; Drug: Control
bRsbLcbRsbLibLcbLiLsbLsbLgbsbsbLgbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 29; Drug: Control
bRgRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 30; Drug: Control
bRjbsbLsbRsbRsbsbRsRsmbLsbsbRsbsbsbsbsbsbsbsbsbsbsbsbLsbRsbRsbsbLsbsbL
sbsbsbRsbRsbLsRsbRsbsbRsbLsbLsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbLsbRgRsRsmmbRcbLcbRcbLcbLcbRcbLjbsbRcbLobLebLgbRibLhLsbRsbLibRcbLs
bLcbLibLgbRsbRibLibLiRsbLgbLgbRsbRibLibLsbRsbLgLsbReRsmbLcbRjbLcbRsbRg
bLhLsbLibLgbLibRhbLibLhbRobRsbLsbLibLhbRibRsbRgbRsLsbLibRcbLibLebLjbLc
LsmbLcbLjbLjLsmbRibLgbRsbLibLsbRibRcbLhbRjRsRsmmbLibRjRsRsmmbLibLjLsmb
RcbRsbLgLsbRiRsmbRsRsRsmmbRibLjLsmbLhbLhbRsbLhbRibLibLcbRgbLsbLsLsmbRg
bLibLhbRsRsmbLhbLibRiRsmbRgbRsLibLcbLibRcbLjbLhbLsbRiRsmbRgbRcbLjbRobL
ibRibLjbLhbRgbLibLjbsbRjRsmbLibRcbLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bLibsbsbsbsbsbRjRsmbLobRibRibsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bLsbLibLibLiLsbsbLibsbLcbLibLibLsbLibLsbLibsbLsbsbLhbLiLsbLibLhbLibLib
LebLjbLhbLiLsbLibLiLsbLhbsbLcbsbLhbRsbLibLsLsmbLibLhb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbLgbLibRcbRgbRsbRsbLgbRebLcbLcLsmbLcbRcbRjbRcRsmbLcLsmbRjbRcbsbRibR
hbLhbLcbLcbLcbLsRibLsbRjRsmbsbLibLsbLiRsbRjbRcbLcbLsbRiRsmbLcbLcbLcbLh
bRgLsbLsbLgbRsbLgbLgbLibLjbLcbLcbLcbLgbRcbRcbRsbLgbRgbRibRcbLsLsmbLiLs
bRsbLsbLsbLibLgLsbRobRcLsbRhbRibRgbRiRsmbRgbLsbRsbRgbLsbRsbRgbLsRsbRgb
RsbRgbRgbRsbRgRsmbRsbRgbRsbRsbRgbsbLsRsbRgbRsRsLsRsmbRgbRsbLjLsmbRibRg
bRgbRsbRgbRsbRsbRiRsRsmmbRsRsmbRsLsbRgbRgbRgbRsbRsRsmbRgbLsbRsbRgRsmbR
sbRgbRgRsmbRgbRgbRgbRsRsmbRgbRsRsmbRgbRsbRsbLsbRsbRjbLjbRobRcbLgbLcbRi
bLcbRiRsmbRgbRsbRsbRgbRibRgbRsbRgbRgbRsbRsRsmbRsbRgbRgbRsbRgbRsbRsbRgb
LgbRgRsmbRgbRgbLsbRgbRgbLsRsbRgbRsbRcbLsbRobLsLsmbRsLsbLgbRcbRhbRiRsmb
RjbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbLcbsbLsbLcLsmbLgbLhbsbLiRsbLiLsbRibLgbRebRhbLcbLeLsbLcbLgbLsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bRibRsbsbRjRsmbLibsbLcbRjbRgbRjbLcbLjLsmbRsbRhbReLsbLhbLibLcbLgLsbLibL
jLsmbsbRebsbRjbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbRhbRibLcbLibLsbLsbLsbRsbRsbsbsbsbLsLgbRiLsbLibRhb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbRsLsbRsRsmbsbRgbLsbRiRsmbRsbRsbLibRiLsbLobRsbRcbLsbRibLsbLgbLgbRib
RibRgRsmbLsbLsbRgbRobRibLsbRsbLsbRsbRsbRsbRgbRcbRsbRibLsbRibLsLsmbLsbs
bLcLsmbLsbRsRsmbRsbRibRcbRsbRibLsbRcbLsLsmbRgbLgbRhbRibLsbRiRsmbRgbRgb
LgbRcbRhbRgRsLsmbRsbRibRsbLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bLibsbsbsbsbsbsbsbsbLiLsbLsbRibLsLsmbLsbLsbLcbLsbLgbLsbRsbLibLsbRhRsmb
LsbLibLibsbLgbLsLsLsLsmmmbLibRgbLsbLgbLibLgbLgbLsLsmbLgbLgbLsbLsbRsbLg
bLsbLsbsbRcbRgbRsLsbLsbRgbLsbsbLibLsbLsLsmbRjbLeLsbLobRsbRgbRgbLhbLsbL
obLsbsbLsbLgLsbLgbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbsbRcLsbRcbRcRsmbRsbRcbRjbRibRhbRibRjLsbRjRsmbRebRcRsmbRibLgLsLsmbR
ibRgbRgbRibRhbRcbLjLsmbLcbLobRibLhbLibLcbLsbLgbLobLsbRsbLcLsmbRcbRhbRc
bRsbRcbRgbLsLsmbLcbLibsbRgbRcbRjRsRsmmbLibRcbLcbLcbRjLsbRcLsbRcbRsbLcb
RhbRibRcbsbLgbRcbRcbRgbLgbLobLcbRjRsRsRsmmmbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bLgLsRsbRebRgbLjbLoRsbLgLsbLgLsbLibLibLgRsbRsLgbsbLgbLibLjLsmbRibLsLgb
LibRjbRiRsmbRibLsbRhbLgbLcbLhbRgbLhbRibLiLsbLibRsRsLsmbLgbRsbLgbLibRsL
sbLsbLsLsmbLsLsmbLgbLsbLgbRsbLsbLgbLsbsbLibLsbLgbLsbsbLcbLsLsmbLsbLibR
gbLibRsbLibLsbLgbLsRsbLgLsbLsbLgbLgbLsLsmbLhbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bRsRibRsRsmbLjbLhbRcbRsbRhbLoLsmbLsbLcbRjbRcLsbRcbRcbLsLsmbLibRibRibLs
bLhbLgbLcbLgLsbLibRiLsbLebRgbRibRiRsmbsbRhbLjbLibLgbRebsbLobLsbLgLsbRj
bReLsLsmbLcbLebLsLsLsmmbRsbRgbLcLsmbLiLsbRibLibRibLgbRjbLhbLgbsbLsLjbL
ibRsbLgLsbRiLsbLcbRcbLhbLobLgbLgRsbRobLhbRgbLsbRjbRcbLgbRibRsLcbLsbLcb
LgbLsbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bRsbLgbsbRgbLsLibLibLibLibLgbLcbLgbLiRsbLsbRsbLcbRsbLgbLsLhRsbRsRsmbLg
bLsbRgbLgLsbLgbLgLsbLsbLsbLgbLgbLsbLsbLsbLsbLsLsmbLgbLgbLgbsbRsbLsbLgb
LgLsbRsbRobLsbRsLgRsbRgbRhRsRsmmbLgLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bLsRsLsbLjbRhbsbLhLsbLsbRobRibRgbLibsbLcbRjbRobLgbLcbLgbLhbLsbLsbLsbRc
bRgbLcbLibRsbLjbRgbLgbRgbLhbLsLsmbRobsbRhbLcbLgbRibRhbsbLgbRgbRcRsmbLi
bsbLjbLcbLibLsbLsbLsbLibLgLsbRsLsbLibsbsbLibLgbLsbRibRsbsbRgbRibsbLsLs
RsmbRgbsbLsbRgRsmbRobRhbsbRiRsmbLcbLgbLgRsbRgbLebLcbRgbRgRsmbRgbLsLsmb
RsbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bRcbLgLcbLsLsRsmbLiLsLsmbLsLsmbRsbRsbRcbRiLsbRgLsbRiRsmbRibRgbRiRsmbRs
RsmbRgRsRsmmbRgRsRsmmbRcbRibsbRhRsmbRibRiRsmbLgbRibLsLsmbRibLgbRibLjbR
gbRgbRcbRhbLjbLhbLiLsbLgbLgbLsbLgbLobRgbRgbRcbRcbRhbLcbLgbLgbLgLsbLgbL
gbLgbLsbLibRibsbLoLsmbRgbRhbRibsbRibLibRcbRibLibRsbRhbLibRebLsbLcbLcbR
ibRgbRibLsLsmbLsbRhRsRsmmbLibRcbLsbRsbRgbLsbRhbLgbRcRsmbLsbRobRhbRgRsm
bLebLibLgbLgbLgbLsLsLsmmbLibRsbLcbRgbRibRcRsmbLobsbLobRgRsmbRgbRcbRsbR
gbLgbRoLsbLhbLsbLsbRjbsbLoLsRsmbRiRsmbRcbRibRgbLjLsmbLcbLibLgbRsLsbRgb
RhRsmbLjbRobRibRibRibLgbLcbRgbRsbRgbRhbRsbLgbRhLsbLgbsbLjbLcLsmbLhbRgb
LcbRgLsbRgbRhbsbsbLcRsRsmbsbLiLsbRgbRcbLjbRjbRibRgbRibLjLjbLobRcbLebLo
bRsbRibRjRsmbRibsbRgbRsRsRsmmbLsLsRsmbRsbLsLsmbRgRsmbsbsbRiRsRsmmbsbRs
bsbRibRgbRiLsbRiRsmbLgbLcbLgbLhbLsLgbRibRibsbRcbRhbLcbLeLsbRgbsbRhbLgb
sb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbLgbLgLsbLgbLsbRsbLgLsbLgbLsRsRsmbLebLebsbRsLsbLsbRsbLsLsmbRjbRibRe
bLsLgbLebLgbRhbRsbLsRsbRsLsbLsbRsbRibRibRsbRsRsRsmmbRgbRgbRgRsmbRibRiR
sLsmbRgbLjbLgLsbLibRsbLibLgbRiLsbRcbRsbLibLibLsbLgbRsbLgbLgbLsbLgLsbLg
LsbLobRibLjbLebsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bLibRgLsbLgbLibRgbLcbRibLibsbLibRsbLgbLsbLsbsbLsbsbLgbLgbLgRsbLsLsmbRc
bLjRsbRcbRibLgbLsbLsLsmbLgbLsbLgbRibsbLcbRjbLibLsbRgbRjbLibRgbLgbRsbLi
RsbRjRsmbLhbRgbRcbRibRiRsmbRibRsbRsbRsbLgbRcbRgRsmbRgRsmbRsRcbRsbRibRg
bRsbRsbRsbRgbLcbLhbLibRsbLibRgLsbLibRjbLcbRgbLibLgbLibRgbLgbRsbLgbLsbL
ibLgbLgbLsLsmbLiLsbRgbLibRsbLibRgbLoRsbRgbLibLsbRsLsbLgbLgbLsLsmbLgbRs
LibLgbLgbLsbRsbLibRgbLcbRsbRsbRgbRsbRjbRibRibLgRsbRhbLsbRibRgbRsbLsbLs
bRsbRibLsbRibRgbRsbLsLsmbRgbRibLgbRiRsLsmbLsbRgbRsbRsbRsLsbRgbLgbRibRg
bRsbLgbRgbRgbLgbRibRgbRgbRibLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 163034; End: 163534;
Recording: 4-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bRgRsmbRgbRsRsmbRsbLgbRiLsbLsbRibRgbRgbRsbRgbLsbRgbRgRsmbLsLsmbRgLsbLs
bsbRsLsbRibLgbRibRgbRgbRsRgRsRsmmbLsRsbRibRsRsmbRgRsmbRgRsmbLsbRgbRiLs
RsbRsbLsbRibRgbRgRgbRgbRibRsRsmbRgRsmbRsbLsbRiRsRsmmbRiLsbLsbRgLsbLgbR
gbRjbLjbRibLebLsbLibRgbsbLcbRgbLibLgbLibLgLsLsmbsbLsbRsbRsLsbLiLsRsbRs
bRjbsbLsbLsLhbLibRgbRibRsRgbRibLcbLiLsbLsbLiLsbLgbLgbLgLsRsbLgbLsbLibL
gbLhLsbLeLsbLgbLiLsbLgbLsbLibLgbLcbRcLsbLsbRiRsmbRgbRjbLibLcbLsbLgLsbR
sbRjbRibRsRgbRsLsRoLsbLsLsLsmmbRsRsmbLcbRsRsLsmbsbLsLsmbLiLsLsmbLsLsmb
LsbLhbLsLsLsRsmmbsbRsbsbLhLsLgbLsbsbRsbLibLibLsLsmbsbRsbLsbRsbRsbLsLgb
LhLsbLsbLibLibLebRsLsbRibLhbLcbRgbLibRgbLcLsRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 1; Drug: Control
bLgLsbLcLsmbRgbLsbLgbLibRobRoRsmbRsLsbRiLsbRebRoLsbLcbLoLsmbRsbReRsmbR
sLsbsbRsbsbLoLsmbRgbLsRsbsbLcbLsLsmbLsLsmbLgbLsbRsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 2; Drug: Control
bLobLebRcbLobRobRobLobLobLjbRcbRebLobLcbRcbLebLebLjbRebLebRsbRobLsbRjb
RebRebLobRebLobLobLebRebRjbLebRibLcbRibLobRebRibRcbRcbRobRgbRcbRebRobR
cbRebLebRjbRebRcbRebRjbLebLgbLobLebLgbLjbLobRgbLgbRobLcbLobLsbLobLebRo
bRcbLebRobRebRcbRebRibRobRgbRcbRobRibRebRgbRobRobLobRobRebLobLebRebRob
LgbRobRebLcbRebRebRebRobLibRgbLcbLebLgbLcbLobLibRgbRibRibRibRcbLgbRibL
obLobLobLebRebLobRebLibRgbLsbRobLcbRobLgbRobLgbLcbLjbLobLibLobRobLcbRs
bRobRebLsbRobLobLsbRgbRebRebLobRebRcbRcbLcbLobRcbRhbRobRibLcbLobLebLob
RobRcbLjbLebLobLcbLebLebRobLibRcbRobLcbLebRcbLobRjbRgbRcbLebLebRjbLjbL
obRjbRibLobRobRjbRebLobRobLjbLcbRebRebRebLcbRjbLobRobLobRobLsbLobLgbLo
bLobRobLcbRebRobRobLjbRobLebLobLobRobRsbLobRebRobRjbRebLebRebRobRobLob
RsbLsbRebRsbLjbLebLhbLjbRobLebRjbLobLsbRebLsbLobLobRobRjbRobRobRjbRebL
ebRobLjbLobLebRobRibLsbLgbRjbRobRebRobLjbLebLsbLobRobLsbRebRsbLobLebLj
bRcbRebLgbRjbLobLjbRcbRebRobRobLjbLjbRcbRobRebRjbLsbRcbRobLobRobLebLob
LebRjbRebLebLjbLebRobLjbLebLobLjbRobRjbRobRobLsbLgbRebRobRobRobRjbLebL
ebRebLobLobRsbLebLebLjbLsbLobLsbLobLjbRjbRebRjbLibRjbLebLobLebRobRjbRc
bRsbLjbLjbRobRobLebRebRobRobLebLjbLcbRobLebRjbLobLjbRjbRcbRjbLsbRobLob
RobRcbLebRobLjbRjbLobRobRobLebLsbLobRsbLcbLobLobLsbRobLcbRobLcbLobRobL
obRobRgbRobLobRjbLobLobRsbRibRjbRobRobRgbLgbRebRebLobRsbLjbRebRjbRobLj
bRebRobLibLsbRobLobRobRjbRobRsbRebRjbLobLobRobLobRobRebLcbLcbLcbRebLjb
RobLebLebLjbLobRobLobRobLebRebLobLgbRobLsbLebRebLobLebLjbLebLjbRobLobR
ebRobRcbRobRjbLebRsbRobLsbRebLebRobRobRobRjbLebRobLebLobLobLobRjbRebRo
bLebRebRjbLobLjbLobRsbLobLcbRsbRjbRsbLebRobLsbLsbLebRjbRsbRobLjbRobReb
RjbRobLobRebRebLobLjbRebLcbLsbRjbLsbRsbLsLsmbRobLsbLsbRjbLebRsbLsbLjbL
sbLebRebRjbRebRsbLsbRebLobRjbLcbRjbRjbLsbLjbLjbRjbLsbRsbLebRsbLobLsbRe
bRsbRobRebLsbRjbLsbRsbLjbLsbLebRobRobLsbLjbLjbLjbLebRgbRjbRjbRsbLsbRjb
LjbRjbRebRsbLebLjbLjbLobLjbLjbRsbRebRsRjbRobRobLsbRsbRebLjbLsbRsbLjbRs
RsmbLobLgRsRsmbLobRobRsbLsbRobRebLsbRebRjbLsbRjbLsbLobLobRsbLsbLjbLcbR
obLjbRjbLjbRsbLsbRobRebLsbLobLebRjbLjbLsbLcLsmbRjbRsbLobRsbRjbLsbLsbRj
bRsbRebLobRsbLsbRsbLebLsbRjbLsbLsbLsbLsbLsbLsbLjbRebLsbRebRsbLobLsbLsb
RjbLsbLebLebRjbLsbRsbLsbLsbRgbLsbLsbRsbRjbLsbLsLsmbRsbLjRsbRsbLoRsbRsb
LobRebRsbRebLsbLsRsbRjbLjbLsbLsbRsbLsbRobRsbRsbLsbRsbLgbRebRsbLsbLsbLs
bLsbRsRsmbLjbRsbRsLsbLsLsmbLjbRobRsbLjbRsbLgbLsbLsbLsbRebLgRebRsbRsbRe
bRjbLsbRsbRsbLsbRsbRsbLjbsbRsbRobLjbLsbRsRjbLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 3; Drug: Control
bLibLcbLobLhbLcLsmbLsbLobRcbLcbLiRsbLebsbLgbLcbLcbRobLjbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 4; Drug: Control
bLcbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 5; Drug: Control
bRibRibRjbLgbRhRsRsRsmmmbLgbLgbLjLsmbLsbRibRsbRsbLcbRsbRsbRsbLiLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 6; Drug: Control
bRsRsmbLibRsbRgbRsbRibLsbsbRsbRgbRgbRgbRgbRsbsbRgbRsbRgbLsbRcbsbRibLib
LsLsmbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bLibsbLgbLhbLiRsbRgbLsbsbLhbRibLiLsbsbLjbLcbRibRsbLsRsbLcRsbsbRhbLebLi
bRcbRibLsbRsbRibLsLsmbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bRgbRgbRgbLiRcbLibLsLsmbLsLgbRhbLhLsbLsbRsbRcRsmbLibsbRibRgbLjLsmbsbLc
bLjbLcbRibRsbRcbRiRsmbRgbRibLjbLcbLgLsbLsLsLsmmbLsLsmbLgbLsbLsbLsRsbLg
bLoLsmbLjbLibRjbRobLgbLiLsbLibRsbLgbLiRsbsbsbsbLgbLhRsbRsbRsbRsbLcbRjb
RhbLhbLhbRjbLhbLibLgbLgLsbRsbLsbRibLjbLsRsbRjRsmbRhbLibRsLsRsbRibLgbRg
bRhbLcbRobsbLibRibsbsbsbLjLsRsmbRibsbLcbLjbLjbRcbRhbLjbRibLhLsbLcbRgbL
obRjbLibRsbRsRsmbLibRsLsbLobRsbLobRsbRgbRhbLibLgbLsbLsRsRsmbRgbLsbRgbL
cbRcbLgbRgbRcbLibLgbRsbLsbRobLiRcbRibLgLgbRibLjbLjbRjbRsbLibLibLibRgbR
cbRgbLjbRcbRcLsbLibLgbLsLsmbLgbLgLibLibLsbRsbLcLsmbRgbRsbRcbRibLjbRibR
gbLsbRsRsmbRgRsmbLibRjbRiLsbLibRgbRgbLsbRjbRgLsbRsbRsbRibLibLhbLgbRsRs
mbLsRsbLgbLsLsRsmbLsbLgbLiRsbRgbRibRibLibLibLsbLgbLsbLgbLgbLsbLibLgbRs
bRsbLgbLibRsbLsbLiLsbLgbLobLobLibLjbLibLcRsbLgbRgbRgbLsbRsLsbLibLsbLhR
sbRibRjbRcbLjbRibRibRibRgbLibLibLsLsmbLsLsmbLibRsbRsbLgLsbLsbReb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bRiLsbRibRcbLcbRgRsmbLobRcbLgbLjbLcbLsRsbLcLsmbLhbRsRjbRhbRsbLsbRjLsbR
jbLsbRobLebRibLibRcbLibRcbRibRebRibsbRcbsbLgbLsRsbRcLsbLsbLebLhbRhbLib
Rcb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bRcRsmbLsbRsbLiRsbLsLsmbReLsbLibRhbLcRsbLibLibLgbLgbLibLiLsLsmbLibRjbR
jbRsbLsbReRsmbLsRsbsbsbLsLsmbLsRsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbsbRibRibLjbRibRjbLibLsbRibLjbLsbRjRsmbLjLsmbRibRibLibLcbsbsbRibRcb
LibLcbRibsbLibLcbLobRebLcbLibLcbRibLsbLsbRiLsbRcbRebLsRsbRibRhbsbRcLsb
LiLsbRcbRcbRjbLcbRjbLjLsmbLgbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bRibRcbRcbsbRibRgbRsLsbLibRcbRhbLhRsbRcbRhbLsbLgbsbLcbRjbRcbRibRiRsmbR
cbsbsbRebsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bLibRibRsRsmbLibRgbsbLibRgbRibLsbRibRiRsmbRgRsRsmmbRibLibLcLsmbLiLsbLg
bRibRsbRsbLgbRibsbLgLsLsmbsbRibRgbLjLsmbsbRhbRgbLgbLgLsbRgbRibRsbLibRg
LsbLcbLibLibLgbRiRsmbRibLiLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bsbsbLebRsbsbLsLsmbLsbLoLsmbRhbsbLcLsmbRobRhbRsbLobsbRgRgbRcRsmbRcbsbR
gbRjbsbLsbRcRsmbRgbLgbRgRsmbsbsbRcbRgRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bsbLcbRcbLjLsmbLgbsbLibLibLgbLsbLsbsbRcRsmbRibRjRsmbsbLibLibRcbRcRsmbL
cbLhLsbRcRsmbRobLgbLcLsmbsbLiLsbLgbRsbLgbRgLsbRobLjbsbRoRsmbLcbLiLsbRs
bRjbRcbLibRsRcRsmbRibLcbReb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bLibLcLsmbRsbLhbRsRsmbRsbRsbRgbRcbLsbRsRsmbRoRsmbRsbRhbRjRsmbRibLsbRib
RibLsbRsbLiLsbRjbRibRsbRsbsbRgbLsbRcbRsbRsLsbLobLibLibLsbLgbLibRsbRgbR
ibLsbRgbRsRsmbRiLsbRsRsmbLsbRibLsLsLsLsmmmbLsbRhbLsbLsLsmbRsRsmbRsbRsb
RsbLsbRhbRgbRsbRsLsbRsbsbRsbRgbRjRgbsbLsbLsbRcbRgbRgbRsbRcbLoRgRsmbLsb
RhbRgbRsbRsbRsbRsbRgbRjRgbRgbRsRsLsmbRsbRgbRsRsRsmmbRsbRsbRgRsmbRsbRsb
RsRsmbRsbLsLsmbLsbRsRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbLjbLcLsmbLibLjLsmbLcbLcbLibLgbLibLcbLcbsbLibLiRsbLibLhLsbLsLgbLgLg
bLgbRgbLcbLibRibRoLsbLgbLsbLibLiRsbLsLibLjLsLsmmbLibLibLjbsbLsbLibLsbL
ibLhbLcbLhbLgbLiLsbLcbRcbRobLgLsbLcbLiLsbLibLcbRcbRsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bsbsbsbsbRiRsmbRjLsRsRsmbRgbRsbLgbRgbRsbRcbLsbRsRgbRjRsmbRsbLsbRsbsbLc
bLgbLibLiLsbLsLsmbLsbLibRsbLiLsbLsbLsbRcbLsbLibRjRsmbLhbRcbRsbLsbLsbLs
LsmbLiLsbRsRsmbRsbRsRsmbRsbRibRsRsmbLsLsmbLgbsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bRsbRobRsbRgbLsbLsbRiLsbLsbRiLsbLgbRibRsbsbRgbRgLsbLgLsbRgbRgbLsbRibsb
RsbRgRsmbLsLsmbLsRsbRsbRgLsbLsbLsbRibLsbRsbRibLjbRibRibLgbRibLsLsmbLsb
RjbRhbRibRsRsmbRgbLgbLgRsbLgLsbRjbRibRibLsbRibLsRsbRsbLsLsmbsbLjLsmbLh
bLsbRibRsRcbsbLgbRibLgbLgbLjbLibRhbLsbLjbLibRsbRibRsLsbRiRsmbRsbsbLgbL
cbLibLibLgbRiRsmbLgbLgbLgbLsbLgbLsbLgbLsLsmbLgbRgbRjbLibLsbLgbRsbLgbRs
bLsLsmbLsbLsbLsLsmbLsbRsLsbLsbRsbLsbRsbLsbLsbsbLsbsbsbLsbRsbLsbLgbRsLs
bsbRjbRebRcbRiLsbLgbLsbLgbLgbLsLcbRsbLsRsbRjbLsRcbLjbsbsbsbLsbsbLsbsbL
sbLsbRsbLsbsbLsRsRsmbLsRsbsbLsLsmbRsRsmbLsbLsRsbRsLsLsmbLsRsbLsbRsbLsb
RsbLsbRsRsmbRsRsRsmmbLsRsbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbLcbRgRsmbRiRsmbRiLsbRebRgbsbLgbRgbRgbRsbLsbLcbRgbRiRsmbsbLgbsbRibL
sbLsRsbRibLsbRiRsmbLsbLgbLcbLibRhbRcRsmbRibLsbRgbRgLsbLsbRibLsbRhbRsbL
ebsbRcRsmbRgbRibLgbRsLsbLobsbRsbLiLsbLgbLibRgRsmbLibLsbLsbLobRgbRsbLcb
RsLsbLgbLsRsbLgbRsbLcbsbRsbRsbLiLsbLsLsmbRsbsbRsbLibRgbLoLsmbRgbRsbRjb
RgbRgbRibLgbRgbLsbRsbLcbLhbRhbRsRsmbLcbLibLsbLsbLgbLsbLgLsbLsLsmbLgbLs
bLgbRsLsbLgbRsbsbLibRgLsbsbLgLsbLgbLsbLsbLgbLsLsmbsbLgLsbLsLsmbLsbLsbL
gLsbLsLsmbLibLsbLobLgRsbLsbLibLibLsLsLsmmbLsLsmbLsbLibsbReRsmbRcbRgLsb
LsbRgLsRsbRsbRsbRhLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bRibRgRsmbRgbLcRsbRsLsbRsbRsbLibRibRsbRsbRibRsbRibRsbRjbLsbRsbRcLgbRsb
RgbRsbRsbRjbLgbRsbLjbRsRsmbRjbLsbRobRibRsbLsbRobsbsbLsbLjbLebRgbLiRsbR
gbLgbLiLsbLgLsbRsbsbsbsbLsLsmbLsbRsLsLsRsmbRsRsmbRsbLgbRsLsbLsbLebRsbL
sbRjbLsLsmbLsbLibLibLobLgbRgbRsRsmbRibLgbRibLsLsmbRgbRebLsbLsbLibLibRg
bRgbRhbLgbRibRsbRibLgbLjbLjbsbLsbsbLsbLsbsbsbLsLsmbRsLsbLsbLiLsbLgbRgb
LibRsLsbLgLsbLsbLgbLgLsbLgbLsbLgLsRsbLgbsbLsbRjbLsLsmbsbRsbLibLgbLsLib
LsbLjbLcbRsbLgLgbLsLsmbRsLsLsRsmbLgbsbLsbLibLobLibRebLsbLibsbLibLgbRsb
LsbLjLsmbsbsbLgbsbsbsbLgbLsLsmbLgbRebLsbRgbRsbRgRsmbRsbLgbLeLsbLsbLsbR
sLsLsmbLibLsbRsbLsLsLsRsmmbRsRsmbLsbLsbRebRsbLob

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bRibLsbLsbLgRsbRsbLgRsbLsbRobLgbLjLsmbLhbsbRiRsmbLibLibLgbRjbRsbRsbRib
RgbLhbLiLsbLgRsbRsbLcbRsbLcbRsRsmbLgLsbRgbLibLsbLhbRhbLibLjLsmbRiRsmbL
sLsmbLibLgLsbRsbLjbLcbsbLgRsbRoRsmbLsbsbLibLcbLcbRsbsbRsRsmbLibLibReRs
mbRhbLebLcLsmbLsbRgRsmbRsbRjRsRsmmbRgbLiLsbLibLgbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bLsRgbLsbLibRgbLcRsRsmbRibLsbLsbRsbRsbRiLsbRgbLsbRsbRibRsLsbRgRsmbsbRg
bLoRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
b

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 25; Drug: Control
bLsLsmbLsbRsbLsbLsRsbLsbLiRsbLebRcLsbRebRsbRobRobLcbRsLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 26; Drug: Control
bRhbRcbRobRibRebsbLjLsmbRsRsRsmmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 27; Drug: Control
bLsbLsbLgbLibLibRhbLgbLibLsbsbRsbsbLsbRhbRcbRcbRibRiRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 28; Drug: Control
bLobRobsbLobRobsbLgRsRsmbLibLhbRsRsmbRgRsmbRhbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 29; Drug: Control
bsbRjbsbRgRsmbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 30; Drug: Control
bLsLsmbRsbsbRsbsbRjLsbLcbLsbsbsbRob

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bLcbLhbRcbLebRhbLibRgbRsbLibLsbRgbLsbLhbRsbRsbRibRibLibRsbsbRiLsbsbLib
RibRgbLibLcLgbRibRhbLjRsbLibRhbsbLhLsbsbRjbLebRcbLcLsmbRcRsRsmmbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bsbsbsbsbsbsbsbsbRgRsmbsbRgbRjbLoLsmbsbRibRebRcbRibRcbRibLibsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bLcLsmbLcbLibLeLsbLibLhbLibsbLgLsbRcLsbRsbLibLcLsmbLibLibLhbLgLsbRsbRs
bLgRsbLibRjbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bLibLgbLibRcbRjLsbLibLhbRgbLcbRcbRgbLsbRibLsbLcbRsbLcbLsLsmbsbLibRcbLj
RsbLsbRibLibLgbsbsbLgbRcbRobRsbLibLcbLebRjbLibLhbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bLsLsRgmbLibLibLibLsRsbRibsbLsRsRsLsmbRgbLobLjbRgbRibRgbLgRsbRsbRgbLoL
smbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bsbsbRiRsmbLsbLcbLcbsbsbRibLsbLsbLsbRcbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbRsbLgbsbLcbRcbRsLjbRebRcbRcbRcbRsbRsbLjLsmbsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbsbsbsbRsRsRsmmbLsbRiLsbLsbLsbRjbRiRsmbLsLsmbRgbRsRsmbRsbRsbLsLsmbR
ibLsLsmbRsbRcbLsbRgbRhbRsbRibRsRsmbRsbRjbRibsbLsRsbRgbsbRibRsbLgbLsbRc
bRsbRsbRibRhRsmbRiLsbLsbLgbLsLgbLsRsbLsLsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbRibRgbLcbLsbLobRsbsbLjLsmbLhbLsbRgbLsLsmbLibLsbLibLsbsbLgLsbLgLsbL
sbRsLsbLcbLsRsbRgbLiLsbLcbRsbLgbRibLhbLsbLhLsbLsbRiRsmbRebRsbLibLobRsb
RgRsmbRjbLcLsmbLsbLsbsbsbLsLgRsbLgbLgbLobLcbLsbLsLsmbRsbRsbLgbLhbLoRsb
LjRsbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bsbLhbLgbRcbRsRsmbLcbRibRcbRcRsmbRcbRjRsmbRsLjbLgbLsLsRsmbLsLsLsmmbLib
RgbLjbLiLsbsbRjbLjLsmbLsbLsLsmbLsbRhbRjRsmbRgbRibRcbLhbLgbLsLsLsmmbLcb
sbLsLsmbRcbRsbRsbLcbsbLgLsbLcbLibLibLjLsmbLgLsbLsbRcbLsbLsbLsLsmbLsbsb
LgLsbLjLsmbLjLsmbLcbLgbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbRgbRgRsmbRgbLhbRsLsbRjbLcbRcbLebLgbRhbRsbRobRcbLiLsbLibRjbLcbLibLs
bRgRsmbRsbRsbRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbLgbLhLsbLibRibLhbRsbsbLsRsLsbsbLsbLsbLgbLcbRsRgbLsLsLsmmbLibLgRsbR
sbLsRsbLibLiLsbLgbLibRsbLgLsbRcbRgbRobRsbRsbRgbRgbRibRgbsbRgRsmbRsbRib
sbRiRsmbRoLsbRibLebRgLsbLsLsmbLcbRgbLcbLgbLsLsLsmmbRsRsRsmmbsbRjbRibRi
bLjbLhbLgLsbLsbRsRsLsmbLhbLibRibRcbRoLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bLsRsbLgLsLsmbRsbsbLiLsRsbLgbRiRsmbRhRsmbRsRsmbRgbRsbRgRsmbRebRcbRsbRg
LsRsRsmbLsbLgbLiLsbLsRsbLgbLsLsLsmmbLgRsLsbLgbLgbLgRsLsbRgbLgbLgbsbRsR
smbLgbLgLsbLgbLgbLgbsbLsLsmbLhbRsLsbsbLsRsbRgbLsRsRsmbRsbLjbRsbLsRgRsm
bRgbRgbLjLsmbsbLgRsbLeRsLsbLgbLgLsbLgbLgbRsLsbLibRsRsmbLiRsbRsbLibLsbL
gbLsLsRsmbLsRsbLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbLsRsbRsbRibRibRgbRgbRsbLiRsbLsbRsLsLsRsmbLsLsmbLgbRcbRoLsbLsbLoRsb
LibRsLsbLibRgRsmbRgbLsLsmbRibRoLsbLgbLibLiLsbLgbRsLsbLgbRsbLgbLiRsbLsb
sbLsLsmbLsbsbLhbLgbLiLsbRcbRcbLgRsLsbRoLsbRsbsbLiRsbsbRhbRhbLgbLjbLhbL
ibLcbLsbLibLobsbLibRsbsbRjbRobRgbRgbRsbLhbLibsbLcbLsbLgbLibRgRsmbLcbLs
b

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bRiLsbRgbRgbsbRgbLjbRibRibRibRiRsmbRhbRibsbsbLsbRsLsbRgbRgbRsRsmbRgRsL
smbRibRcLsbsbRibLjbRjbRsbRsbsbsbsbsbRibRgLsbRgbRhbRibRcbRiRsmbRiRsmbRs
RsmbLsbRiRsmbRcRsRsmmbRibsbRsbsbsbsbsbLsbRgbsbRibLjbRiRsmbsbsbRibRibRc
RsmbRibLsbRcbLjbLoRsbRgbLgLcbRibsbRsbRsbRhbRhbRiLsbRgLsbRiRsmbRgLsRsbR
gb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbLobsbsbLgRgbRgbRjbLgbLsbLibLsbLsbLgbLsbLsbLibLibRgbRsbLsbLhbLsbLsb
sbLgRsbRsbLgbLgbsbRsLgbLgbLsRsbLgLsbLgRsbLsbLgbLsLsmbLsbLsbLgLsbLgLsbL
sbLgLsbLsbLsbLsbsbsbLebLoLsmbRhbRibLgbLsbRcbRsRsmbLcbsbsbLsbsbRjbRobLj
bRcbRcRsmbLsbRsRsmbLiLsbLsbLebRibLobLibsbRibRhbLsbLsbLgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbRibRibsbLsLsmbLsRsbLgRsbLsRsbRhbLgbLsbRhbRgbRgLsbLsbRibLsbLgbLsbRi
bRibRibLibRhRsmbRsbRsbRsbRsbLjbRibRsbRgbLgbRibsbRgbLsbLsbsbRgbsbRgbRsb
RgRsmbRibRgbLsRsbRibRhbRibRsbRsbRgbRibRsbRgbRgbRgRsmbLsbRgbRgbsbRgbRsb
RgbRgbLcbRebRibRibRibRgbRcRsmbLsRsbRgbLgbRiRsmbRsbLsbLsbRgbLsbRgbsbRgb
LsbRgbRgbRsbRsbsbLhbLobRhbRibRibRibRgLsbRibLsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 163536; End: 164036;
Recording: 5-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bLcbRsbLhbRsbLcbRsbRjbsbLiLsbLsbLsbLgbLhLsbLgLsbLibRjbRjbLgbRibRgbsbLs
bsbsbLsRsLsLsmbLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 1; Drug: Control
bLcLsmbRcbRsbRjRsRsmmbLibRgbLoRsbRebLeRsLibRcbRgbRjbRsbRsLsbRgbLsbLebL
ibLiRgRsmbLibLcbRibRgbRebRcbLjbRibLjbRhRgRibLcbRcbLcbLsLcbLjbRibLsbLjb
LcbRsbLcbRibLsbLjbLjbLhbRgbLiLsbRjbLibLebLhbLsbRgbLiRsbLgbLjbRsbRibLjb
LsbRcbReLsRsbRgbRibLhbLebLsLsmbRsbLiLsRsRsmbLsbLhbLibRobRcbRsbRiLsbLgb
LgLsbRibLgbLcbLcLsmbRhbLjbLibRgbLsbRiRsmbRgbLhRsRsLsmbRsbLibRsLsbRcbLe
bLobLsbRibLibLsbLsbLobRsbLjbRibLjbRibLibLjbRgbLobLibRsbRgbRiLsbRsbLgbL
sLsmbRsbLjbLiLsbRgRsmbRjbRgRsRgmbRgRsmbLjbRgbLcbLobsbLsbRjbLcbRgRsmbsb
LiLsbLsLsmbRjbRebRobLgLsbLibRibsbLcLsmbRsLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 2; Drug: Control
bLobLsbRobLjbRjbRsbLjbLsbLsbRsbLjbRsbRsbRsbLobRsbLjbLsbLjbLobRsbLsbLsb
LsbLjbLcbLjbLsbLsbLsbLjbRsbRsbLebLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 3; Drug: Control
bRjbRcRgbRhbRebLhbRobLcbRobLcRsbLobLsbLhbLobLjLhbLcbLgbLibsbsbsbLsbLoR
sb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 4; Drug: Control
bRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 5; Drug: Control
bRibsbsbsbLsLsmbLsbRobRgbRcRsmbsbLsbsbLsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 6; Drug: Control
bLobLsbRgbsbRjbRsbsbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bLibLsRsbRgbsbsbLgbLsRsbLhbLsbLoLsmbLgbLsRsbsbRoLsbRgbLjbLhbRcbLcbRsbL
sbLobLibLibLsbLsbLibLsRsbRsbLcbRcbRgbLjbLibLib

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bLibLgbLsLsmbLgbLsbLsbLgbRsbLsLsmbLsbLgbRsbRsbLgbRcbRibRibLjbLobRsbLhb
RgbLobRgbLsLsLsmmbLebRobRhbLhbRiRsmbLjbLcbRcbRibLgbLibLibLcLsmbLcLsmbL
cRsbRsbLibLsbLibRsbLgLsbRsbLgLsbLibLibLiRsbLibLgRsbLibRsbLibLobLhbRibL
ibLibRsbLiLsbLgbLsLsmbLsbRsbLgbRsbLsLsmbLhbLibLibRjbLiRsbLibRobLgLsbRg
bLgbLhbRjbRcbLhbRhbLgbLibRjbsbRcRsmbLjbRhbLjbLcbLobLcLsmbLsLsLsmmbLsbL
cbRsRsmbLcbLhbLgbLsbRgbLgbRsbLibLgbsbRjbRhbLjbRiRsmbLgbRibLcbLcbRjbRcb
LjbRhbLsbLgbRibRgbLcbRcbLhbsbRcbLiLsbRjbLcbLsLsmbLibRjLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bRjRsmbRebRgbLgbRiLsLsmbRebLebLsbLsbLobLobRsbLibLcLsmbsbRsbRgbRibRcRsm
bRsbLebLcbRcbLsbRcRsmbRoRsmbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbRiRsmbsbRhRsmbLsbLobLsbLsbRjbRebLcbLgbLibLgbRjbLgRsbLibsbLgbRibLob
LibLgbRobRobRibRoLsbRgbLobRsbLibRsbRsbRsbRsbRoRsmbLjbRcbLhbRsbRcbLiLsb
RobRibLgbLjbRiRsmbRibRsbRgRsRsmmbRsbRiRsmbRcRsLsmbsbLiRsbLjbRhbLibLsbR
sbLhbRjbLibLsbLsRcbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bLibLcbLhbLsbRhbRsbLibRcbLiLsbLgLsbRibLsbRgbRibLibRjbsbLsLsmbLsbLgbRsb
LgbRibRibLjLgbRgbLibLsbLsbLibLiRsbRhbLgbRjRjRsmbRcbRsRibRsbLsbRibLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bRibsbRsRsmbRjbRibLsbRsLcbRcbRoRsLsmbRobRhbRcbLcbLoLsmbLsbLgbLgbLiRsRs
mbRgbRsbRobRoRsmbRobsbRcbRcbRcbRcbRjbRjRsmbRjbRcbLsbRcbRcbsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bLcbLgbRgbRibRjLsbRcbRibRibRgbRjbRhRsmbRcbRcbRsbRgbLjbRjRsmbLibRibRobR
cLsbLibRhbRibRibRgbLiLsbRsbRibLsbLibRjbRiRsmbsbLibLsbRcbRcbRhbRibRibRc
RsmbRcbRhbsbRibLgbLsbRsLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bRgRsmbLgbsbLsbLgbsbsbsbRsbRgLsbRgbRhRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bLcbsbsbsbsbLgbsbLgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbLhbRgbLgbLhbLgbsbRsRsmbLibLibLsbLobLsLsmbLgbLsbLibLgbLgbLgbLsLsmbR
sbLgbLcbLhbLsbLibLsbLhLsbLgbLcbLsbLibsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bLiLsbRsbRgbLibLibLibLibLibLibLibLibRcLsbRgbLibLibLibLjbLibLgbLiLsbLeb
LjbLsbsbLcbLibLjLsmbRiRsmbLgbsbLhbsbRgbLoLsmbLibLcbLhbLhbRhbLhRsLsbRgR
smbRoLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bRibsbsbLsRsbRsLsbRiRsmbsbLcbLebLoLsmbLibLsbsbLsLsmbLsbLsbsbLsbLgbLsbR
gbsbRibLcLsmbRgRsRsmmbLibsbRsbsbLgbLcbLibLsbLcbLsbLibsbRsbRjbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bLgLsbLsbLsbLsbLjbRcLsbLiLsLsmbLgbRsbsbLibLsbLgbRsbRgbsbRsLsbLgLsLsmbL
sbLgLsLsLsmmbLgbLiRsbRsbLsbLibsbLiLsbRsbLgRsbLsbRsLsbLibsbLgbLsLsLsmmb
RsbLibsbLgbRgbLgbLsbLsLgRsLsbRsbLibLibRsbRsRsmbLibRgbRsLsbsbLibsbLsLsm
bLibRgbLibLibRsbLibRgLsbLibLibRsbsbRsRsmbLgLsbLsLsmbLgbRgbLibRsLsbLgbs
bsbsbsbsbLgbRgbLibRsbRgbLgbLibRsbLibLsbRcbReLsbLjLsLsmmbLibLgbRgRsmbsb
LsLsmbLsbLgLsbRjbRebsbLgbLjbLsLsmbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bRibLsbRgbLsRsbLsbLibLibsbLhbLibLiLsbLgbRgbRgbsbLsbsbRsRsmbRgbRgbsbLsb
LsLsRgmbRgbRsbRgRsmbLcbRibLcbLcbRibRoLsbRsLsbLgbRsRoLsLsmbRsLsRsbLsbRi
bRgbRsRsmbRgbLsbRgbRsbRgRsmbLgbRgRsmbRgbRgbRgbRgbRgbRgbRoLsbLgbLsbLcbL
gbLiLsbsbLsbsbLgRsbRsLsbLibLsbsbLibLsLsmbLiLsbLgbRsbRjbRibRgbRgbRgbRgb
RsbRsbRibLsbRgbRgbRcLsbRsbRibLsbLibLibLibRsbRsbRgbRibLibRibsbLhbLsbLiL
sbsbLsbLsbRsLsbLibRgbLgLsbRgbLhbLibLgbLibLsbLsbLhbLsbLibLgbRgbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bLibLsbRobLsLiLsbRcbRibsbsbsbsbRsLsbRsbLobRebLsbLsRsbLsbRsLsbRsLebRjbR
sLgbRsbRibRgbLsbRsbRgbRoLgbRsbRibLsbsbRsbLebLhbLibRsbRgbLgbRhbsbLsbRib
LsbRibLsLsmbRiLsLgbRibLsbRibRiLsbLgbRobLgbsbLgbLgLsbLsbLibRsbLsbsbLcbR
cbsbRgbLobLibLsLgLsbLgbRsRibLgbRiRsmbLsbRgbRsbRsbRgbLsbRsbRgbRsbRgbRib
RsbRiRsmbLsbRibLsbRgbRgbLsRsbRgbsbLsRsbRsbRibLgbRibLsbRibLgLsbLsbRiRsm
bsbRhLsbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bLibRsbRgbLsbRgbLsbRgbLibRgbRsbLsbRiRsmbLgbRjRsRsRcmmbReRsmbLhLsbLiLsb
sbLgbLsbRcbLibLibRiRsRsmmbRgbLibRgbRsbLgLsbRgbsbLibReRsmbLjLsLsmmbRiRs
mbLibsbRibLgbRsbRibsbLibsbRibRibLiRsbLibLibLsbLgbLsbRsbLjLsmbLobLsbLcb
LgbRsbRgbsbsbLgbRsLsbLgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bRiRsmbRsbsbRhbRgbsbLsbLsbLibLebLsLsLsmmbRsRsmbRgbRsbRhbLsbRibRobLsbLs
bRsRsLsRsLsmbLsbRoLsLsmbRibLgLjbRsRsmbRgbRiRsmbRibsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bRsbLsLsmbRjbLibRobLcbRiLsLgbLiRsbLsLsmbLgbLsbLiRsRsRsmmbLsbLibLiLsbRg
bLhRsbLsLsmbLgbLgbRsbRsbLibLgLsbLsbRsbRsbLgbLsLsmbLsbLsbLgbLsbRsbLgbLg
bLsbLibLibRhLsbLibRsLsbLsbRsbLsbLgbRobLcRsbLsbLobLcbLgbLhRsbLsbLgbRjbL
ibLsbLgRsbLgLsbLsbLjbReRsRsmmbRibRsbLsbRsbLsbLcbLcbRsbRgbRsbLcRsbRsbLs
RsLsRsbRsbLsbLoRsRsmbLibRgRsmbRsbLoRsbRgbLhbLibsbLibLsLsRsmbRgLsbLgbLo
bRgbLgbLibRgbLhRsbRgbLcbLhbLsbLsbRsbRibRobRibLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 25; Drug: Control
bLcbLgbLobRsbLibLiLsbRsbLebRiLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 26; Drug: Control
bLhbsbLgLgbLjLsLsmmbRjbsbRgbRiLsbRgRsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 27; Drug: Control
bsbLgbsbLgRsbLgbsbRsLoLsRsmbLcbsbLsbRsRgbRsbRsLsbRobLobRsbLjLsmbRsbsbs
bLebLgbLgbRobRcbLsbRibRibLsbLibRsbLhbLgbLibLibLsbLgbLsbRibLsbRibRsRsmb
RibLsbRsbRsbRsbRsbRsbRibRsbRsbLsbRsbRjRsmbRsbRgRsmbRsbRsbRsbLgbRsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 28; Drug: Control
bRgRsmbRobRibRsbRsbRsRsmbRsbRsbRsbRiLsbLsbRibRsbRiRsmbRsRsmbRsbRsbRibL
sbRsbRjbRgbRsbLsbLsbLsbRjLsRsbRgbRsbRgbLsbLjbRobLgbRgbRsbLsbsbRibRsbRi
bRsbRsbRsbRsbRjbRgbRsbRsbLsbRsbLobLoLsmbsbRcbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 29; Drug: Control
bRsbLsbLsbRsbLsbLsbLebRsbsbRsRsmbsbRsbRsbLsbsbsbsbsbsbsbLsbRsbLsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 30; Drug: Control
bLibRsbRobsbRsLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bRebLcbRcbRsbRsbLsRsbLjLsLsLsmmmbRibRsbLsbRsbLsRsbRiRsmbRibLcLsLsmmbLg
bRobLgbRsbLibLsbsbLsbLsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bRjRsmbRibLcbLiLsbRibRsbsbRsLsbLsRsLsbsbRibRiRsmbsbRsRsmbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
b

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbRsRsRsmmbLibLgbLcbRcbLgRsbRobsbLibRgbRiRsmbLibsbLibRibRcbLibRjbLiR
sbRgLsbLibRsbsbRsbRcbsbLhbLibLhbRgRsmbLebsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bsbLsbLibRobsbRibLhLsbRibLoRsbRcRsmbLiRsbsbLibLsbLsLsmbLgbLsbsbLcbLcbR
sbLsbLsLsmbRsbLgbLcbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bLjLsmbRgRsmbRiRsRsmmbRgbsbsbsbLibRhbsbRiRsmbRsbLibLhbLjLsmbLsbRsbLibR
sbLibLsbLsbLsRsbsbLob

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bRsRsRsRsRsmmmmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRjbRibLsbLsbRhbRibLsbRibRsbRibRsbLsbLsbRsbRcbRibLsLsmbLgLsbRcbRgbLsRs
bRgbRibLsLsmbRibRibLgbRobRibRsLsbLsbRiLsbRsbRsbRiRsmbRsbRiRsmbLsLsmbRi
bLsLsmbRibLsbRiRsmbLsbLsLsmbRgbRhbRibLsbLsbLsLsmbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bRhbRsbLibLcbLsbRebLsbRoRsmbLsbLebLgbLjLsmbRsbRsLsbLoRsbLsbLsbsbLibLgb
LsbLhbLgbLsbRgRsmbLsbRgbLobRsbLibRgbLhbRgbRsLsbRobRsbLjbRibRjbRibRgbLs
bRibLjbLebLsRsRsLsmbsbsbLoLsmbRgbLsbLgbsbRgbRiRsmbRsbRgbLsbLjbRcbRsbLg
bRcbLsbLcLsmbLhLsbRcbRiRsmbRsbRsbLoLsmbLcLsmbRibLsbLsbRiRsmbLhbsbLibRs
bsbsbLsbRsbLsbsbsbLgbLsbRsLsLsmbLsLsmbLibLgbLsbLsbLiLsbLgbRsbLcbRsbsbL
sbLsbLhbRsbLgbRjbRjbRgbRgRsmbRsbRibRgbRgbRsbRsbRcRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bsbRcRsmbLobsbRsbLjLgLsbLibLsbLibRjbLcbRjbRcbLjLsmbsbLhLsbLcbRcbLsLsmb
RgbLsRsbLcbLibLcbLcRsbRhbRcbLcbRgRsmbLcbLjLsmbLoLsLsmmbLsbLsLsLsLsmmmb
LhbLsLsmbLgbLsbLjbLjbRhbLhbLhbLobRhbRsRsmbRgbLcbsbRjRsmbRebRgRsLsmbLsb
LhbLcbLsbRgLsbsbRcbRsbLcbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbLsbRsbRgbLjbRgbLjbRsbRibsbRsbRgbRebsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbLibLsbRibRoLsbLjbRhLsbLjbLibRjbLobLibRgbLsbLsbsbRgLsbsbsbRsRsmbLsb
RgbRgbRgbLcbLibRsLibsbLgbRgbLsbLcbRgbLhbLgbRsbLgLsbLibsbLibLibRgbLiRsb
RsRsmbRsLsbsbRsRsmbRsLsbLsbRcbLgbRibLgbRjbRibLsbLeLsbLgbLgbRsLsLsRsRsm
mbRsLsRsLsbRsbsbsbRsbsbRsbRsbLsRsLsbLsbLsbLsRsbRsbLsbRsRsRsRsmmmbsbsbs
bsbRebRhbLiLsbsbLsbLsLgbRsRsRsmmbsbRsbsbsbsbsbsbLobsbsbRsbsbLsbsbsbRsb
sbsbRsbLsbRsLsbsbsbLibRcbLcbLsbRiRsLsmbRhbRcbLgLsbRobRgbLjbLcbLgLsLsmb
RsbLsLsmbsbLjLsmbRsbRsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bLsLsmbLsLsLsLsmmmbLibLibLsLsmbLiLsbLgLsbLgbLsbLobRsbLibRsLsbLibLgbLjR
sbsbLgbLsbLgbLgbLsRsbLgbLibLsbLgLsbRsbLsbLgLsbLsbLgbLgLsbLgbLgbLsbLsbL
sLsmbLibsbsbRgbRsLsbRgRsmbLsbLgbLsLsmbLibLsLgbLgLsbLsLsmbRsbLgbRsbLgLs
bLsbLgbLgLsbRgbLiLsbLsbRsbLebRgbLsbRsbRibRiRgbRgbRsbRiLsbRiLsbLjbLiLsb
RsRsLsmbLiLgLsRsLgbLgLsbLgbRsLsbLgbLiRsbLibRjRsmbLgLsbRgbLgLsbLgbLsbLg
b

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bRsRsmbLhbRgbRgbLsbLobRjbRsRsRsmmbRgbLcbRsLibsbsbRobRcLsbRsbLhbLibLibs
bLgbLgbLsbLgbLcbLgbsbLsLsmbRgbLiRsbRsbLibLsbRgbRibLgRsbRjbLgLsbsbLgbLo
bLgbLcbLiRsbRsbLibLgbLgbsbsbLhb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bRjbLjbRcbLcbLoLgLsbRgbRcbRibLiLsbLcbLcLsmbRgbRcbLjbRoLsbLgbRcbRsbRgRs
mbRgbRgbRsbsbRsbRgRsmbLsLsmbRhLsbRcRsmbRibsbLgbRcbLsLsmbRcbRcbRibRsbLc
bLgbRgbLsbRcbRhbRcRsmbRhLsbsbLsbLebRjbRcbLsbsbsbRhLsbLgLsRsbRcbsbLibRc
RsmbRibLeLsbLibLibLgbRsbLjbRebsbRsLsbRibLiRsbRcRsmbRibRhbLibLgLsbLsbsb
sbRcbRibRjRsmbRebLjbLcbRcbLjbLjbLjbLsbLiLsbLsLsLsmmbRgbsbsbRgRcbRhRsRs
LsmmbRiRsmbsbRgbRsbRibLgbsbRsbRhbLjbRgbRgbLsRsbRobRsbRgbLibLgbLobRibLc
LsmbLsbsbLgbsbRebRhbsbLgbLhbsbRsbsbLsLsmbRgbRcbRhbLgbLhRsbLiLsbRsbRsLs
bRsbLsbRebLcbRibLhbLcbLibLsLsmbLgbLibLiLsbLgbLiLsbRgbRsLibLgbLgLsbLsLs
mbLgbLgLsLsmbLsLsLsmmbRsbRoRsmbRsbsbLsbLjbLcbLgbLsbRgbRibsbRiRsmbLjbLc
bRebLjbRcLsbLjbLjbLgbLibRgbLcbRiRsmbLibRjbRcRsmbLsbLsbsbRiRsmbRgLsRsLs
bLsbsbsbsbLsRsRjRsmbsbRiRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bLobRgRsmbLebLsbRcbRibRsbLgbLcbLsbRgbRgbRcbLjbLsbRebLcbRibLibRsbRcbLgb
LjbLgbRgbLhbLsbRibLsbLsbRhbLsbLgRsbRgbRiRsRgmbRibRsbLsbLcRsLsbLgbRsbRs
bLibLibLgbLgbLsLsmbLgbLgbLiLsbsbLsbLgbLgRsLsbLsLsmbLgbLgbLgbLgbLsbsbLj
Libsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbLgbLgbLgbRgbRgbRsbRgbLgbRsbRibRsLsbRsbLjbLgbLgbLsbLsbLsLsmbLsbRsbR
gbLgbsbLgLsLsLsmmbLsbRsbLgbLsbLgbRgbLibLibRjbLobLsbLibRsbLibRgbLibLgLs
bLsRsbRcbRibRoLsLsmbRgbLsbRsbLgbLcbRgbLgLsbLgbLjbRsbLsbLgbLsbRoLsbLgbR
sbLgbLgLsbLibRgbRgbRgbRgbRsbRgLsbLgbRgbLsbLoRsbLibRgbLsLibRgbLgRsbRsbL
gbLgRgLsbLgbRjbRibLsbsbRcbLjbRibLgbRgRsmbRsbRibLsbRibRsLsbLsbRibLsbRsb
RibRsbLsbRgbLsLsLsmmbRiLsbLsbLobLhRsbRgLsbLibRgbLgLsbLsbLgbLgLsbRgbLib
RgLsbLgbLgbLibRgbRsbRcbRibLgbRhbRcbLgbLgLsbLsbRsbRsbRibRgbRibLsbRsbRgL
sbRsbLcbRibLjbLibLiLsbLhbLsbLsbLgbRsbLgLsbRsLsbLibRgbLibLgbLsbRibLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 164038; End: 164538;
Recording: 6-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bRsbRgRsRsmmbsbRgbRcRsmbsbRiLsbLsbRsLsbLobRsbsbLiRgbLiRsbRjbRibRsLsbRc
RsmbLgLsbRgbRibRgbRsbRsbRsbRgLsRsbRsbRsbLjbLibLibLsbLibLeLsRsbRsbRsbLc
bRgbLcbLsbLsLibLibLibLgbRsbRsLsRsRsmbLjbRsbLgbLhbRgbRgbRsbRsbLsRsbRgbL
sLsmbRgbLsRsbLgbRgbRibRgbRcLibLhRsbLsbLibLsRsbsbLsbRsbLobRsbRibLoLsmbL
sbRsbLcbRsbRgbRgbRsRgbRsbRgbRebRgbRsbRsRgbRgbLgbRgbRsbRiRsLsmbRgbRgRsm
bRgRsmbRsRsmbRhbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 1; Drug: Control
bRgbLsbRsbLsbLebLiLsbLsbRibLgbLgbLgbLcLsLgLsLsmmbRobLsRsbLsRsLsbLcLsmb
RsbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 2; Drug: Control
b

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 3; Drug: Control
bsbsbRcbRsbLcbRhLsbRsbRhbRibsbsbLiRsbRsbLcbLjbLhbLcbLeLsbsbLcbLcLsmbLi
bLiLsbLcbsbLcbLibsbLoLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 4; Drug: Control
bLjLsLsLsmmmbRcbRcRsmbLoRsLsLsRsmbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 5; Drug: Control
bLjbRebLsLsmbLgbLgRsbLsbLiLsbRcbLhbsbRibLcbLcbLgbLgbLsbLsbRibLsbLibLsb
RsbRsbRgbLgLsbsbsbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 6; Drug: Control
bRgbLsLjLsmbRobLcbsbLibLgbLsLsmbRobRobsbLhbRobLgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bLibLibLibRcbsbLiRsbLcLsmbsbRgbRiRsmbsbsbLgbRcbRsLcbLsbLjbLcbLcLsmbLob
RibRcbLgbLibRcbLcLsLsmmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bRgbLibLobLjbLhbLobLibRibRjbLcLsmbRiRsmbLobLoLsmbLibLiLsbLsLgbsbLsLsRs
mbLjbRcbsbLsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bLjbLsLsmbRibRibRcbLeLgbLsLsmbRsbRoRsmbRhbLobRsbRcbRcbRebLsbRibRsbRgbR
iRsmbRcbLgLsbRibRgbLgbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bRsbRibRgbLgbRsbRsRsmbLsbRcbLibRcbLsRsbRhbLibLibLsbsbLibRsbLcLsmbsbRib
LsLsmbLsLsRsmbLsLsmbLsbRjbLgbRsRsmbLgLsbLobLib

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bRcbLcbLebLcbLgbLcbRibLibLgbsbRhbRgbRsbLcbLiLsbLcbLcbLcbLobLebLcbLobRi
bLsbRgbLsbRiRsmbRgbRjbRcbRobLiLsbRgbLobRebRcbLsbLcbLhbRobLebLhbLcbLcbL
ibRibRibRsbLsbLgbLeLsbsbLsbRebLsbLsbRgbLgbRsLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bRcbLcbRjLsbRibRcbRcbLsbRibRcbRjRgbRibRibRjbLobRhbRhbsbRsbRcbLcLsmbRhR
smbRcbLcbRcRsmbRsLsRsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbsbLgbLibLcbLcbLibLibRibRjbLobRcbRibsbLobLjbLibLibRgbLsLsmbLgbRcRsm
bLgbRobLibRhbLhbLobLhbLhLsbsbLsLgLsbsbLhbRibsbLcbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bsbsbsbRsbRsbsbsbsbsbsbLsbLobLgRsbRibLoRsbLgLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bLcbLibRsbRgbRsbLhbLsbLibRcbRcbsbRcbsbLsbLiRsbLiLsbLsLsmbRjRgbLgLsbLsR
sbLobsbLcbLcLsmbLgbRibRgRsmbLibRsbRcbRibsbLgbsbLibsbsbRcbRgbLgbLebRgbL
ibRiRsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbRsbRgbRsbRsbLibLibRsRsmbRsRsmbLibLhbLobLgbLsLsmbLsbLoRsbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bLiLsbLgbLsbsbLhbRjRcbRgbRgbLcbLibLgLsbLibLibLibLibLibLibLibLiRsbLhbLi
bLcbLjbRibLebLibLgbLcbRsLsbRobRcbRgLsbLsbLgRsRsmbLibRibLgbRsbLgbLgLsbL
ibLibRsbRsbRcbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bsbRjbLcbLiLsRsbLsbLibLsbRsbsbLhbLsbsbLgLsbLsbRsbRsbLcbLsLsmbLobLcbLsb
LsRsbRgbRsRsmbRcbLsbRsbRgbLsbsbRgbRgbLgbLibLsbsbRgbLgbRsbsbsbRebLcbLcb
LibRgbLcbLsbRsbRjbLcbRsbRsbLsbLgLsbRsbLsbLibsbLcLsmbsbLibsbsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbLgbLgbRjbReLsbLobLibLsbsbLhbLsbsbsbLgbLibLibLsbLsLsmbLgbLsLsmbRsRs
mbRsRsmbRsbsbRsLsbsbLgbLgbLsbRjbsbLhbsbLsbRsbLgLsbRsbRgLsbsbsbLsLsmbLs
LgLsbLsLsmbLsbLgbLiRsbLgbLsLgbLibLgbLsbLgbLgbLsbLibLiLsbLgbRsRsmbLgbLg
bLibLgRsbLgbLsbRsbLhbLsbLgbLsbRgbsbRcbRgbLsbRgRsmbRgLsbRgLsbRibLibLcRs
bLgLsbRsbRsLsRsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bLiLsbLgbsbLgbRsLsbLgRsbLsbLibLgbRsbLgbLsbRcbLjbLibLiLsbLsbLgbLsbLgbLs
LsmbLibLgbRgbLibLibLsRsbRsbLgbLgLsbLgbLsRsbRsbRsLibRsbLgLsbLgbLgbRsbsb
LgbRgbLhbLibLgbRsbLcRsbLgbLhbLgLsbLsbLibLibLsbRsbsbLgbLsbLgLsLsmbLgbLg
bLgbsbLgbRgbsbLiLsbLibsbRsbRsbLibLsbLgbRsbLibLsbsbLibRgbLgbLsbLsbLibRg
bsbLibRcbRiLsLsmbRibLjbsbLibLibLsbLgbRsbLibLsbRgRsmbRsbRcRsmbRibRibRib
RsbRsbRibLgbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bRcLsbRsbRsbRgbRjbRsbLjRsbLcLsmbRgLsbsbLiLsbLsbRjbLiLsbLhbRibLhLsbsbRs
bLibLsbLsbLsLsmbLsbsbLsbLsbLibRsbRsbLiRsRsmbRsLsbLsLebLgbLsLsRsLsmbRsL
sbRsbLsbsbLebRgLsbLgbLgbLsbLiLsbRsbLsbLcLsmbRsbLsbsbLgLgLsLsmbLibRsLsb
sbsbsbLsRsLsRsbLobRgLsbLiLsbRsbsbLibLibLsbLsLsLsmmbLsLsmbLibRsRsmbRgbL
ibLibRgbLibRsbLeLsbRgbRsRsmbsbsbRsbRibRgbRibLgRsbRcbLsRsbRsbRibLjbsbLi
bRebRgRsmbRsLsbsbLsRcbsbsbRgbLgbLobLsbLsbRsbLiRsbLgLsRsbRgRsmbRsRsmbLg
bRgbRobLsbLsbRcbLgbRobRhbsbRhbLgRsbRsbRgbRsbRjbRibLsbLgbRibLsbRibLsbsb
LhbRgLsbRibLsbLhbLgLsbRjbsbsbRsLsbRsLsbLsbRsbRsRsmbRsbRsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bLsLsmbRiLsbLhbRsbLibsbLgbLsRsbRsRsmbRebLiLsbLcRsbLibLsbsbLibLsLsmbLiL
sbLsLsLsmmbLcbsbLiLsbRibLgbLgbRsbRgbRsRsmbLgbRgbRsbRiRsmbLiLsbRsbLibsb
RgRsRsmmbLgbRiRsmbLgLsbRsbRgRsmbLgbRibRiRsmbRsRsmbRsbLibLibRsbRsLsbLsb
RcbLgbRibRgbLobLgbLsRgbsbRsbRgbsbLhLsbRoRsmbRsbLgbLibRgRsmbLsLsLsmmbRj
Rsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bRgbRgbRsbRibRsbLgbLsbLibLsbLgbRgbLibLgbLsbRebRhbRibLibRsbLsLsRsRsmmbR
ibRsRgbRgbRgRsmbRgRsmbRgbRsbRsLsbsbRsLsbsbsbLsbRgbsbRsLsRsRsmbsbRsLsRs
LsbRsbRsLsbRsRsmbLsbRsbsbLjbLoRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bsbRgbRgbLjbLhbRsbsbLibLsbLgbLgLsLsmbLsbLgbLgbLsbLsbsbLsbLgLsbLibLcbLi
bLsbLsbLhbLgbLgLsbLgbRgbLhRsbLsbLgbLgbLibLgbLgbRsbLgbRgRsmbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 25; Drug: Control
bLcbRjbRjbRobLcbLjbLjbRebRjbLcbLjbRsbRobLobRebLjbLcbLjbRsbRsbLsbLsbLeb
LobsbLjLsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 26; Drug: Control
bLiLsbLsbsbLgLsbLoRsbLobLebRjLsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 27; Drug: Control
bsbsbRsbRgbRiRsmbLgbLsbLibRgRsmbsbsbsbRibLsLsLsmmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 28; Drug: Control
bLoLsmbsbRcbLgLsbLcRsbRibRsbRebRibRob

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 29; Drug: Control
bsbsbsbsbRjLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 30; Drug: Control
bRhbRsRsmbRsRsRsLsmmbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bRibRsbLibLeb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bLobLiLsbRcbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bRhRsmbLjbLgLsbRoRsmbLiLsbLhLsLsmbLsbLibLobLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bLobRjbLcbLcbLhbsbRsbRsbLsbLibRibLgbLjbLebRob

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bLsLsmbLobLiLjbLcbLiRsbLobLgbRiLsLsmbRibRibRsbLsLsLsmmbRsbLsbLsbRsbLib
LibLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bRiRsmbsbLcbRsbRsbRgLsbLsbLsbRsbRobRibLoRsbRobRcbRcRsmbLsbsbsbRgLsbRgR
smbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bRjbLsbLjLsmbRibLsbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbLgbsbRsRsmbLibRcbRiRsmbRoRsRsmmbRgbLgRsbRcbRibRibRibRhbsbsbLjbsbRi
bLcLsmbLiRsbLsbRsbRgbRoRsmbRibLsbRgLsbRhbRgbRhbLsbRsbRgbLsLsmbLibRibLs
bRobLsbLgbLsbRcbRgbRgbLgbRiRsmbLgbRibRgbRgbLsRsbLsbLsbRibLsbRhbsbLiLsb
RcbRhbRcbRgRsmbLsbRibRsLsbRsbRhbRibLsbRsbRibRsLsbRgbRsbRsRsmbRiRsmbRgL
sbRsbLsbRgbRibRibRibLgbRgbRgbRiLsbRgbRgbRsRgbLgbRgRsmbRcLobLiLsbRibLgb
LsbRibLsbRibRsbLiLsbRebLcbLibLoRsbRsbLsbLsbLibRsLsbRjbLsbLibLgbRjbRsLs
bLibLsbRjbRibLjbRibRgbLoLsLsmmbLibLsbLsbLgbLgbLsbLgRsbRgbLibRgbLibLsbL
gbLgbRsLsbLiRsbRsbLibRsbLsbLsbLgLsbRsbLibRsRsmbLibLgLsbLgbLsbLgbRgbLhb
LibRgbLsbRsbRibLsbRcbLcbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bRiRsmbRsbRsbRgbLobLgbLibRsbRibRobLsbRcbRsbRibLgRsbRgRsmbRsRsmbRhbLibR
sRsmbLoLsLsmmbLsLsmbLsbLsLsmbLoRsbsbRiRsmbLsbsbLcbRsLsbsbLiLsbLsbRgbLs
bRcbsbRgbRibLjbLcbLjLsmbLsbRjbRcbRgRsmbRsRsmbRsbRiRsmbLcLsmbLibRibLcLs
mbLiLsbLsbRsbRibLsbLibRjbLcLsmbLsbRobRsbRgbLjbLiLsbLobRibRgbLebLgbsbRj
bRobLsbRiRsmbLsbLoLsmbLsLsmbLibRgbLibLsbRsbRsbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bLcbLhbRgbRcbsbsbRobRhbRobRoLsbRhbRcbsbRjbRcbRcbRjLsbRcbRibRcLsbRcLsbL
cbsbLjbRcbRibLcbRcRsmbRgbRhLsbLhLsbLsbRgRsmbRcbLcbRcbRjRibRibRjRsmbRsb
RsbRibRcbRcbRsbRcLsbRibRebRsbRgRsmbRsbRcbRibLcbLobRcRgbRcbLsbRcbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bRibsbRgbRgbsbRsRsmbRgbRoRsRgmbRgbRibLhRsLsbRgbLibLsbLobRcbRcLsbRibLgb
RobLsbLcLsmbLcLsmbRsbLsLsmbLgbRsbLcbRgbLsbLiLsbLsbLgbLsbsbsbsbsbsbLsbR
sbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bRsLsbsbLibRsbLibRjbRobLsRsbLcbLcbLgbLoLsmbRibLgbRgbLgbLhbLibRsbLhbLcb
LgLsbLibLsbRiRsmbRsbLcbLibRgbLoRsbLcbLgbLgbRgbLsbLibLgbRjbLibLsbLsbLsb
LiRsRgbLsRsbLsbLibRgbLiLsbRsbLgbRsbLgbLsbsbRsbLsbLsbLsbRcbRhbLsbRiRsmb
LgbRgbLcbLgbRgbsbRibLgbRgbLjLibRjRsmbRibLjbRjbRiLsbRsbRcbLgbLsbRcbLgbL
jbLibLobRibRsbLgbLibRibLcbLsLsmbRgbRgbLhbsbLgbRsbLsbLebRsbRgbLcbRsbLgb
LgbRibRibLjbLibLibsbLgbLsbsbLcbLsbRhbLsLsmbLsbsbLsbRsbsbRhLsRsbRsRsLsm
b

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbLsLsmbLgbLgbLgLsbRjLsbLobLsbRsbLebLiLsbRsbLebRsbLibsbsbsbsbsbsbsbR
sbsbLiRsbLgbLsbLsbLsbLsLsmbLgbLsbLgbLgbRsRsLsmbLebRibRibLibLgbRgbLsLsm
bLibLgbLsbRcbRibLgLsbRsRsRgmbRebRsbLsbLsbLibRsbLgbLsbRsLgbLsLsmbLgbLsL
smbLsLsmbLsbLgbsbsbRgbRibLsbRsbRebRobRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bRcbRhbRiRsmbRsbsbsbsbRibRcRsmbLgbLsbLcbLsbRhbsbLibRcRsmbRibRcbLsLsLsm
mbLsbRobRobRhbRibLsLsmbRgbRibRibLgbLgbLsbLibLsbLibLibsbLgbLsbLsLsmbLgb
LgbLibRgRsmbLiRsbLgbRsbLgbLgbLgbLgbLsbLgbLgbLgbLsbLsbLgbLgbRhbLibLgbLi
bRiRsmbLhbRgbLobLgbRsbLsbLibLsbLibLsbLibRsbLiRsbRsbLiLsbRsLsbLhbLgbLib
RsbLgbLgbLibRsLsbLgbLgbRgbLgLsbLgLsbLgbRsbLibRgbLiLsLsmbLsLsmbLibLgbLg
bRsbRsbLgbRsbLibRgbsbLibRibLobsbRgbLgbLibLgbLsbRgbLoRsRsmbRgbLsLsmbLgR
sbRgbLcbLiLsbRgRsmbLibLcbLgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bRibRsbLgbLjbLjbRsLsbRsbsbsbsbsbsbsbsbsbsbsbsbLgLsbLhbLgbRibRgbLibLsLi
bRgbLibRsLsbLoRsRsmbLgbRgbLibRgbRcbLsLsRsRsmmbsbsbRibLsbsbRibRibRiRsmb
LgbRiRsmbLjbRjRhbRsbLoLsmbLsbRjbLibReRsmbsbLsbLsbsbRsbRsbLsbsbLsbLgbRs
bLsbsbLsLsmbLgLsbRjRcbRobLibLiLsbLgLsbRsbLsbLibRgbLiLsbRsbLjbLibRsbLhb
LibRjRgRsRsmmbLsbsbsbsbsbsbRjbRcbLjbRcbRsRsRsmmbRgbRibLsbRibLgbRcRiRsm
bRsRgRsmbRgLsbsbRibLsbRiLsbLsbRibLibRibRiRsmbRsbLsbRiRsmbLsbsbsbsbsbsb
sbsbLsbsbsbsbsbsbsbsbsbLgLsbRiRsmbRsbRsRsmbsbRebsbRibLebRhLsbsbRobLsbR
sbRjRsRsmmbsbRcRsmbRiRsmbLibsbsbLjbRsLhbLhLsLsmbLgbRsbRgbReRsmbRhLsLgb
RobRgLsbRsLsbRobRgbLsbLeb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bRsbLobLibRsbRsLsbLcbRsbLoRsbRiRsRsRsmmmbRsRsRsmmbRsbsbRiRsmbRgbRebRcR
smbLebRobRebLcbLgLsLsmbsbsbLsbsbsbsbRsbLsRebLibReRsmbLsbLgbRcbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbLibRgbLebRsbRibRcbsbRjbRhbLgbRibRgbRgbLsbRgbRgbRibRsRsmbRibLsbLebR
ebLebLgbRsLsbRcLsbRgbRsbRgbLgbRhbRgRsmbLgbRibLsbRibRgbRgLsbLsRsbRhbRib
LsbRhbLsbRgbsbLibLgbRgLsbLsLsmbLsbLgbLgLsbReRibRcbRiLsbLibRcbLsbLgbRgb
LibRjbLhLsbRibLcbRsbRsbsbRibRhbRgbsbLsLsmbLjbLiLsbLibLgbLsbRibLcbRibLc
LsmbRgRsmbRgbRcbLhbLgbLsLgbLsbLsbLgbRgLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 164540; End: 165040;
Recording: 7-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bRibRsRebLsbRgbLgLsbRgbLgbsbRsRsLsRsmbLsbLeRsbRsbLibLsbLsbsbLibLhbRsLs
LsmbLsbRsLsbLiLsbLsbLibLsbLiLgbLibLgLsLsmbLgbRgbLibLsbLhbRibRgbRiRsmbL
jbRibRsRsmbLsbRgbLebRsbRgbRjbRebRhbRgRsmbRgbRsbRgbRgbRgRsmbRsLsbRgbRsR
gbRsbRcbRsRsmbLibLsRibRiRsRsRsmmmbLsbRgbsbsbRgRsmbRsbsbRsLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 1; Drug: Control
bRiLsbLcbLgbLsLsmbLsbRgLsbRsRsmbRgRsmbRsbRgbRgbRsbLoRsRsmbRsbLcbLgbRgb
LsbLsbLgbLsbLcLsmbRsbRibRobRsRsmbLjLsmbRgbRgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 2; Drug: Control
bsbRsRsmbRjLsbRsbsbRsbsbsbRsRsmbLsbRsbRsbRsbRsbsbsbLsbRsbLsbLsbsbLsRsb
RsbLsbLsRsbsbRsbLsbsbsbsbsbLsbsbsbsbLsbsbsbRsbRsLsbsbRsbLsbsbsbsbsbRsb
sbLsbLsbRsbRsbLsbsbRsbLsbRsbRsbRsbRsbsbsbLsbLsbsbsbsbsbsbsbsbsbsbsbRsb
sbRsbsbsbsbsbLsbRsbLsbsbsbRsbRsbRsbsbLsbsbRsbLsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 3; Drug: Control
bLgbLgbLibLeLsbLobLcbLibRobLsbLcbRsLsbRibRcbsbRiRsmbLobsbLobRiLsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 4; Drug: Control
bRoRsmbLgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 5; Drug: Control
bRjRsmbLjbRebRsbLibLibLsbLsLibRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 6; Drug: Control
bRsRsmbRgbLibRjbLgbLgbLsbsbRsbRjLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bLibLhRsbLgRsbRibLcLsmbLgLjbRoRsRsRsmmmbRoLsRsbLsbLobLsbsbLsbLibLibLhb
LibLibLebLibRcbRhbLibRibRibLibRgbRibsbRsbLibLcbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bsbLcbLgbLsLsmbRcbLibLjLsmbRibLjbLobLhbLhbsbRjRsmbRsbRiRsmbLoLsmbLsbLc
LsmbLiLsbLcbLcbRjbRhbRsbLiLsbRgbLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbLsbLsbRsbRsbLjbLsbLsbRsbLjbLiRsbLibRebsbLgbRcbLibRebLibLcbLibRobRh
bRcbRsbLsLobLhbLsbLobRsLsbRsbRhbRibRsbLjLgLsbRcbLgbRjbRcRib

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bLhbLiLsbRsRsmbLgbLhbLsbRebRjbLsLsmbRobLsbRgbRobLgbRebRsbLcRsbLhRsbRgb
RcbsbRibRhbRibRibRibRhbRcRsmbLibRcRsmbRhbLcbLiRsbRgbRibLcLsmbLiLsbRibR
jRsRsmmbRibLobLcbLgbLhbRgbLcbLibRgbLhbLhb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bLgbRjbRibLiLsbRiRsmbLgLsbLsbRsRsLsmbRsLsbLsbLcbLibRgbRsbLgbLsLsmbRcbR
sbLsbLsbLcbLgbLibRcbRgbRibRsRcbLjbLsbRiLsbRsbLgbRibRibRgLsbLjbRibRcbRe
bRcRsmbRgbLjbRobRgbRsLsLsmbLgLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bRhbRiLsRsbLobsbRsLsLsLsmmbRcbRobsbsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbLcbRcbRibRiRsmbLjLsLsLsmmmbLgbLcbsbsbRcbRibLcbRsbRibLsRsbLibLibRhR
smbRgbRgbRsRsmbLcbRjRsRsmmbsbLjbRhbRcbLgbRsbRhLsbLsbLcbRcbRoLsbRgbLsbR
ibLsRsbRjRsmbRhbRjRsmbRjbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bLhbLcbLgbLjbLcbRjbLhbLsbLibsbsbRsRsmbLsbsbRibLsbsbLjLsmbLiRsRsmbRhbLs
bRobLgLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbLsLsmbRgbRsRsmbRibRibLhbsbRsLsLsmbLsbRsLsbRsbsbsbRsbRsbLjLsmbRgRsm
bRhRsmbLsLsLsmmb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bLhRsbLhbLsRsbLibLgbLiLsRsbLsLibLsbLibLgLsbLibLgLsbLiRsbRsRsmbRobsbRsb
LsLgLsbRjbRoRsmbRebRibRsRgLsbRsbLsLsLsmmbLgbsbsbsbRsbsbRcbRobRsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bLcLsmbLobLsLsmbLibLsbLibLgbLcLsLsmmbLgbLibLgbLibLhbLibRibLhbRgbRsbLeb
LgbLibLsbLsbLcbLibLcLsmbLgbLjRsbLcbLibLibLcLsmbLgbLibRsbRgRsRsmmbRsbLi
bLjLsmbLibRsRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bLibsbLebLsbLsbLhbLebLgbsbLsbLsbLsbRobRsRsmbRsbsbLjLhbsbLhbLibLsbRsbRs
bLsbRsbLibLsbsbRsbLiLsbRgRsmbRsbRsbsbLibLsbLhbRgbRgbsbRsbRgbRsbRibRsbR
sbLsbLsbsbRjRsmbsbRsbRsbRsbRsRsLsmbsbRibRsbRsbLibRgbRgbRsbRsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bLsLsLsLsmmmbsbRobRibLsbRibRsLsbRsbLebRgbRgbRsbRsbRgbLcbLhbRgbLgbLsbRs
bRhbRibRibRiLsbLgbLcLsmbLibLsbLgbRgLsLsmbLgbLsLsmbLsbLgbLgbLgRsbLgbLgb
LgbLgbLiLsLsmbLiRsbLibRgbLgLsbLsbLgLsLsLsmmbRsLgbLgLsbLgbLgLsLsmbLgbLs
bLhLgbRsbLsbLjbLibRsbLgbsbLsLsmbRsbLiLsbRsbRjbLiLsbLibRsLsLsmbRhbLibLi
bRibLibLgbRsLsbLgLsLsmbLsLsmbLgbLsbLgbLgbLgRsbLsLsmbLgbRsLsLsmbLhbRgbL
sbLiLsbRsLsLsmbLsLsmbRjbLcbLsbRhbRibLjbRsRibLobRsbRjbLjbLibLgbLibLibLi
bLsLsmbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bsbLcRsbLgbLgbRhbRiRsmbRgbLjbLibLgbLiLsbLsbRsbLibRgbLgbLsbLibLiRsbLibL
gbLsLsmbRobsbRiLsbLsbLcbLgRsbLgbRjbRibRgRsmbRgbRsbLsbLsbLjbLibLsbLhbRg
bLhbLgbLgbLsbLgRsLsbLsbLiLsbLibRibRgbLsbLgbLgbLgbRsbRsbLibLsbRsbLgRsbL
sbLgLsRsbRsbRsbRcbRhbLgbsbRibRibRgbLsbRsbLibLibLiLsbRsbRsLsbLibRsLsbLi
bLgbLsbLgbLiRsbRsbRsbsbLiLsbRgbLibRsbLgbRgbLibLsbRsbLibLsbRsbLgbLsbLib
RsbLgbLibRgbRibLibLgbLcbLiLsbLgbLsbRcbLjbLsbRjbRcbsbRsbRcLsRsbRsbRgRsm
bRiRsmbRhbLsbRibLsbRibRsLsbRsbLjbsbRibLgLsbRcbLsbRgbRibLsbRibLsbLsbRib
RiLsbLsbLibLgLeLsbLibLiRsbLibsbLsbLiLsbLgbLgbRsbLibLsLsmbLiRsbLsbRebRc
LsRsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bLobRsbRgRsmbLsbRsRsmbRsbLcbsbLjbLsbsbsbRsbRsbsbsbRcbLhbRgRsmbsbsbRebL
sbRiLsbLsbRsRsmbRibRsRsRgmbLgbLsbRsRsLsmbLibLgbLobLsRsbRsRsmbRibLgbRjb
RsbLiRsbRsbRhbRsbRgbRgbRgbRibRsbRobLgbLgbLsbRebLsbRsbRsLsRsbsbsbRgbRsb
RgbLsRsbRiRsmbRsbRgbRsRsmbRgLsbRgRsmbRsRsmbRgbRibLgbRibRibLsRsbRibLsbR
gbRsbRibRsbRgbLsbRgbRsbRsRsmbLsbRsbsbRsbLsLsmbRgRsmbLsbLjbLgbLebRiRsmb
LsRibLjbLgbRsRibRgbRsbRobLgRsbRjbLoLsmbLsLsmbRsbLsbLsbLibLjbLgLsLgLsbL
sbRcbRgbRcbRgRsLsRsmbRsbRgbRgbRsbRgRsmbRibLgbRibRgRsmbRsbRgbRgbRgbRgbR
sbRibLsbRhRsmbLibLsLsmbLebLsbLsbLsbLgbLsbLgLsbLsbLibLsbLjbRsbLiRsbRiLs
bLebLiLsbRsLsbsbRsRsLsmbRsbRsbLsRsbLsLhbLsbLhbRgbLgLsLsmbLsLsmbLgbLsLs
mbLibRsbLsRsbLsbLsRsbRsbLsbLsRsRsRsmmbsbLsRsLsRsbsbRebLeRsbLibRsbLiLsb
LsbRjbLhLsbRsbLsbLsLsmbLsbRsbRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bLgLsbRsbRibRsRsmbLgbLibLiLsbRsbLcLsmbLcbLgbsbRibsbLgbRsbLsLsmbLgRsbLi
bLibLhbLsbLibLcbLiLsLsmbRgbRsbLgbRgbRibLibRsLsbLgbLcbsbRobsbLgLsbLgbRi
bRsbRhRsmbLsbLgLsbLgbRsbLsLsmbLgLsbLsLsmbLsbLcbRgbLcbLgbRsbRsRsmbLgbLs
bLibRobRsbRhbLsLsmbRibRsbRibsbLjbLcLsmbLhRsbRsLsbLgRsbsbLgbLsbLgbRsbLg
bLgRsRsmbLgbRsbRcLsRsLsRsbLsbLobRsbLgbLgbLiLsbLibLsbLgbLgLsbLgbLgLsbLg
LsbLgbLgbLgLsbLsbLsLsmbRsbLgbLgbLgbRsbLgbLgbLsbLsLsmbLsbLsLibsbsbLibLs
bLgLsbLgLsbLgbLgbLsLsmbLgLsbRsLsbLgLsbLgbLgbsbRiRsmbRgbRibRiRsmbLgLsbR
ibLjbLcbLjLsmbRsbLsbLibLgLsbRibRsbLibLsbRsLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bRgRsmbRsbRjRsRsmmbRsLsbRgbRsbRsRsmbRgbRgbLsLsmbRgRsmbRsbRgRsmbLsbRgRs
mbRgbsbsbsbLsbsbsbLsbLsbsbsbLjbsbLibRsRsRsmmbRsbsbLsbsbRibLsbRibRgLsbR
sbRgbRgbRsbLsbLsbRgbLcRsbRgbRgRsmbsbLjbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bLsLsmbLsbsbsbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 25; Drug: Control
bLcbRsLebReLsbLobLhbRcbLsbLsLsmbLcbLibRsRsmbLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 26; Drug: Control
bLobLobLiLsbLgLsbRsbLcbLibsbsbsbLgbRibLgbLsbRsbLcbLibRgRsmbRsbLsbLsbRs
bLgbRgbRibLoRsbRsRgbRsbRsbRgbRibLsbRibLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 27; Drug: Control
bRcbLjbLsbLgbLgRsbLibRiRsmbLsbLgRsbRjbRebRobRibRjRgbLcbRhRsmbLhbLgbRjb
sbsbLsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 28; Drug: Control
bLobRobRibRjbRibRibRibsbRibLsbLsbRsRsmbLsbLsbLibLhbLsbLgbRob

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 29; Drug: Control
bLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 30; Drug: Control
bRobRoLsbRibRsbRiLsbLgbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bRsLsbLgbLjLgLsbLcLsmbRobLcbRhRsmbsbLcbRsbRgRsRsmmbRibRsbRoLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bsbsbsbsbsbRibsbLhLsbLgLsbRiRsmbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bLsbLsbRsLsbLgbLhbLgbLgbRhbLiRsbLobLibLgbLcbLiLsbsbsbLsLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bLoRsbLjbLebLcbLcbLjbLjbRcRsmbRsRsmbRcbLhbLcbLibLcLsmbLoRsLsbLibRcbRib
RiRsmbRsbLsbLcbLsbRibLcbsbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bRobLsbLhbLibLjLsmbLgbsbsbLsRsbRsbRgRsmbRgbRsbRsbLsbRsbLgRsRsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bLobRcbsbRgbLobLhLsbLsbLhbRgbLcbLcbLibRcbLobsbLgbReRsRsmmbLebRsbLobLob
RibRjbRgbsbRsLsbLcbRhRsmbLsbLhRsbLgbsbRibRsbLsbRobLcLsmbRcbRsbRibLcbRg
bLeb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bLebRibLcRsbRiRsmbRjbLobRibRsbRcbLhbLiRsbRhbLobRgRsmbRgRsmbRobLsRsbRsL
sLsLsmmbRsLsbLobRsbRcbRgbLcbLgbLsbLsbRsRsmbRsbRhbLibRsRsmbLsLsmbRibLhL
sbRsRsRsmmbRsRsmbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bLoLsmbLsLsmbLibRsLsbLsLsmbRsbLibsbsbRhbRibRibLgbRcbLsbRgbLsbLgbRsbRsb
RcbRcbRgbLsbRcbLsLsmbLsbLsbLsbsbLsbRibLsRsbRhbRgLsbLsbRsRsmbRsbRhLsbRs
bLibRsRoLsbLgbRoLsbRsbRibRcLsLsmbRcLsbRsLsbLsbRibRcLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bsbRgbLiLsbRsbLsRsbLibLsbRsbRjbRhbLsbsbLcbLcbRibLsbLsbLsbsbLsbLsLsmbsb
LsbsbLsbLsLsLsmmbLsLsmbRsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbRibRcRsmbRcbRgRsmbRcbRcbReLsbRibRhRsmbRcRsmbRcbRsbLsbLobLhRsbLiRsL
sbsbLsbLgbRjRjRsmbRiRsmbRobLsbLgbRibRcbRgbRgRsmbLsLsmbRiRsmbRsRhbLoLsm
bLcRsbRcbRibRsbRibRebRgbRiLsbRsLsbLcLsmbLobRjbRcbRcbRiLsbRjRsmbLsLsmbR
sRsRsmmbRjLsbRcbsbLsbRsbRibsbRibLobLcRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bLibRibsbLsLebLgbsbLsbsbReRsmbRoLsbRsLsLsmbLsbRsbLebRgbLsLsmbRgbLjbRcb
LjbRibRibRibRsbRhbLhLsbLibRsbRsbRhbLcbRgRsmbsbLcbRsbLibLsbLibLgbLgRsbL
sbLgbRsbLgbLgbLsbLgbLsbLsbRcbRibRibRsbLcbLibRobRibRsbRgbLsLsmbLjLibLgL
sbLgLsbRobRiLsLsmbsbRhbLibRobLsbLsbRibRsbRsLsbRgbRgbLgbLcbLibLgbRsbLsb
LsbLibLsbLsLsmbLgLsbLsbLsbLsLsmbLgbLgbRgbLibLsbLgLsbLsLsmbLsbLgbRsbLgb
LibRibsbRjbRsbLsbLcbLsbLsLsmbLcbLcbRgRsmbRgbLsbRibLjLibLibRhbRcbRgbRgR
smbRsbRgbLgbLjbLcbLsbLibRsbLgbLibRsbRgbLgbRsbLsLgbLsbLibLsLsmbRsbLgLsb
RsLsbLgbLsLsmbRgbLiLsbRsLsRsbRsLsbLibRsbLibRgbLibRsbRcLsRsbRibLjbRsLcb
RgbLgbRcbRgbLgbRsbRoRsmbRoLsbLibLibRgRsmbLiRsbLhbRsbLgbLgbLsbLobLgbLib
RsbRcbRgbRgLsbRsbLsbLgbLhbLibLsbLcbRsbRsbRhbRgbLgbRhbLgbRgbLjbRibRgbLh
b

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bLjbRgbLobsbRjbRobRgbLjbLcbLgbRebLgbLjbRcbRgbLgbRcbLjbRcLsRibRcbRgRsmb
RobRgbRcbRgbLibLsbRgbLgbLcbLcRsbLibRcbRgbRhbsbLgbRgbRiRsmbRsbLhbLhbRjR
smbRibRobLcbLjbLgbLgRsbLhbRgRsmbRjbLiLsbLgLsbLsLsmbLsbLsLsmbLsbRsRsmbL
gLsbLsbLgbLiLsbRgbRsbLibRjbRibLjbLibLsbLsbLibLgbLibLgbRgbRsbLibRsLhLsR
sbLgRsbLibRhbLsbLsbLibLgbLgbRsbLgbLsbLsbRjbRsRsmbRsbRsbLiRsbRcLsbRcRsm
bLsbRsbRibLcbRsbLjbLgbLgbRsbsbLsLsmbsbLcbRcbRsbLibLcRsbLibLgbRsbRhbLgb
LibLgbRjLsLcbLobLibRjLsbLibsbLibLibLibLibLibRsbRcbLibLgbRgbRiLsbRgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bRcbLsbLcLsmbLibLcbLsbLsbLhRsLsbRgbRsbLhbLgbRsbLsbRcbRhbLsbRgRsmbRsbLe
bRgbsbRsbsbLcbLgbLgbLgbLsRsbLsRsbLibLsbLiLsbLsLsmbLgbLsbRsbLgRsRgLsRsb
RgRsLsmbRgbRgLsLsmbRgbRiRsmbRgbRsbRiLgbRsRsmbRgbRjbRhbLcbRebLsLsmbLcLs
mbLhbRsLsbLiLsbRsbLgbLiRsbLsbLiLsLsmbRsbRobRsbRgbRibRibRgbRiRsmbLibRgb
sbRsRgRsRsmmbRsbRgbLsbRsbLobLibLibLhLsbRsbRibLebLibRgbLibLgbLgbLsbLgbL
gLsLsLsmmbLsbLiLsRsbLiLsbLsbLgbLsRsbsbsbRebRebRsLsbReRsRsmmbLsbLsbRjbL
jbRcbLebLsLgLsbLiRsbsbLgLgbLiLsbRsRgbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbRgbRsLsLsmbRgbLcbLcRsbRsbsbRjbRcbRgbRgbRcbLsbRcbLgbLibLcRsbLsRsbsb
LcbRgbsbsbsbsbRiRsmbRibLcbRibLsbRiLsbRgbRcbLsLgRsbRgbsbsbsbsbLoRsRsmbR
gbLsbRgbLcbLsbLibLsLsmbRsLgbLsbLgbLgLsbLgbLsRsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbLibRsbLcbRgRsmbsbLcbRsbLiRsbLsbLsRsbRsbsbRsbRsLsbRcRsmbRibReLhLsLs
LsmmbLsbRgbRhbRcbLibRibLsbRobRobLibLibLsbLgbLibLsbLgbRebsbsbsbsbsbLsbs
bRibLcbLiLsbLiLsbLgbLgbLhbLobRgbLobLsbLobRgLsbLibLcbRibRgbRcbRibLgbRsb
RcbLhbLeLsbLiLsLgLsbLgLsbLsLsmbLibLsLsLsmmbLgbLsLsmbLibLgbLgbLsLsmbRsb
sbsbLibLiLsbLsbLgbLibRsbRsLsLsmbsbRsbRsbRsRsRsmmbsbRcbRibRibLcbsbLsbLg
bLgLsRsbRsLsbLgLgbLgLsbLgLsbLgLsbLgbLsbLgbLgLsbLsbRsbRcbLjbsbsbRibRsLs
LsRsmbLsbsbRgRsmbLsLsmbsbRibRibRibLebLobLsLsmbRgbRibRibLgbLsbsbLsbRibR
sbRsRsmbLcbRibLsbRhbRjbRiLsbRsbRsbsbLhLsbLsbsbRsbsbsbRsbLcLsmbRiRsmbRi
bLsbLibLgLsLsLsLgLsmmbRgbRcbRiRsmbsbRgbLsRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbsbRsbsbLsbsbsbRhRsmbsbRsRsLsmbRsRsmbLebRsbRsbRcRsRsmmbRjbRsbLgRsbL
gbLgRsRsmbLsbRsLgbLsbLgbRgbLsLobRsRsmbLobLsLsmbLgbLsbLgbLsbRsRsmbLgbLs
bRcRsmbRsbRgbLsRsbRiLsRsbRsbRgbLsbRiRsLsmbLsbRsbsbLsRsbRgRgRsmbLsRsbRi
bRsbRsRsmbRgbRebLsbLibLibRibRsbLhbLgbLsbRsRsLsRsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bLiRsbLgbRibsbLibLgLsbLgbRjbLibLibRgbLhRsLsbRgbLhbRsbLibRgbLsbLibLgLsb
RsbLgRsbLsLsmbRsbLibRsbLiRsbRcbRgbRibRgLsbsbLgbLibLcbLibRjRibLcbLgbLsR
sbRjbLibRhbRibLsbRiRsmbLsLsmbRibLgbRibRsLsRsbLobLibRgbLgbLgbRsbLgbLsbL
gLsbRsbRibRibRsbRibLgbLcRsbLsbLgbRobRsbLibRgLsbLibRgbLgLsLsmbRsbLhbRsb
RsbLiLsbLgRgbLgbLgbRsbLgbRjbRibLsRsbRibLgbRsRsmbsbRibLgLsbRgRsmbRsbRgb
RibLsbLgbLcLsmbLibLiRsbLsbLgLsbLsbLgbRsbLibLsbLiLsbRgbLoRsbRgRsmbRgbRs
bRgLsbRibLsbLsbRgRsRsmmbLsbRgbLgbRibRsRsmbRibLibRibLsbRsbRgbRsbRgbRgbL
sbRgbRgRsmbLgbRibLsbLsbRhbLsbLgbRhLsbLsbLgbRibRsRsmbRgbRibRibRgbRsbLgb
LsbsbRsLsbRgbRibRsbRgbLgbRgbRibLsbRsbRgbRgbLsbLsLsmbsbRhbRcbRgbRgbLibs
bRibRibRgbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165042; End: 165542;
Recording: 8-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bRsRsmbRibLgbLibLibLgLsLsmbLgbLgbRsbLgbLgbRsbLibRsbRsbsbLgbRsbLgbLsRsR
smbLgbLgbLobLsbRjbRgbRsbLsbLcbRsbLhbRgbLibLiLsbRsLibLiLsbRibRsbLibRiLs
bRgbLsLsmbLgbLibLcbRibLcbLsbLgbLgbLibLsbLgbLsbLgbLibRibLcRibRsRgbRibRg
RsLsmbRebRsRsmbLcbRibsbsbRibLsbRgbRsbsbRsbLsbsbRsbLsbLjbLibRhbRgbRsbRs
b

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 1; Drug: Control
bRsLsbLgbRsbLsbsbRiRsmbRsbsbRsbLsbRsLsbRsbRsbRsLsbRsbLsRsbLsbLsLsLsmmb
sbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 2; Drug: Control
bLebLebLcbLsbRebLobRebRsbRobRhbRobRobLobLobLobLobRsbRcbLgbLebRcbLobRob
RobRobLobLibLobLobRgbLobRobRebLobRobLgbLobRcbLobLobLgbLibLsbRsbRobRebL
ebLobRobLebRebLobRcbRebRobRobLebRebRebLobRobLcbRebRobLsbLobRcbLibRobLe
bLcbLobLebLebRcbRcbRobLobLobRgbRcbRgbRebLobRobRobRjbLebRgbRsbLobRcbRob
LgbRebLebLebLobLcbRobRebLibRcbLebLobRobLsbRobRobRsbRibRsbLobLcbLebLcbR
cbLobLebRobLcbRibLobLebLebRobLgbRobLebLobLobLsbLjbLebRgbRgbLcbRcbLobRg
bLobRebLcbRibLcbLobRebLobRobRobLgbLebRebRobLcbRibRcbRgbRsbRobRobLcbLcb
RobRcbRobRobRibRobLobLobLobLobRsbRsbLcbLobLobLobLhbRebLobRjbLobLebRebL
gbLobRebRobRobRobRobRobLibRcbRebRobRobLcbRhbLgbRcbRgbRebLobRcbRibRobRs
bLebLebLobLcbLcbLobLobRobRobLebRebRibLebRebLobRgbRsbRebLsbRcbLobRobRgb
LhbLgbRhbRobRobRsbLebRcbRobLcbRobRebLebLibRobLgbRobLebLcbRobLobLebRobL
hbLobLcbLobLcbLsbLobLebLibRebLobRcbLebRobLebLcbRobLsbLebLcbRgbLebLobLi
bLebLobRcbRjbRibRebLcbLebRibRebRobRobRobLsbLobRobLobLebLobLobRhbLobLcb
LobLobRcbRebLebRebRobRebLcbRobLebRhbRobRgbRebRcbLobRibLebRcbLsbRgbLobR
ebLobRcbLobLibLcbLebRhbLgbRsbRobRobRcbLhbLhbRcbRobRebLebRobLcbRebRobRe
bLebRcbRobLobRobLobRcbLobRcbLcbRsbRcbRcbLobRobRebLebRibRobRcbLebLobRcb
RibRcbRebLobRobLsbLcbLobLobLobRobLobRobLobRibRgbLcbLebLobLibRobRebRcbL
cbLcbRcbLebLcbLjbLgbRobLebRobLhbRcbLobRebRgbRcbRobLibLhbRobLcbRjbRobRo
bLobRsbRsbLebRcbLebLsbLebLcbRebLibRgbLibRobLcbLobLhbRcbRebRgbLobRcbRsb
LcbLobLibRebLebRobRobLcbRcbRgbRsbRcbLsbRobLobLcbRebRebRobLgbRobLobLebL
cbRobRobRobLobRgbRobRcbLebRobLobLobLobRgbLsbRcbRcbRobRjbLcbLcbRobLobLc
bRobLibRobLobRobLibRebLebRobLobLobLebRsbRgbRebRobLebLibLhbRcbRobLebLib
RebLobRgbRgbLobLebRhbRobRebRobRebRobLcbRebLobLobLobRobRobRcbRobLcbRebR
ebRobLcbRobLcbRgbRcbRobLobLebLobLebLsbLibRcbRibRobRhbLjbLcbRibLibLobRc
bLebRobRobRgbLibLobLjbRcbLobRcbLibLjbRobLobRgbLobLobRobLcbRebLibLcbRhb
LobRebRebRebRsbLobRebLcbRgbLibLobRobLcbLebRobLobRebLibRebLcbRobRcbLobR
cbLcbRobRobRebLcbRebLebRcbLebLgbLibRobRobLcbLibLobLsbLobLcbLebRcbRobLj
bLobLcbRjbLobLobRcbRcbLcbLgbRobRibRobRebLobRgbRcbRibLobRobLibLcbRsbRcb
LsbLobRebRobLobRibLgbLobRebLobLjbRcbLobRhbRobLobLobRobRobRsbLebLibLobL
ebLobLebRgbRebRcbLobLebLcbRobRcbLebLobLobLobRibLobLebRsbRcbRebLobLobRo
bLobRobLobLebRcbLobRobLobRebRobRebRobRobRsbRobRcbRebRobRobLibLebRobRib
LcbRcbLibRibRebRebRsbLobRobLobRobLobRobRobRcbLobRobLgbLobLcbLobLobLebL
ibLgbLhbLibRebLobLobRobRgbRobRobLobLcbRobLsbLcbRjbRobRebLebLsbLgbLibLe
bRcbLobLobRsbRebLebLobLibRcbRibRibRebRcbRsbRgbLobRebRebLebLsbLebLsbRob
RobRobRobRobRobRebLebLebRobLcbRibLhbRobLebRobLibRobLebRebLobRobRcbLebR
ebLhbLobRobLsbRobRobLobRebLsbLhbLebRebLebLobLobLobLebRobRebLcbRobLobRe
bRobRgbLcbLebRibLebLcbRobLobRobLobRobLobLgbLobRebLsbRsbLobRobLobRebRgb
LobRobRcbRcbRgbRcbLcbLebRobLobRobRebRcbLhbLebLcbLcbLibLgbLcbLobLcbRobR
sbRobRobLobRsbRgbLobLibLebRibRsbRobRobRgbRebRobRobRibLcbRebRcbRobLsbLi
bRgbRobRcbRibRebRobRebLebRebLobLebLobLebRcbRcbLcbRobLibRobLebLobLobLob

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 3; Drug: Control
bLcbRcbLibLhbRcbLoLsmbsbsbRebLcbLjbRcbLgbRibsbLhbRhbRcbRoRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 4; Drug: Control
bLjbLjbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 5; Drug: Control
bRcbRoLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 6; Drug: Control
bRcbLhbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bRgbRibRibLcbRibLsbLgLsRsbLsbRcbLoRsbLhbsbRibLcbRsbRgbsbsbLiRsbRebLsbR
ibsbLibsbsbLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bLsLsmbLsbLiLsbLjLsmbsbLcbLibLhbsbLebsbLhbLsLsmbLsbLobLsbLibLgbsbLebsb
RcbRoLsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRibRcbLibLgbRsbRgbRcLsbLgbLsLsmbRsbRsbLoLsmbRcbRsbRcLsbLiLsLsmbsbLe
bRsbRiLsbRsbRobLsRsbLgbLcbsbLebsbRibRsbRsbRcbLibRebLobsbRgRsmbRsbRhbRs
bRhbRsbLsbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bRibRgRsmbLebLibsbLgbLsbLgLsbRsbLgLsbLsbLgbLgbLsLsmbLsbLgbLgbRjRsmbLgb
LgLsbRgRsmbLsbLsbsbRsLsbRjbLeLsLsmbLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bRgLsbRgbRibLsbsbLsbLcLsmbRhbRsLsbRcbsbLibLsLsmbsbRcbLsbRsbRcbLgLsbLcR
sbLgbLcbLobLebsbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bLsbsbsbRgbLeLsbRobRjRsmbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bLjLsmbRjbsbLibRibRsbLibRsbLgbLsbRsbRcbRcbLhbRsbRjRsmbRibsbLgbsbsbRgbs
bRsbRgbLcbLibLibLsbRgbLibLhbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bsbsbRsbRsRsRsRemmbLibLsbLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bsbsbsbsbLsbsbsbsbRsbsbLobRsbLibLgLsLsmbLibRebRcbLcLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bRobLobLobRibLobRobRobRgbRobLebRobRhbRebRcbRgbLgbRebRobRibLebRobLobReb
LebLobLobLcbLobLcbRobRobLsbLobRobRebRgbRobLsbRgbRobRcbRobRebLobLobLcbL
cbRobRcbLobLsbRjbLibRgbRibLobLcbRebLobRobLobLhbRcbRebLobLsbLsbLebLobRs
bLgbRobRibRobLcbLsbRobLebRibRebLgbRobRebLsbRibLcbRjbRobRobRobLebLobReb
LcbLcbRebLibLcbLcbLebRobRcbLebLjbRobLebRobRobLebLobLebLobRgbRibLobRobL
obRebLobRobRobRcbLcbLcbRobLobLcbLcbRibLebLebLobLibRobRobLobLcbLsbRebRe
bRibLcbLibRebRibLobLebLebRebRebLobLibRcbRcbRebLsbLgbRobRebRsbLebLebRib
LobLobLobRobLjbLibRobLobLcbLcbLibLobLebRcbRibRobRebLebLobRibLobLgbLibR
obRcbRibLcbLgbRebLcbLobRcbLebRebRobLobRgbRobLibLobRobLebRjbLebLcbLebLg
bLebRcbLobRibLobLobRobLcbLebLibRobLcbLgbRobRhbLobLebRebRibLebLobRgbLob
LobRhbLebRcbLobLobLcbRebLibLjbRebRjbLebRcbLobLgbRobRsbLobRcbRobLobLebR
cbRebLebLsbRebRobLibLobLebRobRebLcbLobLibRcbLebLebLcbLobRibRgbRobRobRe
bLcbLhbLebLcbRcbLobLgbLobLibRibLhbRebLhbRobLibRgbRobLebLobRobRobLebLib
LobLcbLibLebRgbLobLsbLhbRebRebLibLobLcbLobLebRebRcbRcbLebRcbRcbLebRebL
obRhbRobLebLebRcbLjbRebLebLibLobLebRobRebRsbRcbLobRobLebLsbLcbRobRobLo
bLobRgbRebLebRibLobLhbLcbLebLobLobLebLibLebLobRhbRobLebLcbRobLebLsbRob
RcbRobRgbLibLobRebRobLebLcbRcbLebRobRcbRgbRcbRcbRebRcbRibRibRsbRobRobL
ebRcbRobRobLgbLebLobRjbRobLcbRebRobRobLibRsbLobRobRobLgbRcbRebRibRobLc
bRebLobLebRobLebRobRgbRcbLcbLebLobLcbLobRobLobLobLebRebRobLobLebLhbLob
RhbLibRobLebRobLsbLhbLibRobRibLebRobLcbLobLebRcbRibRobLhbRcbRobRobLobL
obRobRibRebLobLobLsbRebRgbRobRobRcbLcbRgbRobRobRobRobLebLgbLobRobRobRi
bLebRcbRebRobRebRebLcbLibLcbRobLebLobLobLobLobRibRebRcbRebRebRibLebLob
LobRgbRobRobLcbRibLebLebRjbRobLobLobLobLobRebRobRcbRobRcbLebRobLobLobL
ebLobLobRebLobRobLebLgbLobRibLobLsbLgbLebLobLhbLebLobLebRgbLcbRobRobRe
bLobRcbLibLgbRgbRgbLibLibLobRobLebLobRobRobLobRcbRcbLcbRibRobLcbLcbRib
RcbLebRebRgbLebRebLibRobLhbRcbLcbLobRobLcbRebLebLobLibRgbRobRebRobRobL
obLebLebLibRcbLebLebLebLcbLcbLgbRgbRebRcbRcbRobLobRcbLobLgbRcbRjbLcbRc
bLcbRsbRcbLobLibLcbLebLcbLebRcbRobRebLsbLobLobRobLobLsbLobRibRebLobLgb
LebRebRobLebLibRobLobLobRebLsbRobRobLobLobLebRcbRobLibLobRobRobLobLebL
obRcbRebRcbLobRobRibLebRobLcbRibLebRobLobLgbLobLcbRobRjbLobRebLobLebLc
bRgbRgbRobRsbRebRgbRibLebRebLhbLobLobLcbLobLobLobLcbLcbLsbRcbLobLebLeb
LobLobLgbRobRobRgbLobRobRjbRibRgbLobLibLibLobRsbRsbRobLibLgbRobRibRobR
ebRcbRobLobRcbLobLcbRebRcbRebRcbRsbRibLebLebLjbLobRobRebLobRgbRebRhbLi
bRibRobLgbRobRobLobRobRobRobLobLebLcbLcbRobLibLobLebLcbLibRobRobLcbLob
LibLebRhbLebLebRsbRobLobLcbRcbRjbRcbLcbLobRobLobRobRgbRebLgbLobRebRebR
obLobRibLobLibLebRebLebRobRgbRgbRgbLhbRobLebRobLcbRobLibRcbRcbLjbLobRi
bRjbRebLgbRobRgbLcbLobLobRibRcbRebLjbLobRobRibLcbLobLobRobLjbRebLobRob
LobRobLcbLibLibRobLobRobRibRobRobLhbRcbRobLebLobLobLcbRebRsbLcbLobLobR
sbRgbLjbRobRebLhbRobLibRobRcbRcbRobRebLobLcbRebRobRsbLsbRobRobLobRebLj
bLobRobLobRebRobRebRobRgbRobRibLebRebRobRgbRebLobRebRobLobLcbRobLobLob
LobLobRobLobLebRgbLcbLcbLobRebLebRebRebLhbRobRcbRebRgbRgbRcbLobRebLebL
gbRobLobRebRobLobRcbLobRcbRobLsbLcbRobLebRebLcbRebLobLcbLobLjbLobLobLe
bRcbLcbRebLcbLebRebRebLcbLobLobLobRobRobLob

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bLcbLibLibRobLcbLibLjbLibLsLsmbLgbRsLsbRcbLsbLgbLgbLsbLsbLcbLsRsbLgLsb
LhbLgbLiLsbLibLcbLsLsmbLsRsLsbLibLibLibRhbLgbLjLgbLcbRobLibLebLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbRsbRsbLjLebRsbLibRibRjbRsbsbLiLsbRibRsbLsbsbLgbLcLsmbLebLsbLibRgbL
sRsbLsLsLsmmbLgbLiLsbLsLsmbRibRsbRsbLsbRgbRsbRgbRhbsbRsbLsLsRsmbRsbRsb
RgbRsbRsRsmbLsbRibLjbsbRebLhLsbRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbLgbLsLsmbLgLsbLsbLsbRsbLiLsbRsbLhbLsbsbRgbRgbLcLsmbLibLsLsmbLgLsbL
sbLibLgbLsLsmbLhbRgRsmbLgbRsbRiRsmbLjbRsLsLsmbLsbRsLsbLsbRsbLcbRgbLiLs
bLsLsmbLgbLsbLgbLsbLgbLiLsbRsLsLsRsmbRibLjbLiLsLsmbRsbLgbRsLsLsmbLgLgL
sbLsbRjbLebLgbLsbLgbLsbLsLsmbLgbLgLsbRibLhbRsbLsbLsbLgbRsbsbsbRsbLhbLs
LsLsmmbLsLsmbLgbLgLsLsLgmbLsbLsLsmbLibLsbsbsbLsLgbLsbLsbLjbLiLsbLiLsbL
gbLgLsbLsLsmbLsbsbsbsbsbRsbsbRsbsbsbsbLsbLgbLgbLiLgLsLsmbLibRsLsRsLsbL
sLsmbLibsbLsbRgbLhLsbLgbLsbRgbRcRsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bLibLcbRsRsmbLiLsbLgbLgbLgRsbLgbLibRgbLgbLibRibLiLsbRsbLibRsbRsRsmbLsL
gbRsbLgbLsbLgbLgbLgLsbLgLsbLsLsmbLibRgbRhbRgbRcRsmbRcbRgbRsbRsbLhbLhRs
bRgbLibLibRsbLgbRsbLsRsbLibRgLsbsbLgbRgbRsbLibLgLsbsbLsbLgbRsRsmbRsbLg
bLsbLibRsbLgbLgRsbLsbRjbLibLgbLsbLsbsbsbLiLsbRgbLibRsbLsbRsLsbLsbRsbLi
bRsbLgbRsbLibRsbLgbLgLsbLiLsbsbLsbRsLsbLgbRsbLibLiLsLsmbLiLsbLgbLsLsmb
LgLsbLibLgbLsbLgbRibRebRobRcLsbRjbLgLsbLgbRsbLibLgbLgbLgbLgbLsLsmbLgRs
bRsLsbLiLsbLgbsbLsbRsbLsbLibLgbLgbLsbLgbLibLibRcbRgbLhbLibLgRsbRsRsmbL
ibLsbLsbLgbLgbLsLsmbLgbLsbLiLsbRsRsmbLgLsbRsbLgbLgbLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bRsbsbsbLsLgbLgbLsbLhLsbLgbLibLsbLgLsbLsLsmbRebRhLsbLgLsbRibRgbLsbRgRs
mbRgbRsbsbsbRsRsmbLsbRibRsbLgLsbRcbLsbLsRsbRgbRibLgbLcLsmbLibRsbRibLjb
LiRsbLgbRebRibRsbRibLgbLsbLsbsbsbsbRjbRibRibLgbLibRebRgLsbRsbRgbRsbLsb
LjbsbLsbsbRsRsLsmbLsLsmbLsbLcbRibRgbRcRsmbLsbsbRsbLsbsbRjbRiRsmbLsbReb
LgbRsbRsLsbRcbRgbLsbRiLsbLsbLgbRhbRsbRibLsbRibRsbLjbRgbLibRsbLsbRebLob
LeLsbLgLsbLgLsbLsbLsLsmbLgbLgbLgRsbLibLibRjLsbLgbLgLsbsbLibRgbLibRsbLg
bLgbLibLobRgRsmbRgRgRsmbRiRsmbRgLsbRiRsmbLsLsmbRgbRgbLsbRgbRgRsRsmmbRs
bRgbRsbRgbLsbRobRsbLgLsbReRsRsmmbLsbsbRsbRcbLsLsmbRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bRgbLibRgbLibRgbRgbRsbRsRsmbLibRsbLibRgbLibRgbLgbLiLsbRsbLgbLgbRjbRsbs
bLibRsbLibRsbLibRgbRsLsbRsbLibRgbLibRsbLgLsbRsbLgRgbLibRsbsbRjbLibRsbL
hbLibRsbRsbLsbLgLsbLgbRcRsmbRgbRjbRjRgbLhbLgbRsbRsRsmbRjRsRsmmbRebsbsb
LcbLibRibRiRsmbLiLsbLiLsbsbRhbRiRsRsmmbRcbRsLsbRobLsLsLsmmbRsbLjbRoRsm
bRgbLibLiLsbLgbRhbRsbRgbRcbsbLjbsbsbLibLgLsbRgbsbsbLibRcbLibsbLibRcbLg
bRgbRsbRgbLibRcRsmbRgbLjbLcbRiRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bsbRibRiRsmbLibRsbRsRsmbRibLsbRiRsmbRibRsbLsbLsbsbsbRsbLsbRsbRsbRsRsLs
RsmbLjbRsbsbLibRsRsLsmbsbsbsbsbsbsbsbsbsbRsLsRsbLibLgbLcbRsbRjbLsbRsbR
sbLebLibLebRgbLhbLcRsbLgbRsLsRsbRgbRibsbRgRsmbRiRsmbLsbLgbLsLsLsRsmmbR
ibLsbRebRsbRgbRgRsmbRsbsbRgRsLsmbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bLcLgbLgbLjbLibLibLsbLgLsbLsbRsbLobLgbRsbLobLgbRsbLsbLiLsRsbLgbLibLgRs
bLsbLibRsbLgbLgRsbLsbLibRgbLoRsRsmbLgbLsbRgbLoRsbLsbRsbLibLgbLsbLgLsbL
sbLgbRjbRsbLjLsmbsbLjbLibsbsbsbLjbLsbLgbLsRsbLgLsLsmbLsbsbLibRibRjbRsb
sbRgRsmbRgRsmbRgbRsRsmbLsRsbRibRsbRgbRgRsRsmmbRgbRsbLsbRebRibLsLsmbLiR
sbLsbRsLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 25; Drug: Control
bRobLoRsbLsbLsbLsbRsbLsbRgRsmbRcbRibsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 26; Drug: Control
bRgbLjLsmbLjLsmbsbRsbsbsbLjbLhbLibsbsbRjbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 27; Drug: Control
bLibsbsbsbsbLcbRiRsmbLjLgLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 28; Drug: Control
bRibRgRsmbLsLsmbLsbLsbLsbLcbLsbLhbLsbRsbRcbRsbLhbLgbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 29; Drug: Control
bRgRsmbRgbRgbRsRsmbRsRsmbLsLsRsmbsbRgbRgRsmbRob

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 30; Drug: Control
bRgRsmbLsbLsbRsLsbReb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bLhbLoLsmbLcbLibsbRgbRjLsbsbLobLcbLibRibLsRsbRjbLcLsLsmmbRsbRjbLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bRiRobsbsbLsbsbsbLcbsbLcLsmbRjbRobRoLsbRhbLjLsmbLgLsbLibsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bLhbRibRgbRibRjbRsLsbLsbRgbsbsbsbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bLgLsRsbRgbRhbLcbLibRcbRgbLcbRsbsbLibRgbRgbLhbLsbRjbLibLsbsbRcbLjbLcbL
cbsbsbLebRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bRjbRibRgRsmbRobRsbRiRsmbLsbRibLsbLibLhRsbRsbLibLoRsLsbLgbRsbRsbsbRsRs
mbRibsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bRiRsmbLibRibLibLgbRibLgbRhbRcbLsLsmbRgRsmbsbLhLsbLjLgbRsRsLsmbRjbLibR
sbRgbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bLjbRibLcLsmbLiLsbRsbRsLhLsbRgbLcbRibRsRsmbsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbRsbLsbLgbRjRgbLsbLsbsbLsLsLsmmbLiRsbLsbRibRjbRsbRsbsbLgbRsbLgbLsLs
mbRcbRsbsbsbsbsbsbsbsbRjbLsRobLgbLibLibRibLsLsLsmmbLsLsmbLsbLsbLcbRsbL
ib

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bLiRsbLsbLsbLoLsmbsbRibRobLsbRsLsbLeLsbRjbRgbRibRcbLsbRibLsbRcbRibsbLo
bLsLsmbRgbRcbRsRsmbRgbRcbRsRsmbRgRsmbLsbLsLsmbLhbLsbLibLsLsmbsbsbLoLsm
bRgLsbLsbRsbLsbLsLsmbRhbLsbLcbLibLsbRsbLoRsbRgbRsLhbLsbLgbLsbLhbLsbLib
LsRsbLgbRcbLhbRsLsbLsbLibLsbRibLoLsmbLibLsbLibLibRsbsbLgbLibLibsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bRibRcbRcbsbsbRsbRcLsbLsbRjbRebRcbRcbRibRcbLcLsRsmbLcbRhRsmbRiLsbsbRib
LibLcbRjRsmbLsbRsbLsbRgbRjbRhbRsbLgbLobLiRsbLcbLcbRebRiLsbLcbLcbLjLsmb
RsbRibRsRsmbLsbLcbLcbLcbRgLsbRjLsbRgRsmbLobRcRsmbRsRsLsmbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbRsbLhbRgbLibLgbRibLsbLibLsbLgLsbRsbLgbLgbLgbLgbLgbLgbRgbLibRgbRobR
obRsbLgbRgbLobRibRebRibRgbLsbRibLsbRsRsmbRgbLjbLcbLiRsbRibRoLsLsmbLibR
gbLjbRhRsmbRsbRibRsbRsbLgbLeLsLsmbLhbRgbLcLsLsmmbRsbRgbLcbRhbLcbLsLsmb
RgbLibRjbRibLgbRibLgbRibLgbLcbsbsbLsLsmbRsbLibLsbRgbLsbLibRsRsmbRjbLsb
LcbRsLsbLibRsbRsbLibLsLsmbRgbLcbLiLsbLsbRibRibLjbsbLsRsRsRsmmbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bRiRsmbRsRsmbLsbRibRsbRgbRsRsmbRgbRsbsbsbRsbsbRcRsmbLsbLjLibRebRcbRcbL
ibLcbRgbLiRsbRsbsbLibLibRsbLsRsbLsbLsbsbsbRsbsbLgbLsbLiLsbLibLhbLibLib
sbsbRsbLsbsbLsbLsbLsbsbLsLsmbLsbLsbRcRsmbLgLsbLgbLhbRibLjbLgbLibLsLjLs
LsmmbLgbRjbRsbRcbRsbRcbLibsbRcbRsRsmbRcbRgbLsLsmbsbLibRcbRhbLibLebLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bsbRjbRcbRebLibsbRsLeLsbRibLibLgLsbLsbLgLsbLsbRsRsmbRsbLsRsbLsRsbRsRsm
bLebRgbRibRjbLcbLobRcbRjbRsbLcbRibRsbLgbRgbRcLsbRsbRoLsbRgbLgbRiLsbRgb
RgbRgbsbLcbRcbRsLsbLgbLebLgbLiRiLsbRcbRgbRgRsLsmbRsbRgRsmbRgbRgbRsbRgb
LsbRgbLcbRibsbLgLsLsmbLibLgbLcLsmbRibRgbRiRsmbRgbRgbRgbRgLsbRgbRsbRgbR
gRgbRsbRgbRebLjbRibRsbLjbRebRebRsLeLsbsbRgbLeLsbRsLsbLibLhRsbRjbRcbLgb
RcbRgLsbRibLgbLsbLsbLsLsmbRgbLoLsmbLgRsbRsbLibLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bLgLsLsmbLsbRsbLsbLibLsbRsbRsLsbLhLsbRgbLsbLobRsbRgbLibRcbRhbLjLsmbsbR
gbRcbRsLsRsbRgbsbRsRsmbRsbRgbLsbRibRsbLcbLibLibLobLgbRiLsbRibRgbLgbRib
LsRsbRiRsLsLsmmbRsbRgbLoRsbLibRsbLgRsbLgLsbLgRsbLcRsbRgbRsbRgbsbLgbRjb
LjbLgbLsbLgLsbLgLsbRsLsbLibLibLibLsbLgbLgbLsbRsbLcbLgRsbLsbRgbLibRgbLh
bRjbRcbRobRhbRiRsmbLgbLibRsbRsbLibLibRsbLsbLsLsmbLgbLgbRsRsmbLgbsbLsbL
ibRsRsmbRcbRibRiLsbRsbRsbRgRsmbLgbRsRibRsbRgbLsRsbRibLibLibLibLsbLgbRs
bLsRsbLsbLgbLibRgbLibLgbLgbLiRsbRgbLsbLsbLiRsbLsLsmbLgRsbLgbLsbLiRsbRs
bLcRsbLgbLgLsRsbLhbLgbLgbLgLsbRsbLgbLgbLgLsbRsLsbLsbLgLsRsbLgbLhbRgbRc
bRhbLsbRgbLsbRgbRgbLgbRgbRgRsmbLgbLcbLibRgbLjbLgbLibLsbRsLsbLgbLgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbRgbRgbLgbRhbLsLsLsmmbLhbLcbLsbRjbRcbRiRsmbLgbRhbLgLsbRoRsmbRgLsbLg
bRhbsbsbsbsbRsLsRsRsRsmmbsbsbLsbLebRcbRgbRgbRgbsbRhbRibLsbsbsbsbsbsbsb
sbRsRsmbRiRsmbLsbRgRsmbsbsbsbLjbRhbLjbsbLsbLsLgLcbRhRsmbRibRsbLeLiLsbL
ibLsbRgRsRsmmbRibLsbRsbRibLgbRibRibLsbRibRobLiLsbRibRgbRsbRiLsbLgbRcbL
jLsmbRobRgLsbRsLsbRhLsLgbRobLsbRcbLjbRcbLsbLsbRsbRiRsmbRsRsmbRgbRsLsbL
sbRibsbLgbRibLgRsbsbLgbsbRsbLsLsmbsbLsbRhbRibRhLsbRjRsmbRgbRsRsLsRsmbL
sbRibLsbLjLsmbLcbRibRsLsbRjbRhbLjbLsbsbLsRsbsbRsLsbRsbsbRsRibLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bLibLsLsmbLsbLgbLibLgbRcbLebLsLgLsbRgbLsbLsbRsbLsbRsbRsbLsRsbLsbLsbLsb
sbsbRiRsmbRsbLebLhbLibRgbLsbLeLsbLgbLsbsbRjbLsbLsbLsLsmbRsRsLsmbsbLgLs
LsmbLsLsmbLebLcbLibLsbRsbRsbsbRibRibRsbLjbRibLgbRsbRcbLsbLebLsbLsLgbRg
bRibRgbsbRgbLsbRsRsmbRgbRgbRgRsmbLjbLjbLcbRsbLibRgbRcbsbLsbRibLsRsbRsb
RgbRiRgbRgRsmbRgbLsbLibRcLsbRsbRibRcbRibsbRhbRgbRcbRgbLgbLsbRsbRibRsbR
sLsRibRebLsLsRsmbRsRsmbRsRiRsmbRsbRiRsmbRjbLgbRcbRcRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbRibRsbRgbRsbRgbLsbRcbLgbLsbRibLsbRibRsbRgbRibRsbLgbRibLsLsmbRibLjb
RibRibLsbLjbLcbsbLgLsbRsLsbLgbRsbRjbRibLjbLcbRgbRgbLgLsbRjbLgbRjbRcbsb
RibLsbRobRgbsbLhbLibLcLsmbRgbLobRgbRiRsmbRcbRibLsbLsLsmbLsbRiLsbRgbRgb
RsbRgbRsbRhbLsbLsbRsbRebRsbsbLcbRsbLibLgbLibRgbLibLgLsLsmbLsRsbLibRsLs
bLiLsLsmbLsbLgbLsbLgbRsbLgRsbRsbLgLsLsmbLsbsbLgbRsbsbLgbRsbLsbLsLgbRgb
RjRsmbLgLsbLibRsbRsbLibRgbLhbRsbLibRgLsbLibRsbRoLsbRsRsmbRiLsbRsbRgbRg
bLsbLsbRibLgbLcbLgbLsbLsLsmbLibRgbLcbRgbLsbLgbLiLsbRgbLcRsLsbRibLiLsbL
ibLgbRcLsbRibRobLsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 165544; End: 170044;
Recording: 9-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bLobLcbLsbRgbRsbRsbRibsbRgRsmbRsLsbLsRsbLjLsmbLsbLebLcbRgbRsLsbLgbLgbL
gbLgbLsbLiLsbRjLsbRjLsbLsRsbsbLgLsRsbRsbRcRsLsmbLgLsbLiLsbsbRibRibRgbL
sbLsRsbRgbRsbsbRgbRsRsmbRsbRsbLcLsmbRibLsbRgbRgbRsbRgRsRgRgmbRgRsmbLsR
ebRsbRgbRgbRgbRgbLsbRibRgbRsLsbLhbRsbReRsmbLsbRibRsbRibRsbRsLsbRibRsbR
gRsmbRsRsmbRgRsmbRgbRsbRgbRgbRgRsRgmbRgbLsbRiRsmbRsbsbRgbLsbLsbLebRebR
ibRsRsmbRgbRgbRsbRsLsbRsRsmbLsLsmbRebRjRsmbsbLsbRsbRgbRhbLsbLsbLjbRiRs
Rgmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 1; Drug: Control
bRsbRibRsLsbLcbRjbLcbLibLibRobRiRsmbRcbLcbRsbRgLsbRgLsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 2; Drug: Control
bRcbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 3; Drug: Control
bRcbLsbLiLsbLiLibRsbLobLobLcbsbLcbLcbRhRsmbLjbRgbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 4; Drug: Control
bRjbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 5; Drug: Control
bsbLebLsLsLsmmbLgbRjbLsRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 6; Drug: Control
bLsbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bRjbLcLsmbLiLsbLsbLobRobLcbLibRiRsmbsbLjbsbLcbLcLsmbRgbLobRebRjbRsbReb
RiLsLsmbsbLsbsbRgbReLsbsbLoRsbLgbRjbLsbRobRgRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bLoLsmbRobRobRjLsbRhbsbLibRsbRgbRiLsbLibLcbRobRibLgLsbLcbLhbLsbLjbLhbL
ibLibLcbLibLjbLibRgbLoRsbLibRsbLhbLibLsbLsbLcbLibRjbLibRebLgbLhbRjbLjb
LibLsbLjbRsbLobRsbLobLibLsbLgbRsbLsbLgbLibRsbLibLobLsbLsbLcbRibLibRjbL
ebRibLsbLibLsbLgbsbLobRgbRgbLibRsbLsbsbRibLjbLhbRsbLhbLsbRsbRgbLibLgbR
sbLgbLgbRsbLhbRgbLsRsbLibLgbLsbLibRsbRsbLibRsbRsbRjbRibRgbLhLsbLibRgLs
bLgbLgbLsbLgbLgbLsbLgbLibLsbLsbLsbLhbLcbRgbRsbRsbRgbLsbLibLibLgbLsbRcb
LcbRibLjbRsbLibLsbLgbLgRsRsLimbRgLsbLsRsbLibRgbLibLjbLobLsbRsbRjbLibRs
bRcbRobRibLgbLgbRsbRsbRcbLgbLgLsbLjbLcbRgbLibLsbRsbLsbLgLsbLsbLsLsmbLg
RsbRsbLgbRgbLibLgbLsbRgbLgbRsbLsbLibLjbRsbRsbRsbLibLsbLsbLibRsbRsbRsbL
gbLibRsbLgLsbLsbLgbLsbLgbRsbLgbRgbLsbLgbLgbLsbRsbRsbRsbLsbRcbRhbLgbRib
RsRsmbRcbLsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bLcbRsbLgbRjRgbLibLcbRgbLebLebRsRgbLcbLcbRibLobRsbLcLsmbLibsbRibLsbLeL
sbRsbLobLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bLjLsmbRjbRcbRiRsmbRiRsmbLjLsmbRsbRjRsRsmmbLcbLibRcbLcRsbsbLcbLhbRcbLi
bsbLcbRcRsmbLebLgbLsbLgLsRsbLeLsbLibLib

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bRibLgbLgbRobLcbLcbLsbLhbLhbRhbRsbRcbLcRsbRhbLiLsbRcbLgRsbsbLjLsLsmmbR
ibLcLsmbRhbLibRsbRsbLibLibRcbLibRsLgbLsRsbRcbLjbRcbRjRsmbLebRhb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRebsbRcbLcRsbLcbRsbLcbLcbRcbLobsbRebLebRjLsbLsRcbRjbRcbRibRsbRcbRcb
RcbsbRhbRsbRcbRibsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbLsbRcbRibLgbLcbLibLibRgbRcbRhbRcRsmbRhbRhbRgRsmbLibLgbRgbLsLsmbRsb
RiRsmbsbLjbLibLsbRcbRcRsmbRibRgLsbLiLsLsmbLibRcbRcbRibRibRgbRgRsmbRgbL
sbRjRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bsbsbLsbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bLcLsmbRgLsbRsbLibLsbLiLsbRsbLgbLhbRsbRsbRsbLibLgbLibRsbLhRsLsbRsbLiLs
bLibLibRsbLgbLiRsbLiLsbRsbLibLsbRsbLibLsbLibRsLsbRgbLhbRibLoRsbLgbRsbR
sbLhbLgbLsbLsbLsbLgbLibRsbsbRgbLsbLibLibLgbRsRsmbLsbRsbLibLibLgbRsRsmb
RgbRsbLobRiRsmbLibLhRsbRsbRsRsmbLgbLgbRsbLibLgbRsbRsbRsbLhbLgbLsbRgbRg
bLcbRgRsmbRsRsmbLcRsbLiRsbLgRsbLsbLgbRsbRcRsmbLsRsbRjbLobLsbLibRsbRobR
ibRsbLgbsbLjbRjbLcbLsbLibsbRsbLibRgRsmbLibLsbLsbLsbLsbRsbLgbLgbLsbLsbL
gLsbLsbRcbLibLcbRsbLibRsbLsbLibRsbLibLgbRsRsmbLsbLibLsbLibLgbLsbLsbLsb
LcbLcbLibRhbRcRsmbLgbLsbLibRjbRibRibLibRibRiRsmbLjbLiLsbRcbRoLsLsmbsbL
ibLibLcbRibRcbRhbRibLibLibLcbsbRjbRcbLcbRsLhLsbRsbLsbLibRibLibLgbRgbLj
bLgbRsRsLsmbRjbLiLsbLgbLgbLgbLibLibRgbLibLgbLgbRsbLgbLgRsbRsbLsbLgbRsb
LgLsbLgbLiLsbLgbLcbsbLgbLjbLibRsbRcbLjbRcbRjbLcRsRsmbRgbLgbLsbRcbRiLsb
LgbRgbRgRsmbLgbLobLibRsbRcbRhbLjbRhbRibRsbRsbRobLgbLibRsRsmbRcbRhLsbLg
bRobLibLsbRsbRibRgbLsbRibLsbLgbRibRobLgbLibRgbRsRsmbRsbRsbRcbLjbRibLib
RibRhbRsbLsbLgRsbRoLsbLgbRobsbRhbLsLsmbLibLibRsbLcbLiLsbsbLsbLsLsmbLsb
LibRibLsbRobLibLcLsmbRcbRgbLibLjbsbRcbLgbRcbLjbRhbLibLjbRcbRiLsbRgbRsb
RibLjLibLhRsRsmbRgbRsbRsbLebLiRsbLibRsbRsbLsbRsbRsbRgRsmbsbRgRsmbRgRsm
bRsRsmbRgbLsbRcbLgLsbLcbLgbRsbLibRsbRgbLibLgbLibLsbRsbLgbLsbLgLsLsmbRs
bRjbRsbLhbRgbLgbLibRgbLsLgLsbLgbRsbLgbLgbLgbRjbLgbRcbLcbLibRiRsmbsbLib
RsbLibLsbLgbLgbRsRsmbRsbRsbRobLcbLobsbRcbLhbLsLsRsmbLgbRsbLsbLgbRsbLgb
LibRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bRgLibLobLsbLhbsbLobLibRcRsmbRgbLsLibLcbLsbLibLsbLsbsbLgLsLsmbLhLsbRsR
gbsbLsbRgbsbRcbLsbRcbLsbLibsbLibLsbLibLsbRibRiRsmbRsRsmbRgbsbLcbLiRsbL
iLsbLgbRsbRgbRibRcbLsLsmbLsbRhbLjLsmbLsLsmbLcbLgbLibRsLsbsbRhbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbLobRsbsbLsbLcbLjRsbLcbLcbRcbsbRsLsbLiRsbLhLsbLibLgbLcbLobLibLiRsbL
hbLcbLibRob

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbRsbRsLsbRgRsmbRsbLsbLsRsbRgRsmbLibLsbLgLsbLsbsbLsbLhbLsbLcbLsbLjbL
sbRsbRjbLsbRibLibLsbLcbLhbRcbRgbRsbLcLsmbLcLsmbLhbLsbLsLsmbLsbLgbLibLg
bLiRsbRoLsbRsbRibLgbRibLjbLibLcbLiLsbLibRsbRsbLcbLhbLibRsbLsbLebLsbRsb
LsbLsLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bLcRsRsLsmbRsRgbRsbLsbLcbLibLsbLgbRsLsbRjRsmbRcbRsLsbLsbRiLsbLsLsRsmbR
ibRgbRgRsmbRgbRsbRgLsbLgbRiRsmbRsbRgbRsbRibRgbLsbRsbRhbLsbLsbLjbLobLjb
LhbLjbLjbLgbRebRjbRjLsbLsbLgbLgLsbLgbRsLsLsmbLgbLgbLgLsbLgLsbLgbLsbLsb
LiLsbRsbLsbLgbLgbLsLsLsmmbLsLsmbLgbLsLsmbLsbLgbLsbLgbRsLsbLibLsbLgbRsb
LibLgbLsbLgbLgbLgbLsbLsbLgbLgLsbLsbLgbLsbLiLsbRgbLsbRsRsmbLsbLsbLsbLgb
RsbRgLsbsbRsbRcbRibLiRsbRcbLsbLibLjbLeb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bRibLjbLibLsLgLsbRsbLgbLgbLsbLgLsbLsbLgbRgbLgRsbLsbLsbLibLgbLsbLsLsmbR
jbRcLsbLjbRiLsbRibLsbLcbLibLibRsLsbRsbLiLsbRjbLgbRsbRsbLgbLsbLsLsmbLgb
LsbRsbLsbLgbLsbLgRsbLsbLibRsbLibLgbLgbRgbsbLibLiRsbRsbLsbLgbLgLsbLgbRs
bRsbRsbLhLsbRgbLsbLsLsLsRsRsmmmbRsbLibLsbRsLsbLgbRgbLiLsbRsbLsbsbLcbsb
RgbLhRsLsbLhbRsbRobRsbRibLsbRcLsbsbRibLsbRibLsbRgRsmbRsbRgbRsbRibLsbLs
bsbLiRsbLsbRsbLgbRgbLibLsbLgbLsbLgLsLsmbLgbLsbLgbLsbRgbRcbRsLsbRibLsbR
gbRsRsmbRgbLsbRgbRgbRsbRibLsbRhbLiRsbsbLibLibRsbsbLgLsLsmbLgbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bLebRsbsbLsbLsbRsRsmbRsbLsbsbsbLibLsbLgLsbLgbLgbLhbRgbLibRebRgbLobLgbL
hbLgbRgbRsbRsbRsRsmbLsbRjbsbsbsbsbsbLsbRsbRsbLsbRsbLsLsmbLjbLsbRsbLgbL
sbRsbLiRsbRsbRibRsbRgbRsRsmbRibRsRsmbRcbRibLsbRgbRcbRsbRiRsmbsbLsbRsbR
sRsLsmbRgRsRsmmbsbRsbRgbRgbRgbRgRsmbRgbRsbRgRsmbLsRsbLsbsbRebRibRgbRsb
LhbRsbLiLsbLsbLibLgLsbLgbRsRsmbLhbRgbRjbLibLibLibRsbLgbLgbRsbLibsbRsbL
gbLsbLsLsmbLsbLgbLsbLgbLibRgbLsbLcRsbRgbLgLsbLsbLsLsmbLibRgbRjbLibLsbL
sbRsbRsbsbsbLgbLsLsmbLsbLsRsbLsbLgbRgbRcbRsbLgbLsbsbLsbLobsbLgbRgbRgbR
gbLcbLgbRgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bRiRsmbLcbRiRsmbRcbRsLsbRgLsbRobLsbReLsbLgbLcbLhbsbRgRsLsmbRsbLsbLcbsb
LgLsbLgbLcbLgbLhbLsLsmbRsbLsbsbLsbLgbsbLgbLgbLgLsbRjRgbLibRjRsmbsbLjLs
mbRcbsbLibsbLjLsmbRjRsmbLsbLgbLsbLgbRsLsbLsLsmbLibLcbRebLcLsmbLibLsbRg
bRoRsmbLgLsbLcbLgbLgbsbLgbLsbRebsbLjbLobLhbRgbLibRibRsLsbLgbLibLsRsRsm
bRibLobRcRsmbRibRsbRgRgRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbLgbLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 25; Drug: Control
bsbRsLsbRsbRsRsmbRsbLebRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 26; Drug: Control
bRgbsbsbsbRgbRsLobRsbLibLsbLsbRsLsbRebRob

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 27; Drug: Control
bLhbLsbRgbRibLibsbRcbLsRsbsbsbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 28; Drug: Control
bLibRsbLgbLsLsmbLsRsbLsbLsbRcbRsbLsbLsbLsbRgbRsRsmbRgbRgbLsbRoLsbRsbLc
bsbRobsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 29; Drug: Control
bsbRjLsbRsLsbLsbRjbRiLsbRgbRsbRsbLsRsbLsLsmbLibLibLsRsbRiRsmbsbLobRjLs
bsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 30; Drug: Control
bRibLsRcbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bLobLgbLcbLibRobsbLibLsbRsbsbLsLcLsmbRibLgbRebRob

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bLsbsbsbsbLsbLsbLsbsbLsbRsbRsLsbRsbsbRsLsbRsRsmbLsRsbRsLsbRsRsLsmbLsbL
sbRsbsbsbLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bLsbsbsbLsRsbRsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bLibsbsbRsbLebRjbsbLobsbRebLsbLgbRibRibLcRsbRgbLgRsbLjbLcLsmbLsbLibLcb
RsbsbLhbLjLsmbRgRsmbRgbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bRsbRsbLsbRsbRsbRsbRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bsbsbsbRsbLsbsbRcbRebsbRibsbLcbRsbLcLobRsbLebRobRobLobRgbLhbRsRsLsmbLs
bRgbLsbLsRsbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bRsLsbLibLsbLibRibRhbRobRcbLgLgbRhbLcbLcbRibLcRsbRhLsbLibRcbRhb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbLsLsLsLsmmmbLsbRhbRibLgbLsbLgbLsbRsbsbRcbRibRgbsbRcbRibRsbLsbLgbLc
bLcbRibRobsbLsRsbLibLgbLibRibRiLsbLsbRcbRgbLsbRibLsbLsbRgbRhbRsRsmbRiR
smbRcbLgbLsbLsbRcRsmbRsbRhbLibRgbRhbLsRsbsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bLsLsmbLsLsLsLsmmmbRjbLhLsbLsbLsbRgbLibLgbRsbRibRsRsmbRebRjbRcbRibRgLs
bRsbRsbLobRcbRibsbLsbRcbRsbRsRhbLsbLibRsRcbRsbRibsbLebLsLsmbLibLebRhbL
sbRibRgbsbRobRgbRsbLhbLgLgbLjbLsbReRsRsRsLsmmmbLibRobRibLiLsbRsRsmbRsb
RcbLjbRcRsmbRsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bLjLsmbsbLhbsbRjRsmbLgLsbRsLsbsbLjLsmbRgbLcbRcbRcbRsRobRibRcbRebRcbLsb
RhbRjRsmbRhbRcbRcRsmbRcbRcbRcLsbRcRsmbRcbRcRsmbRcbRibLibRhRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbRsLsbRiLsbRobLsbRsbRcbRhbRgbLsbRgbRibRsbRgLsbLcbLsbLcbLsbRsbRjbsbs
bLcbRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bLibRsRsRsmmbRibLsbLibLsbLcbLgbRibRoRsmbRsbLjbsbRjbLgbRobRcbRibRobsbsb
LiLsRsbLgbRcbLcbRsbLoLsmbLoRsbLgbLobLcLgbLsLsmbLgbLgRsbRsRsmbLibLcbRib
sbLcbRgbRsbLgRsbRsbsbRcbLcbLcbLibLibRgLsbLgbLsbLibRgbLsbRcbRobRhbLgbLg
bRgbRgbRjbRibLibRhbLibRobLgbRobLgbRcbRibLgbRibLgbRsRibRibLgbRobLsbLsbR
obLgbRhbLgbRibRgbLsbRibRgbRcLsbLgbRcbRibLibRsbLgbRhLsbLjbRcbRgRsmbRgbL
gbRsbRsbRiLsbLgbRhbRsbRgbRgbRjLsbLjbRibLgbRgbRgLsbLgbRibLsRsbRgbRsLsRs
LsbRgbRsLsbRjbLsbLsbRgbRgbRiLgbLiLsbRibRiLsbLsbLoRsbLgRsbLgbLgbLsLsmbL
gbLsbRebRibLibRcbLsbLjbLibRjbLcbRsbLibRsbLibRsbLsbRjbLibRsbLgbLgbLobRi
bLhbRiRsmbLgbLgbLcbRibRibRcbLjbRgbLsRibLgbRhbLgbRobLibLgbLibRibLibLibL
gRsbLgbLsbLgLsLsmbRsbLgbRsbLibRjLsbLhbRsbLibRsbLiRsbLibRgbLgbLibRsbLsb
RibLgbRibRgbRsbRcLsbRibRcbRhbLhbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bLcbRjbRsRsRsmmbsbLsbRsRsmbRebRgRsmbRgbRgRsmbRibRgbRcbLibLibLebReLsbRe
LsbRsRsmbRgbRsbRgbRgbRgbRsbRgbRgbRsbLjbsbsbLgRsbLibRsRsmbRsbRibsbsbReL
sLsmbRsbRgRsLsmbRsRsRsmmbsbRiRsmbRsbRsRsRsmmbsbsbsbRhbRgRsmbRgLsbRgbRi
Lsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bLiRsbRgRsmbRsbLiRsbRjbRobLibLibLibLgbLibLgbLsbRgLsbRsbLibLsLsLsmmbLgb
LsLsmbLgbLgbLgbLsLsmbLgbLsbLgbRjbRobRsRsLsmbLibRjbsbLibLgbLibRgRsmbLoR
sbLibRgbLsbLhbLsbsbRsbRsRsmbLjLsmbLiRsbLsRsbLgbLgbRgbLcbLibRgbLcbRgbLo
bLsRsbRsbLibLibRgbRoLsbRibRgbRibRibLgbLibsbLcbLgbLgbLgbsbRsLsbsbRsLsbR
sLsbLsRsbsbsbsbLgLsbLgbRsbsbLgbLobRgbsbRsLsRsbRsbRsbLsRsLsLsmbLsbsbRsb
LsLsmbLsLcbRsbRjbRsbRibRibRgRsmbRibRhbRibLsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bRgbRgbsbLsbsbRiRsmbRsRsmbRsbRgbRcbRibLsLsmbsbRsRsmbsbsbsbsbRsRsmbRiRs
mbLgbLgbLsbRibRibRiLsbLoRsbLhbLhbRgLsbRjbRcbRsbRsRsmbRsLsLsmbRsLsLsmbR
sbRibRibsbLcbLobRsLsbRsbRsLsbRsbRibRcbRgbLsLsmbLebLobRgbRgbRobsbLsbRiR
smbsbRgbLgbRhbLjbRhbRgbLgLsbLcbRsRsmbLhbRcRsmbRhbLobLhbLsbsbLibLiLsLsm
bRjbRjbLcbLiLsbLgLsbLgbLsRsbLibLsbLhbLgLsLsmbLgbLgbLgbRsbLoLsmbRsRsRsm
mbLibLibLcbRgbRjbRcRsmbLibLjbLobRgbRsbLsbRhbRhbRgRsmbLsbLgbRcbsbLibRiR
smbLsbLsbLgbLcLsmbRibRsRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bLebRsbsbsbLsbRsbsbLgLsRsbLgbLibRsbLsbsbsbLsLsRsmbLgLgbLsLsmbRsbLsLsmb
RsLsbLsbRsLsbsbRcbLsbsbRgbLjbRiRsmbRcbRgbRibRsbRgbLsbLsbRsbRsLsbLsRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbRsbLibRgbLgbLsbLgbRsbLgbsbsbLgbRsbLgbRsbRgbLibLibRgbLiLsbRgLsbLhRs
bRgbLibRsbLsLsmbLgbRsbRsbLibRsbRhbRiRsmbLgbLobLiLsbRgLsbLgbRgbLgbLsbsb
LsbLgbLgLsbRsbRsbLgbRsbRsLsRsbLsbLibRsbRsLsbLgbLsbLibRgbRoLsbRgbLsbLgb
RgbRiRsmbRgbLsbRsbLiRsbsbLgLsbsbLibRgbLhbRgbLiRsbRgbLsbLibLgbsbRsbLgbL
sbsbLgLsbRsbLgbLibLgbsbLibRgbLgLsbLsbLgbLgbRgbRcLsbRgbLibRjbLibRgbLgbs
bLgbLgbLgbRgbLiLsbRsbLsLsLsmmbLibRsbLgLsbRsbsbLgbLsbLgRsbRgbsbRsLsbRsb
LsRsbLibRsbLibRsbLibRgbLgbLgbRgbLibRgbLibRgbLgLsbsbLsbRjbRibLeLsbRibsb
LcbRcbsbRhbLgLsbLebLsbLgbRhLsbRsbRgRsmbRgRsmbRgbRsbRgbLsbRgLsbLsLsmbRi
LsbLjLsmbRobsbRhbRibLgbRsbRibRgbRgbRsbRgRsmbRgRsmbRsbRgbLsbRsbsbsbsbsb
LjbLibRiRsmbRibRiRsmbLgLsLsmbLsbLsLsmbLobRebRibRibLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170046; End: 170546;
Recording: 10-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bLibLgbLsbLsbRjbRgbLsbLjbLhbRgRsmbRgbLsLsmbLiRsbLiRsbRsbLiRsRsmbRjbLib
LibLsbLgbLsbLiLsLiLgbLibLgLsbLiLsRsbLgLsbLgbLgLsRsbRgLsbLcbLsLsmbRsbRi
bLsLsRsmbRsRhLsbLgbLhbRjbRibLebLsLsmbRsbLgLsLgLsbLsbLibLsbLsbLibLgbLsL
smbLgbLgbLiLgbLgbLgRsRsmbLiLsbLgLgbLiLsbLgbsbLsbsbLgbLhLsbRgRsLsmbRibL
gbLjbRgLsbRgbRsbLjRsbLgLsbLsLsmbLibRsbRsLsLsmbLsLsmbRsbsbLibLgbLgLsbLg
bLiLibLgbsbLiLsbsbRsbLgbLiLsbLsbLsbLhbRsbRcLsbsbsbReLsRsbRsbRgbLsbRsbR
sRsmbRgRsmbLsbLsbRsRsmbsbLsbLsbsbRsRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 1; Drug: Control
bLcLsLsmmbLiLsbLsRsbRsLsbLobLsbLibLsRsbRgbLjbRsRsmbLgbLjbRebRiLsbLsLsm
bLsLsmbLjRsbLsLsmbLebLgbRsbLsbRibRgbRgbRsbsbsbLsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 2; Drug: Control
bLebLobRibRjbRob

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 3; Drug: Control
bRgbRiRgbRcbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 4; Drug: Control
bsbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 5; Drug: Control
bRibRibLsLsmbRsRsRsmmbRsbRsbsbRsLoLsmbLhbLsbLibLsbLsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 6; Drug: Control
bLobLobLobRsLsbLsbRsbsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bsbLgbsbLcRsbLgbRibLgbLibLgbRebRibReRsmbRgbLsbRobRobRsbLeb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRhbLsbRcLsbLgLsbLsLsmbsbRoLsbRcbRcbLobLobRsbLibsbLjbRjRsmbRjbLcbLsb
LobLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bLsLsmbRoLsbRobLgbLsbLsbRoLsbLeRsbLsbRebRgbLcbLsbLibRsRsmbRsbRibRibRsR
smbRibLibLgbLibLcbLibLibLsbRsbRsbLcbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bRgRsmbRibLcRsbLgbLibRjbRsbRcbRcbsbLobRcbRhbsbsbLsbsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bLibRibRcbLgbLcbRgbRgbRcbRibLhbRcbLcbRcbLcbLhbRhbLsbRiLsbRgbRcRsmbLibL
sLsmbRiLsbRcbRsbRsbRibLsbLibRcbRibsbRiRsmbLsbLsRcbLcLsmbsbRibRjRib

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bRcbRobRcbRsbRebRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbLhbsbsbLiLsbLibRcbRjbLibsbRcRsmbRibLsbRgbLibRcRsmbLsbRibLibLhbLcbL
ibLsbLibLibLsbRsbRsbLcbLibLibLiLsbLgLsbRsbLgbLsbLgbRcbsbLsRsbLsLsmbRsb
RgbRibRiLsbRcbRibsbRjbRjRsRsmmbLeLsbLibLsbLhbLhLsbLcbRibRibsbRibLibRib

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbRjRsmbLsLsmbLeRsLsbLsbRcbsbRcbLgLsbRcbRcbLsbRibLgLsbLcbLcbRsRsmbRg
RsmbLsbRhbLgbRsbLhbRibRgbLcbsbLobLhbRcbRgbLgbLcbRsbLoRsbRsbLsbLsRsbLib
RsLsbLiLsbLibsbsbRsbLsbRsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bRibLibRsbLgbLgbRsbLgbRsbLgLsbRebLjbRibLjbRsRsmbRhbLibRgbRibRobLjbRcbL
iLsbLsbLsbLibLsbLsbLsRsbLgLsbLsbLgbLgbLibLgbLgbsbRiLsbLgbRcRsmbLjbRcbL
gbLgbLhbLibRsRsmbLjLgbRgbLibRsLsbRsbRobLoLsmbLcbLibLibLgbLibRgbRcbRsRs
mbRcbLgbRcbLsbRibLiLsbLgbRobRgbLsbLcbLhbRjbRcbRsRsmbRgbLsbRibLibLcbRjb
LsbLgbLjbLsbRsRsmbLgLsbLsLsmbLgbRsbLgbLgbRgbRsLsbLibRcbRcLsbLgLsbRibRg
bLgbRcbLgbRsbLjbRiRsmbRgbRibLibRcbRhbLibRhbLgbLiLsbRcbLsLsmbLjbLcRsbRc
bLibLhbLibLibRgbRsbRsbLsbRsbRobLjbRhRsmbRoLsbRcbLsLibRibLgbLgbLcbLhbLg
bRhRsmbRebLibRsbLsLsmbLcbsbRgbLhbRgRsmbLgbRjbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRhbLhbLsLsLsmmbLiLs
bLsbLibLsbLsbLobLgbsbRsbRobRgbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbLsbLsLsmbLsLsmbLgbRjbRobLgRsbLhbLcbLobRcbRobRsRsRsmmbRjbRcbRsbRcbR
ebLsbLcbLsbLsRhbLgbRibLibLsbLjbLibLgbLgbRhbLjRsbsbLhbLibRjbRhRsmbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbLibRsbLsbRsbLsbLsbRgbRibLobLibLibsbRhbLcbLsbLibLjLsmbLobsbRgbLgbsb
RobLcLsmbLjbLcbRsbLsbLibLsbLgLsbLsbLgbLiLsbRsbLhbLgLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbRsbLsbLibRsRsmbLiLsbLgbLsbLsLsmbRsLibLsbLsbLgbLgbLsbLgbLgbRsRsmbLg
bLgLsLsmbLsbRsbRjbLgbLjRsbLiLsbRsbRhbRsbRebRsbRcbRjbsbLjbLibRsLsbLgbLg
bLgbLsbLsbLgbLibLsbLsbLsLsmbLsbLsbsbLiLsLsmbRhbRibLjbLsLsmbRsbRsRsLsLs
RsmmbLsLsmbLibLsLsmbRsbReLsbRgbRcbRibRjbLgbLiLsbsbRsbRsbRgbRsbRibLcLsm
bLobRsbRiRsmbLsbLibLibRsbsbLgbRsbRsbLgLsbsbLsbLsbLgbLsLsmbLsbRsLsbLsLg
bLsbLsbLsbLsbLsbLsbRobRsbRcbLsLsmbLsbsbRcbLsLgbRsbLjbRsRsLsmbRsbLgLsbR
sbLsbRgbLsbsbsbsbsbsbRsbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbRgbRgbRsbRgbLgbRsbsbsbLjbLibLibLsbLgLsbLgbLgbRsLsbLsLsmbsbLgbRsLsb
LsbLgbLsbRsbLgbLsRsbLgbLgbsbLgbRsbLiLsbLsbRibLgbLgbLibLsbRgRsmbLibRsbL
gbLsLsLsmmbLsbLsbLsbLgbLsbLgbLsbLgbRjbRcbRhbRsbRgbRgRsmbLjRobRsbRibRcR
smbRsbRibLsRsbRibRsLsbRibRsRsmbRsbLiLsbLsbLgbLiRsbRibLsbLsRjbLibLibLgb
RgbRhbLibLgbRsbLgbLgbLgbLsbLgLsbLgbLcbRsbLsbLiLsbLgbRsbLibRcbRgbRsbRgR
smbRgbRgbRsLsbRibLcbLhbLgbLsRsbLgbLgbLsbLgbLgbLsLsmbLgbLgLsbLgLsbLsbLi
LsbLgbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bLjbRibRibLsbRibRgbRgbRsbRibRsbRcbLsbRibsbsbLjbRsRgbRgbRgbRsbsbLibRjRh
RsmbRsbLsbsbsbsbLsLsmbLsbsbsbsbsbsbsbsbsbLgLcbLjbRcbLebRibRibRgbRsbRgb
RsbRgbRsbLsbRsLsRsLjLsmbLibLsbRjbRiLsbLsbRibLsLsmbLjbRibRibRgRsmbLsLsm
bRebRgbRsRsmbRsbLsbRibLsbRsbRsbRgbRsbRsbRsbRgbRibRebRsbsbRibRsbRsbRsbR
gbRsRsLsmbRsRibRgbRsbRgbRiRsmbRgbRibLgbRebRgbRsRsmbRsbRsbRsbRgRibRsRsm
bRiRsLsmbRsbLjbLjLibsbRcbLcRsbLsbLjbRebLsbLgbLsbLjbLjbsbsbsbsbsbLsbsbs
bsbsbsbsbsbsbsbsbsbsbRsLgRsbRgbLsbRcbRibRsRsmbLjbLsLsmbLgRsbsbsbRebRjb
LjbRhbRgbRsbRsLsbLsbLsbLsbLsbRsbRibRgbRsbRgRsmbRgbRgbRgRgbLobsbLibRebR
iRsmbRgbRibLgbRibRsbRsbLsbsbsbsbRgRsmbLgbLcRsbRebRibRgbRsbsbRsbLsbLebs
bRcbRsbLsbRgbRgRsmbRgbRgbLsbRebRebRsbLgbsbRcbRibLsLsmbsbLsbLsbsbLibRgb
RsRibRgbLeLsRsbRsRibRgbRsbRhbLgRsRsmbRsRsmbRibLsbRgbRsRsmbRgbRsLsbsbsb
RsbLsbsbsbsbsbsbsbRsbRsLsbLsbRsLsRsbLsbRsbRsbsbRsbRibRsbRsbRsbRgRsmbRs
bRgbRgbRgRsmbRgbRibRsbRsbRgbRgRsmbRgbLsRsbsbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bLibRjRgRsmbLgbLibRcbLsbRsbRsRsmbRsbLibLhLsbLibLsbRoLsbsbLgbRsRsRsRsmm
mbRhbLgLsbRsLsbLgbRsbLibRsbsbRsbRsRsRsmmbRsbRibRgbRhRsmbLcLsmbLcbRsRsR
smmbRcbLiLsbRhbLsLsLsmmbLjLsmbRcbsbRsbsbLgLsbsbsbLgbRsRsRsmmbLibRobLgb
LjLsmbRgbLibRibsbLjLgbRcbLjbLgbLsbRsbLiLsbsbLgbRcbRgRsmbRsbRsbRgbLobLg
bRobRibRjRsRsmmbLgbLsbLibLiLsbRhRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbsbRsbReLsbRibLsbRgbRgbRgbRgbRgbRgRsmbsbRsbsbLsbLjRsbLsbLsbLibLsRsL
sbLgbLgbLsLsmbRsRsmbRsbRsbLsbRibRgbRsbRgLsbRgbRgbRiRsmbRsbRgLsbLsbLhLs
bLsbsbLibLgRsbRsLsLsmbLiLsRsbRgbLibLgRsbLgbLsLsRsmbLibLgRsbLsbsbLsbLsR
sbLsbLoRsbLebRibRsRsmbRiRsmbRgbRibRsbsbLsbsbLsbLibLsbsbLhbLgbLsbRsbLsb
LiLgLsbLsbRebRsRsmbLcbRcbsbLjbsbsbLjbRibRibRgRsRsmmbsbRiRsmbRjbLsbLsbR
ibsbRsRsmbLsLsmbRsbLsbRsbLsbRsbLsbRsbLsbsbLsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bLsLsmbLiLsLsLsmmbLibLgbLgbLobLibLsbLcbLsbLsbLgLsbLgbRsbLgLsbLgbLsbLgb
LsbLsbRsLsbLsLsmbLgbLebLsLsmbLgLsRsbLgLsbRsLsbRjLjbsbRsbRsbRobRibRgbLs
bRoLsbLgbRsbLsbLobLhbLgbLsbRsbLobRsbRgbLjbLibLgbLgbLgbLobLgbRhbLgbRjbR
sbRsbsbsbRsRsmbLebLibRsbRibRibLsbRsbRgbRgbRgbRgRsmbRibRobRgbsbLgbLgbLi
bRsbRgbLhbsbLsbLgbRgRsmbRsLsbRgbLjbRobRibLgLsbLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 25; Drug: Control
b

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 26; Drug: Control
bLhbLsbRoLsbRiRsmbRobRcbRobRcbRhbLhbRibLibLsbRsbRibRebRhbRibRcbRiRsmbL
sbLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 27; Drug: Control
bLobRiRsmbsbLsbsbsbsbLjRsRsmbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 28; Drug: Control
bLibLgbRgbLcbsbRgRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 29; Drug: Control
bRobRjbLsbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 30; Drug: Control
bRibsbLgbRgbLsbLgbLsbRsbLsbLsLsLsmmbLgbLgbsbLgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bLibRibRsbLsLsmbLsbRsbRcbRhRgbRsRsmbLsRsRsRsmmbLsRsbRsRsmbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bsbLgbsbLsbsbRsbsbsbsbRhb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bRgbRiLsLsmbLsLsmbLsRsbRsbLsbLsbRsLsLsmbRsLsbRsbRsbLsRsbLsLsmbLsbRsbLs
bRsbRsbRsbLsbRsLsbLsbLsbLsbRsbRsLsbRsLsRsbLsbRsbRsLsbLsbRsbLsbsbLsbLsb
LsbRsLsRsbLsRsbRsRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRgbLibLgbLjbLibLsbLibLiRsRsmbLsbRsRsmbRobRibsbLgbLiRsbLibRsbLgbsbsb
sbRgRsmbRsbRsLsRsbsbRiRsmbLhb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bLobLsLsRgmbsbsbLoRsbLibLgLsbRjLsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bRgbLcLsLsmmbsbRgRsmbLjbsbLobLcbRobsbRcbLcbLibRcbLobLobLhbRsbLgbRjbLgb
LcRsbLcbRhbsbsbRcbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bsbRcbRcbRcbLjRsbLibLjbLjbLcbRcbRcbRibRhbLjLsLsmmbRcbRsbLiRsbLgLsbRibs
bLgRsbLsbLsbLgbRiRsmbRhb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbRcRsLsmbRsbRgLsbLsLsmbLsbsbRcbRcLsbLsbLgbLsbRgRsmbLgbRcRsmbRgbLsbL
sbLsRsbsbLobLgbRibLsbLiRsbLsbLgbRsbRcbRcbRiLsbRgbLsbLgbRibLibRobLgbLsR
sbRcRsmbLgLsbLibRibLsbRgbLsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bRibsbRsRsmbsbRgbLsbRsLsbRgRsmbsbLsbsbLcbLibLgbLibLibRgbRibLgLsbLgLsbR
sLoLsmbRibRcbRgbRibLgbRibRgLsbRgbRibRsbRgRsmbLsbLsLsmbRobLsbLgbRobRgbL
gbRibRsLsbLgbLsbRibRibLcbsbsbRcbRibRsbRgbRsbRgbRibRibLsbRibRgbRibRsRsm
bLobLobRjbLibRjbLcbsbsbRgRsmbRgbRgbLsbRgbRibLsbLobLsbRsLsbLsLsmbLsbLcL
smbRsbRgbRsbsbsbRsbsbsbRsbsbsbsbsbsbsbsbsbsbRsbLsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bRibLibsbLibLcRsbLhbLobRgbsbLcbLoRsbLibLgRsbRsbLibLhRsRsmbLsbRsLsbRsbR
obRcbLgbRcbLibRobRibRgbLcbLjLsLsmmbRsLsRsbRgbRsbRjRsmbRgbLibLcbLsbLobL
cbLcbRgbRsRsmbLhbRjRsmbRgbsbLjLsmbLcLsmbLcLsmbLcRsLsbLgbsbsbsbLsbRgbRg
bRsRsmbLcbsbRjbLsbLjbRjRsRsmmbLsbLsbLibRgbLsbLjLgbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbLsbLsRsbLsbLsbLsbLsbLsbRsbLibLsbLsbRgbRebRibRgbLcbRcbRhbLcbLiLsbLg
bLsbRsbRgbRhbLsbsbsbRsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbLobLibRhbLgbsbLsbRjbRiRsmbLsbRsRsLsLsRhmmbLgbRibRgbLgbRcbLgbRsbLcb
RjbRgbRsRsmbRgbRgbLgbRcbLgbRibLgbLgbLsbLsbLgbRcbRibLsbRibRhbRibRgbLibR
ibLsbRcbRsbRgLsbLsLsmbRibLgbRibRibRiRsmbLsRsbRsRsmbRibLsLsmbLsLsmbRibL
sbRgbLsbLoLobRsRibLgbRiLsbRiLsbLgbRibLiLsbLsLsLsmmbRhbLsbRcbLgbRcbRcbR
gbLibsbRibLibRibLibRjbLibLibLgLsbLibLcbLiRsbRgbLibRibLjbRibRgRsmbRiLsb
RiRsmbRsbRsbRgbLsbRgbRgbLgbRgbRgbRgbLgbRibRsbRsbRgLsbLsbRgbLgbRiRsmbRs
bRsRsmbRsbRsbRsRsmbRgRsmbRsbRgbLsbLsRsbRiRsRsmmbRgbRgbRsbRsRsRsmmbRgbR
sbRsbRgbRgbRibLsbRsbRgbRsbRgRsmbRgbRsbRgbRsRsmbRsRsmbRgRsRsmmbRgRsmbRs
bRsRsmbRgbRsbRgRsmbRsbRgbLgbRibRcbLsbLsbRibRhbLgbRibRibLsbRgbLgbRcbRgR
smbLsbRibLgbRgbRibRsbRgLsbLsRsbsbsbsbsbRgbRsRsmbLjbsbLiLsbLgLsbLibLibL
gbLgbRgLsbLibRgbLhbRsbLibsbsbLsbLsbRsbLsbLsRsRsmbsbRcbRobLobLibsbsbLib
sbsbsbsbLcbRibLibRibLibLgbLibLgbLibRibRsbLcbRgbRsbLcbLgbLibLibLgbRibLc
bRcbRibLcbRhbLobLibRibRjbLcbRhbRhbRoLsbLibRgbLibLcbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bRgbRgRsmbRsbRgbLsbRibRgbRgbRgbRgbRgbsbRibRgLsbRsbRgLsbRgRsLsmbRgbRgbL
cLibRibRgRsmbLcbRcRgbRsbRgRsmbRgRsmbRiLsbRgbRsbsbLibRhRsLsmbsbRiRsRsmm
bRgRsmbRgbLjbLjbLgbLsbsbLjLsmbLgbLibLibRsbLsLsmbLsbRsRsmbRcbsbLsbReLsb
RebsbLsbRgbRebLebLiLsbLsbLsbLiLsbLgbRsRsmbLsbRiLsbRgbLebRiRsRsmmbRgbLg
LsbRibLsbsbRgRsmbRgLibRgbRebLoLsmbLhbLibLiLsLsmbLsbLgLsbRsbReRsmbLsRsb
RgbRsRsmbRgbRsbRgbRsLsbRebsbRibLjbLebRgbRgbsbRsRsLimbLebLibLib

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbLhbsbLoRsbRiRsmbsbsbLsLsmbRsRsmbRcbRibLsbRibRibLsRibsbsbsbRgbRgRsm
bRgbRgbsbLsbLobLgLsbLgLsbRsbLgbLsbRgbLgbRgbRsRsmbLeLsbLibRibLobLcLsmbL
sbLgbRhbLsbRgbLcbLsbLibsbLsbLgRsbLgbLsbLgbLsbLebLgbRsbLsbLhbRsLsbLgbLi
bRsbLgbLsbLgbLsbLibLsbLibRsbLgbLibLgbsbRsbLgbLgLsbLsbLgbLsbLgRsRsmbLsb
LgbLgbLsbsbRcbRiRsmbRiRsmbRibRsbRgbRsbRgRsmbRsbRibLsbLebLibRsbLsRsbLgb
LsRsbLgLsbLgbLsbLgbLsbLgLsRsbLgbLsbLgbLsRsbLgLsbLgbLibRjRsmbRoLsbLcbLi
bRibRoLsbRgRsmbRibLgbRsRsLsRsmbRgbRgbLsbLsRsRobLsbLsRsbRsRsmbRoLsbLsbR
iRsmbRibRibRsbLsRsbRibRcbLgbLgbRhbLsbRgRsmbRgbRhbLgbRiRsmbLsbRiRsmbLgb
RsLsbRiLsbRgbLsbLsbLibLcbsbLgLsbRgbLgRsbLsbLibLgbsbLgbLgLsbRsRsmbLgbLs
bLibRsLsbLgbsbLgbLsbsbLsLibRgbLgbLiLsbRgbLgbLgLsLsmbRsbLgbLgbLsbLsbLgb
LsbRoLsbRibRsRsmbLsbRgbLsbRgbLsRsbRibLgbLjbLibLibsbLgbRsbRsbRjbRibRibL
gbLcbRgbLibLgbLsbLsbLsbLgbLgLsbLsbLsLsmbsbLsbLsbLgbLsbLgbRsbLgRsbLsbRs
bLgbLgbLgbRsbLibLsbsbRgbLcbRibsbLibRsbLibRjbRobRiRsLsmbLgRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bLeRsbLibLsLgbRsbRsRsmbLsbRsbLhbRibRcbRibRiRsmbLibLhbRcbsbLgLsbRobRibs
bRibLsbRiLsbRsbLjbLhLsbRjbLjLibLgLsbLgbRgbRsLsRsbLsRsbLibLsbReLsbRcbLg
bLsbLibsbsbLsbLsbLgbRsRsmbsbRsbLsLsLsmmbRsbLgbsbRsbRgbLibLibRsbsbLgRsb
RibLgbLjbsbRjbsbLjbLsbRsLsLsmbRsbRebRcLsbLibLibLobRgbRsbLhbLgbLsRsbLib
RsLsbLsLobRgbRobRgbRsbLsbRcbRibRgbLgbLibLibRebRhbLjbsbRcRsmbRsLsLsmbRg
RsmbRibLsbRhbRiLsbRgbRsbLsLobsbLoLsLsmmbLsbLobLsbLoRsbRgbLsbRibRebLjbR
ebLibsbLsbLsRsbLobRsbRgbsbLgbRibRiRsmbLgRsbLjbsbRsbLoRsbLgbLgbLjbRoLsb
Rebsb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bLibRsLsbRcbRsbLsbLibLibsbRjbsbRcRsmbRcbLgLsRsRsmbRcbRobRiRsmbRgbRsRsm
bRiRsmbRcbRgbRgLsbLsbRsbLeRsbRgbRgbRgRsmbLsRgbRgRsRsmmbRgbRibRcbRhbLiL
sbRsbRjbRsRsmbRibRibRgbLgbLgbRebLobLsbRcbsbLsbRgbLcbLgRsbLsbRgbRgbRsbR
sbLsbRgbLjbRgbLibRsbRsRsmbLsbLhbLgbLgLsbLgbLibLgbsbRjLsbLgbLiLsLgbLiLs
bLibLiLsbLgLsbLgbLgRsbLibLsbLibLsbLibLgbLibLgbsbLgLsbLgbLsLsmbsbLsbLib
LsbsbsbsbLsbLhRsbRibRcbsbRgbLsbsbsbRsbRsRsmbRsbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbLgbRibLgbLibRcbLjbRibRsbsbRgbLgbLebLgbRcbLjbLibRiRsmbLibsbsbLgbLgb
RsbRgbLibRgbLhbRgbRjbRhRsmbLsbRibRgbLsbRsbLobRsLibLgLsbLgbLgbLsbReLsbR
gbRhbLsbRhLsbLsLsmbRcbLsbLobLsLsmbLibRsLsbLibRgbLibRgbLsbLibLobRibRgbL
obRsbLibRgbRcbRibRgbLsbRgbRsbRgbRsRsmbRgLsbRsbRibLsbsbLgbRibRgbRgbLsbR
gbRgRsmbRgbLsbRsbRibRsbRiLsbRsRsRsmmbRsRsmbRsbRibLgbRibLgbLibLibLgbLgL
sbLgbRsLsbLsLsmbLiRsbRsbLgbRsLsbLgbRsbLibRibLgLsbLibRsRsRsmmbLgbLsbLiR
sbRgbLgRsbLgbLgbLgbLiRsbRgbRjbRibRibRibRiLsbRsbRsbRibRsbRiRsmbRgbRgbRg
bRsLsbRibLsbRibLjbLhbLsbLgbLgLsLsmbLsLsmbLgbLsRgbRebRsbRibRgbLgbLcbLgb
LibRgbRhbLgbLiRsbLibRgbRjbRebLjbLgLsbLgLsbRgbLibsbRgLsbLgbLgbRsbLgbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 170548; End: 171048;
Recording: 11-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
b

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 1; Drug: Control
bLiLsbLgLsLsLsmmbLcbRibLsLsmbRiRsmbRibLgbRiLsbLsbRcRsmbRebRebRibRsRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 2; Drug: Control
bLjbRebRcLsbRobLcbRoLsbRcLsbLcbRobLgbLhbLibRsbRjbLgbRobLsbLebLsbLebLeb
LibRebRiLsbRgRsmbRjbLiLsbRhbLsbLjbRobRobRsbsbLibLgbRhbRibLsLsRsmbLebLi
RsbRiRsmbRibRhbLsRcbRcbRgbRibRgbRgbRsbRsbRsbRgbRgbLsbRsRsmbRgbLobLobLc
bLibRibLsbLsbRgbRibRgbLgbRgbLsRsbLgbRsbRjbRibLsbLjbRjbRcbLsbRcbsbRebLh
bLcbLebRgbLobRobLcbRjbLgbRoLsbLgbLobRibRsbRgRsmbRgbRibLsbLsbRsRsmbRsbR
sbRgbRsbRsbRgbLsbRsbRgbRgbRgbRsbRgbRsbRsbLsbLsbRgbRgbRgbRgbRgRsmbRsbRs
bRsbRcbRgLsbRsbLsbLgbRgbLgRsbLgLsRsbLhbRsLibRsbLsbLgbRobRcbRsbLgLsbLgb
RgLsbRjbRibRobLhbLgbRgbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 3; Drug: Control
bRiLsbRobsbRibRcbsbsbsbsbsbLcbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 4; Drug: Control
bRjbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 5; Drug: Control
bRcbsbLcbRsbLgbLgbLsLibLgLsbLsbRsbLsbLgbLsbRjbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 6; Drug: Control
bsbRsLsbsbRibsbsbRcbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bRobRsRsLsmbLiLsbRsbRoRsmbLjbLcRsbLibLcbLhLsbRcbRsRsmbLsbLgbLobLgbRibR
hbRsLsbRibLcbsbRsbRsRebRiRsmbRcLsbRsLsbRsbLcb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bLibLibLibLsLsLsmmbLsbsbLibLcbLiRsbLcbLibLgbLsbLcbLsbLobLsbLgbLhbLgbLc
bLsbLibLsbLibLibLgbRsLsbRsbLgbLsbLgbLgbLibLibLibRibLcbRgbLibRgbRjRsmbL
cbLhbLsbRsLsbLibLsbLjbLhLsbLsbLsLsmbLsbRsbLhbLibLiLsbLsbLibLjbLcLsLsmm
bRsbLcbLsbLsbLgbLgbsbLsbLgLsbLsLsmbRjRgbRhbLiLsbRgRsmbRsRsmbRsbLsLsmbL
sLsmbRsLsbLsbLibsbLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bsbsbRsbLobsbRcbRibLiRsLsbRobRibLcbRsRsmbsbRobRsRcbRcbRcbLibRibLsRsRsm
bLsbRsbLsbRibRcLsRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bLeLsbLhbRoRsmbLsbLsbRobLjbRebRjbRsbRgbLjbLhbLibLsbsbLsbsbRsbsbsbRgRsm
bRsbRsbLgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bLsbLjbRibsbsbLgRsbRcbLsbLcRsbsbLjbLobRebRjbRibRcbLcbLcbRcbLsbLibsbRhb
RgLsbRjbsbRebRibLgbRjbsbRiRsmbLsbRibsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bLhbLcbRibLebRebLebLobRgbRobLibRgbRsbRobRgbRgbLobLcbLobRcbRgbRibRgbRcb
RobRsbLgbRibLcbRcbLgbLobRgbRjbLgbLebRobLebRcbLebLobLcbLebRebRobLobLgbR
ibLobLobRobRobLcbRobRcbLobLobRobRobLobRebLobRobLobLobRobRebRcbLobRobRo
bLebRcbRobRobLibLcbLsbRebRobRcbLebRebLsbRebRobLebLcbLobLobRibRebRebReb
LobRebRibLcbLcbLebRobLgbRobLebLcbLcbLcbRcbLcbRebLebLsbRhbLjbLebLcbRebL
obRgbLobLcbRobLobLgbRobLebRibLobRebRcbLebLebRobLebLhbRibRebLsbRjbRibLs
bLcbRibLsbRobRebLobLcbRcbLobRebLcbLobLobRcbLcbRebRebLebLcbLebRibLcbRob
RobLebRobRobRibLobRcbRibRobRobLgbRsbLebLcbLobRebRsbRebLobLobRobLcbLobL
ebLobLcbLcbRibRobLobRebLobLobRebLebLobRobRebRobLebRibRebLobRcbRobRobLo
bRobRobRebLcbLebLebLebLebRebRebLebRebLobRibLobLebLobRobLibRsbRobLebRob
LsbLebRobLsbRobRobRibRebLcbLsbRobLobRobRgbRcbRobRobLobLobRebRobLcbRcbL
ebLgbRebRebLcbRcbLcbLcbRobLobLibLobRebLobLcbRobRcbLobLebLobRcbLebLobLo
bRsbLobRsbLobLhbLcbRobRhbRebRobRjbRibRebRebRobLibLcbRcbLobRobRobLgbRgb
RhbLcbRebLobRibLebLobLgbLcbLcbRgbRebRebLobLhbLibLobLebRobLobRebRobLobR
ebLobLibLcbRsbRibLsbLcbRcbRobLgbLsbRibLcbRcbRgbLebLobLsbLcbRgbRcbRebLc
bLobRobLebLcbRebLobRebLobLcbRebLobLcbRobLobRobLobRgbLcbRobRobRobRobReb
LsbLobRibLobRebLibRobRibLcbRebLebRobLobRobLobLebLobRcbLebLobLebLobLobL
obLibRobLibLobLcbLobRebRobLebLibLibLebLcbRebRjbRebRibLobRebLebLebRibLg
bLgbRebLobRibRibRobRobLebLcbLobRcbRibRibLibRobRobRobRobRsbRobRcbLobRcb
RcbLobLobLsbLgbRobRcbRobRebLobRcbRhbLebLcbRobRobRebLcbRcbRgbLobRobLsbR
gbLsbRobRhbLibLcbLcbLcbRobLibLobLgbRobLobLobRobRcbLgbRobRsbLebRgbRgbLo
bRebLgbRebRebLibRobRobRsbRcbLebLgbLobLebLobLobRobRebLcbRobRobRebRgbLcb
LcbRhbLhbRobLebRcbLhbLcbLebRebLobRebRobLebRcbLobLebLobLcbLobLgbLebLibR
ebRobLibLebRebRobRobRobLcbRobLobRgbRobLebRobRhbLobLobLobLgbRgbRcbLobLe
bLebLobLobLebRebLcbRobRcbRcbRcbLobLobLebRobLhbLobLobLobRibRebLobLgbRcb
LsbLebRcbLgbLebRobRobRebRobLobLobRobRebRebRobLibRobLobLcbRobLobLobRobL
ebRobLobRcbLebLsbLebRobLobLobRobLgbLobRsbRebRhbRebRhbLobLibLobLibLcbRc
bRgbLebRsbLibLgbRebRcbLobLobRobLgbRebRebRcbLobRobRobLcbRobLgbRsbLgbLcb
LobLobLobLhbLgbRebRcbLgbLobLebRobLsbLobLobLobRhbLobLebLebRebRebLibRobR
obLibRgbRobRobLebLibLcbLcbRgbLebLebLcbLobLobRebRebLebLebRcbLebRobLebLc
bRebRobLobLobLebLobLobRebLebRcbLebRobRobRebLobRobRibLobRebRobLhbLcbLib
LcbLhbRsbLobLebRibRobLobLobLobRobRgbLebLebRjbLobLcbRibRcbLobRebLobLcbL
cbLobLcbRcbRsbRgbLcbLobLobLobLebRibRobRobLobLcbLobRibLobLebLcbLibRobRe
bLebRcbLgbLebLebLgbRebRibRsbRobRobLobRcbLcbLebLobLobRobLobLgbLobLobLib
LobLibRobLhbLobLibRebLgbRgbLobLsbRobLibLebRcbRcbRobRobLgbRobLebLobLcbL
ebLobRobRibLhbRebRcbRobLibLobLebRebRcbLhbRcbRcbRobRgbRibRebRcbRcbRobLo
bRobLobLebLcbLebRgbRebLsbRobLcbRgbLcbLhbLcbRgbLobRcbLcbRcbLcbRsbRcbLib
RebRobRcbLcbRsbRcbRobLobLcbLobLsbRebRebLobRebLcbRobRcbLobRsbLobRobRobL
obLobLobRebRcbLobLobRcbRebRebLibRobLhbRebLebRebLcbLobRobRcbRobRgbLsbLo
bRebLibLcbLebRobRibLebLebLebLebRebRobLibRcbRhbRebLobRobLsbRgbRobLobLeb
Lgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bRibRgbLibRcbRibsbRibLgbRgbLsRsbRgbRsbRgbLsbLgbLcbLibLibRgbLibRgRsmbLg
bRsbLiRsbRobRibLiLsbRhRsmbRjbLhLsbLcLsmbLibLibLsbLibLibLcbLsbLibRgbRcb
RcbsbLhbsbRibLcbLcbLgbRgLsLsmbRebLoLsmbLibRibLiLsbLsLsmbLibRibLoRsbLib
LgbRsbLibLsbLibLibLgbLjbLcRsbLibLgLsbLsbRibRhbLgbLjbLhbLgbRsbRsbRsbRjb
LibRebRhbLcbLiLsbRcRsmbRgbRibLibRsbRhbLsbRcbLibRhbRibRhbRebLibRgbRsbsb
Rgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bRsbRsbLsbLjbRjbRsbRsbRsRjbRsbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bRjbsbsbRhRsmbsbLcbRsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bLibRgRsmbLcbLsbsbLibLgbRsbLgbRsbLcLsmbLiRsbLsbLsbLcbLibLgbLibLgbLsbLg
bLhbLsbLsbLgbLsbLsLsmbLsLsLsmmbLsLsmbLiLsbLgbsbLsbLsLsmbsbsbRsbLgbLiLs
bLibLsbRsbLsLsmbLgbLgbsbsbsbsbLsLsmbLobLgbRsbRgbRsbsbLcbLgbLibLsbRgbRh
bRgRgbsbLsLsRsmbRsbRcbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bLiRsbLebLsbRobRibRsbLjbLcbRobRobRgbLsbRcRsmbLsbLsbLhbLgbLsbLsbLibRgbR
jLebLsbRobRibLibRsbRibRcRsmbLgbLsbRcbLsbRsRcbLibLgbLgbsbLsbLibLsLibLoR
sbLobRsbRsLjbRcRsmbRsRsmbRoLsLsmbRcbLgbLiLsbLgbLebRobRcbRsbLhbLcbLgbLs
bLibLgbLobLgbLgbRsbLibLibLibLsLsmbRsbRsbRcLsbsbLgLsbLsbRsLsLsmbLcbLobR
sRcbRobRib

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbLgbLsbLcbRibRcbRgbLsbLjbLibRsLsbLgbRjbLebRibRcRsmbRiRsmbRsbsbRgbRs
bRobLibLobLiLsbLsbLcbLibRsbRsbLobLibLiLsbLgbLibRsbLobRhbLsbLobLibRsbLi
bRsbRsbRhbLjbLibRsbLibRsbRgRsmbLibLgbLsbLobLgbLgbRsbsbRsbRgbLcbLibLgbL
gbLgbLibLsbLsbLgbLibRsbRgbRibRibRibLsbRsbLgbRobLsbLcbRsbLhRsbRgbRsbLhb
LsbLgbLsbLibRsbRsbRsbLhbRjbLhbRsbRibLjbLgbLsbRsbsbLibLibRsbLsbLhbLibLs
bRsbRsbLgbRgbRibRgbRibRcLsbRibLsbRsbLsbRhbRgbLsbRiRsmbRgbRgbRjRsmbRgbR
sbLibRobLsbRobRibLsbRgbLibRibRsLsbLibLhbLiLsbsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bRgRsmbRhbsbsbLiLsbLgbRgRsRsmmbLibLebRgbLgbLobLgLsbLsbLsLsLsmmbLgbRiLs
bLibLhbRcbLibRsbsbLgbRjbRobRobLsbRgRsmbRgbRsLsLsmbLgbRcRsmbLcbRgbRcbLj
RsbLsbLsbRcbLebRsLsbRgLsbRgbRgbRgbRsRsLsmbRsbRgbRsbRgRsmbRgbLsRsbsbRib
LibRibRsbLobRcbRibRiLsbLibLgbLibLgbLibRsbLsbRjbsbLgbLgRsbLsbLgbLsbLsLs
mbLiLsLsmbRsLsbLsbLgbLgbLsbLgbLsbLgbLgbLjbLsLsmbRjbsbLibRgbRjbLjbRsRsm
bLjLsmbLibLsbLibLgbLsbLgRsbLsbLsbRsLsbLsbsbsbsbsbLgLsbLgbLgLsbRsLsbsbR
sbReLsbLjLsmbLhbLcLsmbLsbRibLibLgbLgbLgbLsLgbLsbsbLsRsRsmbRsLsbLibsbLi
bLgbLibsbLgbLsbLsLsmbRsbLiLsbLsbLibLgbRsbRjbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbLgbLsbLgLsbLsbLgbLsbsbLgbsbLgbsbRsbLgLsbLsbLgLsbsbLgbLgLsbLsbLsbsb
LibLsbLsbsbLgbLibLsbLgLsLsmbLibLiLsbRjbRcbsbRibLsbRibLgRsbRgRsmbRsbRgR
smbRsbRgbRsbsbRhbsbRsRgbRgbRcRsmbLsbRibRgRsmbRgbRgRsmbRsbRgRsmbRiLsbLg
bRoRsmbLsLsmbRgbRcRsmbRsbsbRsbLjbLeLsbLibLgbLgLsbLgbLsbRsbLibLsbLibRsb
LibLgLsbLgbLibLgbLsbLibRsLsRsbRgbLhbLiLsbLgbLsbLsLsmbRobRcbRgbRgbRgbRg
bRsbRcbLgbLsbRhRsmbRibLgbLiLsbRhbRcbLjbLibLgbLsbLgbLsbRgbLgbLgbRgbLibR
sbsbsbLgbRsbLsLsmbLsbLgbLgbLsbLgbLsbLgbRsbLsbRsbLibLsbLgbRsbRsbsbLibLg
bRsbLsbLhLsbRgbLgbLibLgRsbLgbRsbRjbRibRibLsLsmbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbRsbRcbRgbRibRsbRsRsmbRgbRsbsbRgbRgbRsbLsbRibRgbRgbRgbRgbRsbRgRsmbR
sbRgbRsbRiRsmbRsbsbRiRsmbRibLsbLsbRsbRhRsmbRsbRsbLjbRebsbsbRsbRsbRsRsL
smbLsbLsRibRsRsmbRsbRgRsmbRgbRsRgbRsbRgLsbRsbRsbLsbRiLsbRgbRsbRsRsLsmb
RgbLsbRibRsRsmbRgbRsbRgbRsbRgbRgRsmbRsbRgRgbRgRsmbRgLsbRgbRgbRgbRsbReR
sRsmmbRsbLsbLsbLibLgbRsbRebRjbRiRsmbRgbRsRgbRsbLsLcbRebRhbLsbLjbLsbsbs
bsbsbRjbRhbRgRsmbRsbLgbRsbLsbRibRsRsmbRgbRgbRebLsbLgRsbRsbRibRgbRgbRgb
RgLsbRgbRgbRgbRiRgbRgbRsRsmbsbsbsbRiRsRgRgRsmmbRgbRgRsmbRgbRgbRsRsmbRs
bRsRsmbRgRsLsmbRgbRsRsRsmmbRgRsmbRgbLsbRibsbRsbRgbRgbRsbRibLsbRsRsmbRg
bRsbRgbRsbsbRsbLsbRsRsmbRgbRgbRsRgbRgbRgbLsLcbsbRhbRibRsbLjbRgRsmbRibR
gbRgbRsRsRsmmbRibRsbRsRsRsmmbRsRgbRsRsmbRsRsmbRsRsLsmbRsRsRgmbsbRsbsbs
bsbsbRebRgbLsbLsbLsbLgbLibRgbLsbRebLsbLsbRsLsbRhbRgbRsbLsRsbRgbRgbReRs
RsmmbRgbRsbReRsmbLsbLsbLgbLibRgbLiRsbsbLgLsbLibRgLsLsmbLgbRsbsbRsRjbRh
bLgRsbRsbLsbLsLsmbsbRgbRsbRsRsmbRsRsmbReRsmbLsbLgbRsbRsbLsbsbRsbsbRcbR
sRsmbsbRsbRsbsbLsRsLsbsbRiRsRgmbRsbRsbRhRsmbRsRsmbRsRsmbRsbRhRsLsRsmbR
sRsmbRgbsbRsbLsRsLsLsRsLsRsLsRsmbsbsbRiRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bLgLsbRcbLgLsbLgbRsLsLsRsmbRibRgbRcbRjRsRsmmbRsRsmbRgRsLsmbLibRgbsbLsb
sbRsbLcbsbLibLgbLibRcbLhbRiRsmbLibRgbLgRsLsbLoRsbLgbLsLsmbLsbLobLibLsb
RgbLcbRsbLibLcbRsbRsbLobLsbLsbLsbRsLibRgbLsbLibRiRsmbLsbRiLsRsbRgbRgbL
sbRcbLcbLgbLsbLgbRsbLgbLsbLjbLsbLgbLgbLibLgbLgLsLsmbLgLibLoRsRsLsRsRsm
mbRcLsbRgbRcbRgbRhbRcbLibLcbRgbRgbLhbRsbLgLsbLsbRsbRsbLsbLgLsbLgbLgbLg
RsbLsLsmbLgbLgbLsLsLimbLgLibLsLgbLgLsbLsLsmbLgbLgLsbLhLsbLcbLgLsbRsbLs
bLiLsbRgbRcLsbLgbLibLibRgbRsbLjbLsbRsRgRsmbLjLsLsmmbLgLsbRgbLibLgbLgbs
bRgLsbLgLsbRsbLiLsbRgbLibRgbRgbRsbLsRsbsbRsLsbRsLsbLgbRsbLgLsbLgbLgLsb
RsLsbRsLsbRjRsmbRibLibRhRsmbLibLibLgbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bRsRsmbLgbRgbRsbRgbLsLsmbRsLsbLhbLsbRgbLgLsbLgbLsbsbsbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bLobRobLcbRcbLhbRebRebRebLcbRibLebLibRsbRobLebLjbRobLibLobLobLebRgbLib
RcbRcbRobLobLhbRibLobRobRobRibLobRibLobRjbLobRcbLgbLebLcbLgbLgbLsbLebL
cbRebRobRebLebLobLibLhbRobLobLebLobLibRibLibRobRebLobLebLebRgbRobRobLe
bLcbRcbLobLobLobRgbLgbRcbRgbLibLsbLibRebRobRcbLebRobLobRobLebRebRebRob
LibRobRcbLobLobRobLgbRebLebLcbRebRobLebLsbLobRebRobRibRobLibRebRsbRobR
obRobRebRebLobLobRgbLobLcbRgbLobRobRibLibRibLcbLobRsbLobLobRcbRcbRcbLe
bRibLobLobLsbRibLobLobRobLobRobLobLjbRobRcbRebLcbRcbLobRibLebLebLobRcb
RobLobLobLgbRcbLgbRgbLibRobRobRobRibLebRgbRcbLibLcbRebRobRobRebLobLobL
obLebRebRsbRobLsbLobLibRobLebRobLebRcbRebRhbRibLobRobRobRebLobLebLobLo
bLcbLebLobLobRebLobLebLsbLebLebRgbLcbRebRgbLcbLobLobLebRsbRobRebLebRob
LebRebRobLobRobLebLebLgbRcbLibRibRebLcbRebLcbLobRcbRobRibLsbLobRebLsbR
cbLgbRgbRebRebLcbRobLibRobRebLsbLebLobRobLcbLebLobLobRgbRebLobRobRibLs
bLobRibRobLobRsbLobRhbRebRcbLcbRebRobRibLhbLobLobLebLobLgbRobLebLcbRsb
LgbLebLcbLgbRcbRobRcbRebRobRgbLobLebLobRobLobRebRcbLebLobRobRebLobRebR
ebLibRsbRgbLobLebRhbLhbLhbRcbRibLcbLcbRebLobLcbRobRcbRobLebRobRebLebRc
bLcbRhbLobRobLcbRcbRhbLcbRobRobRebRgbRcbLgbRibRcbLebRcbLgbRobRsbLcbLeb
LibRobLcbLobRebLobLobRibLobRobLebLobRibLobRcbLebLcbLobRcbLobLobRhbRebR
ebRcbLebRcbRobLcbLibLobRebRibLsbLobLebLcbRibLobLobLobLsbLebRebLobRobRo
bLhbRcbLcbRobRebLobLobLobRobLcbLcbRobRsbRcbLibLebLebLobRgbRobLobLebLob
RcbRhbLobRebLebLcbLcbRebRobRsbRobLcbLcbLgbRobRibRcbLcbLgbRebLebRobLobL
cbRobRobRhbRobRobRsbLobLcbRebRibRebLebLcbRobRibRcbLibLsbRebLcbLobRcbRe
bLobLcbRebLgbRebRobRebRhbRobLgbRcbRebLjbRibLgbLcbLebRebLobRebLcbRebLeb
LobLobLsbLobRobRebLebLobRgbLibRobRebLsbLebRebRebRobRobLgbLcbLcbRhbRebL
ebLebLebLsbRjbLobRebLobRobLebRibRebLebRhbRebRsbLebRsbLibLebLobLcbLobRi
bRobLsbRjbRobLobRgbLcbRebRibLobRebRobRebLibRobLebRobLobLobLobRebLcbLcb
RcbLobRebRsbRobRcbLobRobLobRobRobLcbLcbLobRebRobLobRebLobLibLobRobLibR
gbRcbRebRobLebRcbRebRgbRibLebLobLobLobLebRcbLebRcbRobLebRobLgbRebRibRe
bLobLebRobRcbLebRibRebLebLobLebRobRcbLobLebLcbLebRobRobLobLebRobLebLob
RebLebRobLobLobLebLobLobRcbLjbRobRsbLobLobLobRebRhbLobRebRcbRcbLcbLgbR
sbRobLhbLcbRobRebLebRcbLgbLhbLobRgbRcbLsbLebLibRobRibLobRibRibLobRibRi
bLobRobRcbLcbRibLibLebLcbLhbLobLebLcbRebRcbRsbLobLobLebRsbRobLcbLibRob
LobRgbLcbRobRobRcbLebLcbRebRibRibRcbLebRibLobRobRobLobRebRcbRcbRebRobR
obRgbRebLibLobRobLobLcbRebLcbLobRobRhbLobRobRobLibLgbLobRobLobLebRibRo
bLsbLcbLobLobRobLgbRobRobRcbRobRobRebRcbLobLebLobLebLgbLhbRobRobRibLib
LcbLibRobRebLobRobLebLsbRcbLcbRobLebLebRcbLobLebRebRgbLhbRcbRobRcbRibR
ibRibRebRcbRobLebLobRebLobRgbRobRgbRobRsbRobRobRobRebLebRebLebLebRebLe
bRcbLcbRcbRcbLebRobRobRobLobLobLobRobRibRibLsbLcbLgbLebLobRobRgbRobLob
LebRgbLsbRobRebRebRebLgbRobRobLibRsbRobLgbRebRobLebRjbRebRibRobLebRebL
obLibRobRibRhbRibRobLobLcbLcbRcbLebLobLhbRobLsbLebLobRcbLebLcbLebLibRo
bLhbRgbRebRsbRgbRcbRobLobLjbRebLobRcbLgbRebLsbLobLjbLsbRcbLgbLebLebRcb
RobRibRobLsbLhbLgbRgbRobLibRebRsbLobRobRobLhbRobRcbLibLobLobRsbLobLobR
obLobLobLob

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 25; Drug: Control
bLjbRobRobRsbRgbsbLobLsbRibLjbRhLsbsbsbLiRsbRsbRsbRsbLeRsbRsbLsRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 26; Drug: Control
bsbLcbLobLobRhbRgbLcbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 27; Drug: Control
bRiRjbRobLcbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 28; Drug: Control
bLgRsbLgbLsLsLsmmbLgbLsbLsbLsbLsbLsbLgbLhbRsbLsbLsbLcbLgbLgbLgbLsbLsbL
sbLibLsbLoRsbLsbLgbLgbLsLsmbLgbLoRsbRiRsmbRsbLsbLibRebLsLsmbLgbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 29; Drug: Control
bLsbLsbRsbsbRebLjbLcbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 30; Drug: Control
bLgbRgbRsbRibLoLsmbLsRsbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bRgbsbRibsbLebRobLcbLeb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bLibRiLsbRgbLcbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRgbRsbLebRsbLjbRoLsbLobLcbLcbLob

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bRcbLibLgbRebRebLhbLibLibLibLgbRibLsbLjbLcbLgbLsbRsbRcbRobLhbLcbRebLcb
LcbRcbsbLibRcbLcbLcbsbLhb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bRcRsmbRibLsbRsbRsbRsbRjbLjbRsbLsbLsRsbRgRsmbLgbRsbLsbLsLsmbsbLsRsbLsb
sbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRsbsbRcbLcbLsbLibRgbLobLcbLobLobLcRsbLgbRibLibLsbLhbLcbLibLibLibRgb
RsbRibLsbLsLsmbLobLiRsbRjbLhbRsbLoRsbRsbLibLibLibLgbLgbLgbsbLibLsRsbLc
bLibLgbLjbLibLgbLsLsmbLibLgbLgRsbRiLsbLibRibLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbLcbRiRsmbLsbLobsbRcbsbLsbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bLobsbLgbLgbLsLsmbRsbLgbRsLsbLsbLibRobLibLsbLgbsbsbLibLgbRsRsmbLsbLibL
sbRsRsmbLsbLcbLcbLjbRsbRsbRsbRgLsbLiRsRsmbRcbRhLsbRgbLsbLsbRobRgbRibRs
RsmbRibRgbRsbRgbsbRgbRgbRibRgbRsbRsbRobRsbRsRsmbRgbRibRgbRgbLibRcbRgbR
sbRibRgbLgbsbRsbRcLsbRcRsRsmmbRibRgbRibRiLsbRibLibLhbLsbLhbRcbRsbRhLsb
RsLsbRsbLsbRibLcbLibLobRsbRibLsbLhbRsbLibRjbLibRsbLsLsmbLgbRsLsbLgbLsb
LsbLsLsmbLgbLsbLsbLsbLgLsbRsbRsLsbLgbLgbLgbLsbLsbLsLsmbLgbRsRsmbLibRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bsbLsbsbsbLsbsbsbRcRsmbRgbLsbLgbLgbLsbLsLgLsbLsbLibLiLsbLgbLibLsbLibsb
LsbLoRsbRsbRgbRibRgbRsbLebLibLsbLcbLsbLhbLibLiLsbLsbLcbLsbLsLsmbLhbsbR
ibRjRsmbLibLsbLibLibLsbLsbLsbLgbLsbLgbLsbRobLsbLgbLsbRibLsbLgLgbLhbLsb
LgbLsLsmbLgbLgbLgbLsbRgbLcbLhbRgbRsbLgbLibLsbLsbLhbLsbRsbLibRgbLsLgbLg
bRsRsmbLibLibRgbLgbLgbLsbLsbLgbLgbRgbLibLsbLsbLobRsRsmbRsbLebRibRoRsmb
sbLsbLsbLibLiLsbRgbRsbLhbLgbsbRjbLhbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbLhbLeLsbLiLsRsbRjbLcbRsbLgbLcbLibRcbRobRcbReRsmbRiLsbLjLsmbLgRsbLc
bLobLobRsbLsLsmbLcLsmbRsbLsbRibRcLsbRsbLsbRcbRcLsbRsbRibLjLsLsmmbLjbRc
bsbRib

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bRgRsmbLsbLobRgLsbLcbLgbLcbLsbRgbRibRobLgbRobRgbLgbRobRsRsmbLgbRcbLgLs
bRobRsbRsbLgbRsbLhLsbRsbLsLgbLibLsRsbLgLsbLcLsmbLgbRibRsbLobLcbLiLsbLs
bLgbRcbRob

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbsbRsbRhbLjbRhRsmbLgRsbRoLsbRsbRibLibsbsbsbsbRsLsRsbRsbLsbsbLibLsbL
gbLsbLgLsbLgbRcbRhbRsbLcbLcbRjbLcbLibLsbLgbRibLibRcLsbLsbRsbLibLibRobL
jRsbLcbRcbRhbLcbsbsbLibRcRsmbRobRhbLgRsbLibRgbRibsbRibLjbRcbLgbRcbLjbL
gbLsLsmbRibRgbsbRgbRibRsbRiRsmbRsbRgbLsbRsbRsbRsbRgRsmbRgbLsbRgbRsRiRs
mbRiRsmbRhbRgbRibRgbRsLsbLgbLcbLcbRibLsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bRibRgbRgRsmbRsbRibRsRsmbRsLsbRibLsbRibRgbRsbRibRsbRobLsbLsbRgRsmbRgRs
mbRsRgbRgRsRimbLsbRibRgbRgRsmbRsbRsbRgbRsbRiRsmbLsbRgRsRsmmbRgbRiRsmbR
sbsbLsbRgbRsbRsbReRsLsmbRsRsmbRgRsmbRebRgbRsbRgbRgbRgbRgbRgbRsbRiRsmbL
sbRsbReRsmbLsRiRgRsmbLcbLgbsbLebLsbLgbRsbRsRsmbRibRgbRgbRsLsbRiRsRsmmb
RgbRibRsRgRsRsmmbRgbRgbRgRsmbRgRsmbRgbRgRsmbRgbRgbRgbRsbRebLsbRgbRgbRj
bRsbRsbRsLsbLsRsbLebLibRibRgRsmbRsRgRgRsmbRibRsbRgbRgRsRsmmbRsbRibLsbL
sbRsLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bRsbRgbLsbRibLgRsbRcbRiRsmbRgbLsbLgbLgbRgbLsLgLsbRjbRhbLgbLgbLibRjbLib
RhbLjbLsbLobLiRsbRgbRsLsbLsLibLsbLibRgRsmbLgbLsbLibLgbLgbLgbLcbsbLhbRs
bsbsbsbLibsbsbsbLjbLsLsRsmbLsRsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbR
sbRgbLcbLobLibRibRobsbsbRgLsbRsbRibLsbRiLsbRoLsbRsLsbLsbRibLsbRgRsmbRg
bRsbRibLsbRoLsbLgLsbLsRgbRiLsbRgbRhLsbLsbLsbRobLgbLhbLhbLsbLgbLsbLibLs
bLgRsbLgLsbLsbLgbRsLsbLgbLgbLgbLgbLibRgbLgbLiLsRsbRsbLibLibRsbLgbLsRsb
LgbLgbLibLgbLgbLgbLsRsbLgbLsbLgLgbLibRgbRsbRcbRgbRiLsbsbLsbLsbRcbLsbLs
bRgbLsbRibLsbsbsbRsbRiRsmbLgbRgbRgbLsbRobRiRsmbsbRgbLsbLjbLgbRcLsbRiRs
mbLgbRibLsRsbsbRibLgbRhLsbLsbRibLgbRhbRsbRhbLgbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bRiRsRsmmbRsRsRsmmbRgbLsbRsRsmbRsRsmbsbRgbLgbLgRsbsbLebRcbLsbRgRsmbLsR
sbRibRebRebLiLsbRcbRibRobRsLsbLgbRcbLgbRcbLgLsbRibRgRsmbLsRsbRobRiLsbR
cRsRsmmbsbRiLsbLibLebLhbLibRibRgbRoLsbLgbRcRsmbLgRsbRoRsmbLgLsLsmbRibR
gLsRsbRsRgbRsLsbsbRgbRcbRcbRebRibRsbRsbRoLsbLibRoLsbRcLsbsbLebRoRsmbLi
bLsbLibRcbLibRibLsbLjbLcbRhRsLsmbRiRsLsmbRhbLjbLcbRjbLibRsbRjbLibsbLeL
sLsLsmmbRsbRsbRsbRsLsLsmbLjbLsbRsLsbLibRgbLsbLsRsbLsRsbRsLsbLsbRsbRgbL
hLsLsmbsbRjLsbLibLsbLgLsbLsRsbLsRsbRgbLsRsbLsbRgbRsbLsbReLsbLibLgbLgbR
sbLibLgLsbLgbLsLsmbLhbLgbLgbLsbRobRcLsbsbLibRibLsbRsbsbRiRsmbRgbRsbLsb
RgbLsRsbLsbsbsbRsRgbLsRsbRsbRsLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bRsRsmbLsbRoLsLsmbRsbsbLobLibLgbLsbLiLsbsbLsRsbsbLsbLsbRiRsRsmmbsbRiLs
RsbRgRsRsRsmmmbLgbsbLjbLebRiRsmbsbLsRsbRcbRebRibRgbLjbRgRsmbLgbRgbLsRg
RsmbLsLsRsmbsbRibRsbRgbRgRsmbRsbRgbRiRebLsbLsbRgbsbRcbRebRgbRhbLsbRgbL
hRsbRibLhbLgbLsbLsLsmbLsbLgLsRsbRsbLiLsbRsbRjbsbRsbLgbLsbRsLsbLjbRibLs
bRgbRibRsbRgbRsbRgRsmbRsbRjbLebLsbRgRsmbRjbRjbRibRcRsmbRebRgLsbLsLsmbL
ibRsbLsLebLhb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bRibRcbRibLgLsbRgbLsbRibLcbLgbLsbLgbRsbLsbLgbLsbLgbLgbLsbLsbLgRsbRsbRe
bLcbRcLsbRhbLibsbLsbLgbRsbLgbLgbLsLsmbRsbLgbRsbLsbLgbRsbLgbRsbRsbLgbRg
bRobRhbRebLibLgbLsbRgLsbsbRgbRjbLgLsbRsbLibLibRibRsbLibRgbLibRgbLjbRib
LgbRcbLsbLibLcbRsbLibRgbLgbLibRgbLibLgbRgbRsbLibRsbLgLsRsbLsbLgbRsbsbs
bRsRsmbLsbLgbRgbLibRsbLibRsbRgbLsbLiLsbLsLsmbRsbLgbLgbRsbLsbLgbRsLsbLi
bRgLsbLgbsbLgbRsbLibRsRsmbLibLgbLsLsmbLgbRsbLgLsbLsbRgbLibRgbLgbRgbLib
RsbLibLibRsLsbLgbRsbLibRgbLibRsbRsbLiLsbRgLsbRibRibLjbRibRibLsRsbLjbRi
bRsbLjbRjbRiRsmbRgbLsbLsbRibRsbRsbRsbRibRgbLsbRibLcbLebRgbLibLiRsbRsbL
gbLgbLgbLgLsLsmbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 171050; End: 171550;
Recording: 12-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bRhRsmbRsRgbLgbRhbRibLgbRgbRiRsmbLsLsmbsbLsbsbsbLsbRsRsmbLsbsbLsbRsbRs
bRgbRsbRgRsmbLhbLiLsbRgbRibLiLsbLibLibRsbLiLsbLsLsmbLiLgLsbLgLsbLibLgb
LgbLiLsbLiLsbLsLgbLibsbLsbLiLibLiLsbLgLsbsbRsLsbLobRjLiRsbsbLsbLsbRsbR
sRsLsmbRsRsmbsbsbRsbReRsmbRgRsRsmmbRgbRgbRsbRibRgbRsbRgbLsbLsLsmbRibRo
bRgLsbRgbRjbRsbRibsbsbLgLsbLibRsbLsbLgbLgbLgbLsLgbLgLsbLgbLibLgRsbLsbL
ibLgLsbLibLgbRgbReLsbRcLsbLgbLibRibRgbRsbLhbLiLsbRsbLgbLsLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 1; Drug: Control
bLsbLgRsLsbRibLsLsmbLsbLsRsbsbsbRsbRcbLiLgbLsLsmbLhbRsRsmbRsLsLsLsmmbR
sbLsbRibLgLsLsmbLsbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 2; Drug: Control
b

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 3; Drug: Control
bRobLibsbsbLjRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 4; Drug: Control
b

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 5; Drug: Control
bLibLsLsmbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 6; Drug: Control
bRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 7; Drug: Cariprazine 1 然 Apo 0.5 然
bRgbLebRcbsbLsbLsbRjbRcRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 8; Drug: Cariprazine 1 然 Apo 0.5 然
bLibLcbLhLsbRsbRsbRsRsmbRsbRsbLiLsbRsbsbRsbLiLsbLobLsbRgbRsRibLobRcbLe
LsbRjRsmbsbRcbLobLibsbLcbLibsbLibLibLgbLgbsbLcLsmbLibLibsbLgbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 9; Drug: Cariprazine 1 然 Apo 0.5 然
bRebRgbLoLsmbRsbRsbRibLgbLcbRsbRsRsmbRhbLsbRobRjbRiLsbLhbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 10; Drug: Cariprazine 1 然 Apo 0.5 然
bLsbRsRsmbRjbRcbRibLcbLhbLhbRcbLcLsLsmmbLsbsbRsLsbLobLibLcbLcbsbLsbsbR
jRsmbRsLsbsbsbRiRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 11; Drug: Cariprazine 1 然 Apo 0.5 然
bRhLsbLhLsbRiLsbRcbLhRsbLcbLjbRgbLsbRhbLsLsmbRcbRiLsbRgbRsbRjLsbLsbsbL
cbRjbRgbLsLobLsbRgLsbRebLibRjbLsbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 12; Drug: Cariprazine 1 然 Apo 0.5 然
bsbLcbsbRsbRhRsmbRcbLoRsbLoRsbLcLsmbRcbLobLibLhLsRsbLsbLobLcbLcbLibRob
RcbLcbLcbRcbRcbRobRibLibRsRsmbLcbRcbLcbRcbRsLjLsLsmmbLcbLobRcbRcRsmbRc
bsbRhbLcbRcbsbRhbRiLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 13; Drug: Cariprazine 3 然 Apo 0.5 然
bsbLsbRsLsbRgbLjbRibsbRcbRibLsbRcbRgbRcbRcRsmbLhLsbRcbRcbLiLsbRhbLgbsb
RhbsbLgbRsbRsRcbsbRsbRgbRgLsbRsbLibLibRibRcbRsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 14; Drug: Cariprazine 3 然 Apo 0.5 然
bLhLsbLobRgLsRsRsRsmmbRsbRsbRgbLcRsbRgbRcbRhbRiRsmbRsbRibRsLibLcbRjbRi
bRibRsbRcRsmbLibsbRibLibLcbLcbsbRibRsbLiLsbRsbRibLjbLhLsbLsbLibRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 15; Drug: Cariprazine 3 然 Apo 0.5 然
bRcbLjLsmbLgLsbRsbLsbLsLsmbLiLsbRibRsbRcRsmbRcbRsbRcbRhbLsbRibRsbRebLi
bRjbsbsbsbLsbRsRsmbLsbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 16; Drug: Cariprazine 3 然 Apo 0.5 然
bLjbLsbLsRcbRsbLiLsbLcbLgbLibLsLgbLhLsbLibLibLobLhRsbsbLgbLibLsbLibLsb
LsbLsbLsLsLsLsmmmbLgbLsbLgLsbLgbLobLsbLsLgbRsbRiRsRsmmbLoLsmbLibRsbLib
RsbLibLsLsmbLibLiLsbLhbLibLib

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 17; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbRebReRebLjbsbLgbRgbLibLgRsbLsbLgbLgbLjbRcbLsbLjbLcRsbLgbsbLibLcbLc
LsmbLcbLibRsbRhbLgbLibRobReRsmbRobRcbLjbLcLsmbsbsbLsbRcbLibRgbLsbLgbLg
bLgbRobLgbsbRibsbRsRsmbLsRgbLgLsbLgbLsLsmbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 18; Drug: Cariprazine 3 然 Apo 0.5 然
bRgbRsbLgbLsbLgLsbLgbRobRgbLcbLsbLsbLsbLgLsbLcbLhbLcbLsbLibRsbLsLsLsmm
bsbRsbLjbLcRsbLibsbLcbRsbRjbRgbsbRgbLsLsmbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 19; Drug: Cariprazine 10 然 Apo 0.5 然
bLgLsbLsRsbLsLsmbRsLsLsmbsbRgLsbRjbRsLsbLsbRsbRsbLsbLsbsbsbsbLsbRsbsbR
sLsbsbsbsbRgbRsbRgRsmbRsbLgbRsRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 20; Drug: Cariprazine 10 然 Apo 0.5 然
bLcbLibLibLsbLgLsbLsbLibRsbRgLsbRjbRibRibLsLsmbRgbRsbLsLsmbLjbRibRibRs
bRsbRsbRsbRsRsmbRgbLsRsbLgLsbLcbRhbsbLcbLibLsbLgbLsLsmbsbLgbLsbLgLsbLs
bRgbLsLsmbLgbRsRsmbLsLsmbLgLsbLsbLgbLgLsbLgbLsbLsbLgLsbLgLsbLgbLsbLgLs
bLsLsRsmbLiRsbLsLsmbLibLsLsmbLgLsbLgbLgLsbLsLsmbLgbLsbLibLgbRsbsbRgbLi
bRjbLsbsbRibLcbLibRsbLgbLgbLsbLsbLibLsbLgbLgbLgbLgbLsbLsbRsbLgbLibLsbL
gLsbLgbLgbLgbLgbLgbLsbLgLsbLsbLgbRsRsmbLiLsbLsLsmbLgbLsLsmbLsbLgbLsbLg
bLgbLgbLgbRsLsbLgbLsbLgLsbRsbLiLsbLsbLsbLgLsbLgbLgbLgLsbLsbLsbLgLsbLsb
LgbRgbLgbsbLsbLgLsbRsLsbLgbLgbRsbLsbLsbLgbLgbLsbRsbsbLibsbRsRsLsmbLsbL
gbsbRsbLgLsbLsbsbLsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 21; Drug: Cariprazine 10 然 Apo 0.5 然
bLebRjbRebRhbLgLsbLhbRhbRibLsLsmbLjbsbsbRsbsbLsbRebRibRgbsbRsbRsRsRsmm
bRgbRsbsbRsbLsRgbRgRsmbRgbRiRsLsmbRgbRgbRsbLsbLsbRgbRibLgbRsbsbRibRgbR
iRsmbRsRsmbRsbRiRsmbLgbLsbsbLebRjbRhRsmbRsRsmbRsbRsbRsbRibLjbLjbRebRsR
ibRibLsbRsbRsbRsRsmbRiRsmbRsbRsbLsRsbRibRgbRiRsRsRsmmmbRsRsmbLsRgbRsbR
hbRiRsmbLsbRsbRsRgbRgbRgRsRgmbRsbRsRsRsRsmmmbRibRsRsRsmmbRgRsmbRgbLsbL
cbLgbRsbLgbLibRjbRebRgRsmbRsbLsRsbRiRsmbRgRsmbRgbRgbRgbRsRsRsmmbLsbLsb
RsRsmbRibRsRsmbRsbRsRsmbRgRsmbRsbRgbRjbRgbLsLsmbLgbLibLibLebLsbLiLsbRg
bLcbRsbLsbRsbLsbLibLgLsbsbLgRsbLsbsbRsbLgbRsbLsbRsRsmbLsbLebLsRsbRsbLi
LsbRsbRsbsbRcbRsRsRsRsmmmbRsRsLsmbLsbRsbLibRsbRsbRsbLsRgbRgbRgRsmbRgbR
gbRibLsRsbRgbRgbLgbRibRsbLibRsbRebRsbLsLsmbRiRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 22; Drug: Cariprazine 10 然 Apo 0.5 然
bLcLsmbRsbRsbLibRsbRiRsmbLgbLsbLsbRibRibLsbLgbLibReRsmbLhbLibRsLsbRibR
sLsbRsbLjLsmbLhLsbLsLibRcbLibLgbRgRsmbRgbLibRcbRsbReRsmbRibRcbLibLcbLc
bLgbLgbRjRsRsmmbLibLjLsmbRcbsbLibLhLsbLsbLcbLhRsbLibLsbRsbsbRsbLgbLgbR
hbRsbLhbRibRibLsbLcbsbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 23; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbRsbLgbLibLsbLiLsbRsbRgbRgbRsbRgLsbRsLsbRcRgRsmbLsbRsbRgbRgbLgbRcRs
mbRsbLsbsbRsbRsbsbsbRsbsbsbRsbLsbsbsbLsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 24; Drug: Cariprazine 10 然 Apo 0.5 然
bLsbLsLsmbLgLsbLibLiLsbLgRsbRsbLcbLgbRsLsbLgLsbLgbLsLsmbLhRsbRsRsmbRsb
RibLjLsmbLgbLibLibLsbLgbLsbLsbLsbLeLsbLibLsbLgbLsbLiLsbLsbsbsbsbsbsbsb
LgbLsbLsbLsbRebLobLgbLgbLcRsbLibLsLgbLsbLgbLsLsmbLgLsbLibRgbRebLcbRebR
ibRgbLsRsbsbRsbRiRsmbRsbRibLibLgbsbRsRsmbLgbLsbLsbLgLsbLsbLibRibLsbRsb
LobLsbRgbRsbLsbLsbLsbRsLsbRsRsmbsbRsbsbsbsbsbLsbsbsbsbRsRgbRsbRsbRsbLs
bLsbRsRsmbsbsbLsbLsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 25; Drug: Control
bRobLjbLsRsbLcbsbsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 26; Drug: Control
bRjbRcbLsbRsbLsbsbsbLsbLsbLsbRsbLsbRjLsbLobRhbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 27; Drug: Control
bLgbLgbRiRsmbRobsbRoRsmbsbRobLsbLgbLgbRibLgbLsbRsLsbRsRsmbLjLsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 28; Drug: Control
bLoRsbRobLibLsbLgbLcbRgRsmbsbLsLsmbRgbRsbsbLsbRgbLsbLsbLsbLibLsbLsbLgb
LibLgbLsbLsbRsbLsbLgbLsbLibLib

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 29; Drug: Control
bsbsbRsLsbRsbLsbRsbRsLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 30; Drug: Control
bRobsbsbsbsbsbsbRobLcbLjb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 31; Drug: Cariprazine 1 然 Apo 0.5 然
bRoLsbLjbRsbLgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 32; Drug: Cariprazine 1 然 Apo 0.5 然
bsbsbLibsbLiLsbRsbsbLsbRobsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 33; Drug: Cariprazine 1 然 Apo 0.5 然
bLsbLsbLsbLjbLebLsbLsbLjbRgbLiLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 34; Drug: Cariprazine 1 然 Apo 0.5 然
bLibRibRibLhbRibLcbRhbRjRsRsmmbsbRsbRgbLhbLjRsbLcbRjbRsbRibLibRcbRgbLg
bLibRcbLcLsRsmbLsbLib

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 35; Drug: Cariprazine 1 然 Apo 0.5 然
bRsbRsbRjRsmb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 36; Drug: Cariprazine 1 然 Apo 0.5 然
bsbRobsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 37; Drug: Cariprazine 3 然 Apo 0.5 然
bRobLgbRsbRcbLibRgRsmbRjbRcRsmbRgbRgbRibLsbRgbRgbRiRsmbLgLsbLsbLsbRsbL
ibRsbRsLsbLsLsmbRobRcbLcbRibRib

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 38; Drug: Cariprazine 3 然 Apo 0.5 然
bRibRgbsbLgbRcbsbLsbRsbRiRsLsmbLsbRibRgbLgbRcbRsbLsbLsbRgbRgbLjbRjbRhb
RiLsbLsbLsRsbRiRsmbRibLibRibRibRsbRsbRibRsbRsbRgbLjbRsbRhbLsbLjbRcbLsL
sLsmmbRcbLsbRcbLgbRcbLibRsbRhbsbRibLcbLgbLhbLibLgbLsLsmbLsbLgbRiLsbRib
LgbRgbLjbLhbLibRsbLgbLsbLgbsbLsRsbLsbLgLsbRsRsmbLgbLsbLgbLsLsmbLsLsmbL
gbRsbLgbLgbLgbRgLsbLgbLsLsmbLsbLgbLsbLsbLgbRsbLgbRsbLsbLsbLgLsbLgbRsbL
gbLgbRsbLgbRgbLgLsbRsLsbLibLsbLoRsbRsRsmbLhbRcbRsRsmbRcLsbRibRsbRgbLsb
RgRsmbRcbRsbRgbLsLsmbLsbRcb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 39; Drug: Cariprazine 3 然 Apo 0.5 然
bsbLsbsbRsbLsRsbsbsbRsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 40; Drug: Cariprazine 3 然 Apo 0.5 然
bLsbRsbRsRsmbRjRsmbLcbsbLibLcbLobsbLgbRjbLcbRsbLsbRsbLsbRsLsbLcbLsbLcL
smbRjRsmbLiLsbLgLsbLibRcRsmbRcbLsLsmbRcbRcbLcbRsRsRsmmbRhbRhbRcbRibRhb
ReRsmbRcbsbLhLsbLsbLgRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 41; Drug: Cariprazine 3 然 Apo 0.5 然
bLgbLibRgbRjbRsRhbLcLsmbLgbRsbLsbLsbLgLsbLsLsmbRsLsRsbLgbRsbLsbLsbLcbR
sbLsbLsLsmbRgbLoLsmbRsbLcRsbRsbLsbLgbLsbRgbLibRjbRsbRibRsLsRsbRgb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 42; Drug: Cariprazine 3 然 Apo 0.5 然
bRjRsmbLcLsmbRgbRjbRibsbsbLjbRibRsbRibRsbLsRiLsRsLsLsmbRsbRsbRsbRhbRsR
sRsmmbRibLsRsRsmbRibLsbLjbRgbLcbRgbLgbLiRsbRsRsmbLgbLsLsRsLsmbsbLibLcL
smbLsbLjLsLsmmbRhRsmbLsbLcbRsRsmbLhbsbRsbRgbLgbRsbsbLibRsbsbsbsbsbRsbs
bsbsbLgbLsbRsbLsLsmbsbsbLsbLgLsbRsLsbLgLsbLsbRjbRcRsmbRoLsbRgRsmbLsRsb
RgbRgbRgbRgbRsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 43; Drug: Cariprazine 10 然 Apo 0.5 然
bRibRibLsRsbRsbRibRsbRsbRibRgbRsbRiRgRsmbRjbRsbRibRiRsmbRsbRgbRibRsbRs
RsmbRgbRgbLsbRibRsRsLsmbLebRgLsbRiRsmbsbRgbLebLgbLgbRgbRgRsLsmbLsbLsbL
sRsLsbLsbLebLcbLebRgbLjbLobRcLsRsbRsbRsbRsbRsbRgbRsbRiLsbLsRsbLsbLsRjb
LhbLcbLsRsbRhbRsLsbLibLgLsbLsbLgLsbLgbLgbLgbLgbLibLgLgbLsbLsLsmbLgbLgb
LgbLgbLsLsmbLiLsbRjbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 44; Drug: Cariprazine 10 然 Apo 0.5 然
bRibRgRsmbRgbRsbLsbRiLsbLibLcRsbLgLsbLgbLsbLgbLgbLsbLibRsRsmbLhbsbRgbR
gbLgbLibRjbRsLobsbLsbLgbLsbRcbRgbRgLsbLgbRibLsbRiLsRsbLgbRgbRgbLsbRgRs
RsmmbRsbLgbRibLsbRgRsmbRsbRibLgRsbLjLsmbLibLsLsmbLibLgbRsbLibRcRsmbRgR
smbRibRgRsmbLsRsbRsbLcbRcbLgbLcRsLsbLgbLgLsbLibRsbLgbLgbRgRsmbLgbLgLsb
RgbLhRsbRgbLgbLiLsbRgbLobLibLibLgRsLsbLsbLiRsbRcbRibRsbRsbRgbRsbRibLcR
sbLhbLibLsbRsbLgbRsbLibLibLgbRgbLibLibRgRsmbRgbRsbLibRgRsLsmbLgbLiLsbR
sbLcbLgbRgRsmbLsbLgbLgLsbLgbRsbLhbRibRjbRibRgbLgbRsbLgbsbRibRgbLsbRgbL
sbRibLgbRibRibsbLgbLsRsbRhLsbLgbRcbLgbLgbRcbsbRibLgbRgbRibLsbRgbRgRsmb
LsbRgbsbRgbsbsbsbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 45; Drug: Cariprazine 10 然 Apo 0.5 然
bRgbRgbLsRsbRgbRsRsmbsbLsbRhRsmbLsbRgLsbRsbLsbRsbLsbLsbRsbRsRsmbRobRsb
RsbRsbRgbRhRsmbRgbLcbRibRibLgLsbRibRsbRsbRgbRiLsRsbRsbLsRsbRibLsbRgLsb
RsRsRsRsmmmbRsbRgLsRsbRiRsmbLhbLibLcbRgbRiRsmbRcbRibLsLsmbRhbLgbRoLsbL
jbRobLjbRcbRsbRibLsLsmbRhbRsRsmbRibRibLgLsbRsbLhbLobLiLsbRgLsbRibRsLsb
RibLsLsmbLsLobRsbRhRsmbLcbLhLsbLsbRgbRhbRoLsbRcLsbRgbRhbsbRibRsbLjbLcb
RjbsbsbLebsbRgbRjb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 46; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbLoRsbLibLgRsbLibLgbLibRgRsmbLibLsLsmbRebRebRoLsbRsbRobLgbRsbRobRoL
sLsmbLsbRsbRhLsLsmbRsRsRsmmbRgbRibRhbsbLgLsbRibLcbLsbLjbLiLsbLgbRsbLob
RibRibRibLsbRsRjbRsRsmbRgbRgbRiRsmbLsRgbRsbRsRsmbRgbLsbRiRgbRibRebRgbs
bRgbRsRsmbRsbRjbRiRsmbRgRsmbLsbRgbsbRsbLsRsbRibLsRsbRibRsRsmbRsbRsbRgb
LebLiRsbRebRjbRebRsbLgLsbLsbsbLsbLgLsbLsbRsLsbLgLsbLgbLgLsbLgbLsbRsRsm
bLhRsRsmbRsLsbLibLsbLgbLgbLsbLgbLibLibsbRsbLibRsbLsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 47; Drug: Cariprazine 10 然 Apo 0.5 然
bLgbsbRibLsbRgbRibLsbRgbRgRsmbRgbLsbRgbRibRsLsbRgbRgbRsbLsbsbsbRiRsmbL
sbLsbsbRibRgbLsbRiRsLsmbLsbRsbRgbRsbRgbRgbRsbLgbRiLsbRibRsbLsbLsbRgbRs
RgbsbLsLsmbRgbLsbLhbLoRsbLgbRgbLibLibLsbLgbLsbLiRsbRgRsmbLibLsbLgbLsbL
gLsbRsLsbLgbLsbLgbRobLsLjbLibLsbLgbLsbLsLsmbLgbLsbLgbRsbLibRsbsbLiLsbs
bLgbRsLsbRgbLiLsbRsbLgbLsbLiLsbRgbRcbRibLjbLsbLsbsbsbRsbRgbLsbRhLsbLgb
RsbRsbRgbRgbLjbRibLsbLsbRibRsbRsbRibRgbRobRibLibRsbRsbLiLsbLsLsmbRsbLg
bRgbsbLiLsbRsLsbLgbRsbRcbRgbRgbLsRsLsbRsbRgbRgbRgLsbRgbLsbLobLgbRgbLgb
LgbRjbRsRsmbLgbRsbRsbsbLibLsLsmbRsbRsbLibRsbRsbRsLsRsRsRsRsmmmbLsbRsbL
gbLsbRebRcbLibRibRgbRgbLsbRobRgbRsbRhRsmbRsbLibLibLgbRsbLgbRsbLgbRsbLg
bRgbsb

>ZF Recording 2016-08-23; tW: 300s; Start: 171553; End: 172053;
Recording: 13-1; Individual: 48; Drug: Cariprazine 10 然 Apo 0.5 然
bsbsbsbLsbRsbRsbLsbLsLsRsmbLibRsLsbLiRsbLibLsLsmbLsbRsRsmbsbRjLsbLibRs
bRsbLsbLiLsbLgbLsbRsbsbLibLgLsbLsLibLsbLgbLsbLgbLgbLiLsbLgLsbLiLsbLgbL
gLsbLsLsmbLibLibLibRcbRiLsbRiLsbRgbRibRsLsbRibLsRsRsmbRsRibLsbRgbRgbRg
RsmbRgbLsbLsbLcbRcRsmbRsbRjbLgbLiLsRsbLgbLsLiLsbLsbLiLsbLgbLgbLib

